var title_f23_61_24528="Sialolith constrict frenulum";
var content_f23_61_24528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50735&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Salivary gland stones: Sialolith and constricted frenulum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 316px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE8AV4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDz62vY0FvLbRfvAfnL55FSJfKuol3jWOFuSAc1jx3YYMApAB61M1wqqFZchunvXIe/Frqbq3zWurK9spa2J3EFeBVnxHq0PiK/t0hjWKVRsJ+pFc+b14lwMfiakS+tphgjbMCCCKl3sWjpzNJpAW1uEjmideGHUZ//AF10fgm88O+VcpqUhWaP5ghPX9a4cSEormTc3AAbmrCW1tMVZkInHfpzU83LqyuW+jZ7HpPizRthgsbBvOXkEggH9aik8Z6ze3ZibS0FsP4yx49O1edtrci26QQ2wS4XjzBxmri65eramNhyRyd1U6jZn7GN7vU7m81rULy3eCa0jeLH3gcgc/SuPTQHRZb5zEYs5ZQegxTLe/aHR98crmVj8yFj7VBPaTGze5FzItvOOY954/zism3c0hHl20KcTSRyM0KYUng+1WZ76S1txIjb+cbVANdHoOu2Nnon2OfTWlXBVZQM5zn2rNEcmlym7lt1+zSHciMM+9S7lqWuo2JVu7RJLmA8jIZc1WtJHk3Ku7aGxjFXtY1B9TS2ltVFsinBjHekjt5YIvMSNirck4qbNOw+hXmIjcF1YjvxUM8kQw8qYRvu4qzM8jrllG3PSmmJZIf3gGwHgelGoyg0W6b92SFI4FLJGyDoSverDqYh90kHvUZu1U/P09xSLK8kMLrwWDU1SLeRIpSBE/JbuKtED/WKuQaiu7ZblAznBI4GaTA73wX4jW6vE0qfyrmAjILEDv7fWr/jMWmlOLu5tWSBGBilAztPp9K8q0Nkg1OJQzxMh+/kjvXq1hrWm+J7F9G1GXaYQCzuOGHsfwq4y5oOL+Rz1IcklUW3Uq6z4h0i70F9QvbAJqe0iF0BKOccZb0zWb4o0m+0GztdQsjK9pMN0yx5ZVPGP5mul1fw1p0+iR3Ok3kYtbRSTGw3B8c4yTxWV4d8RyLot1Nta4sjlDFIc7cZGRntUyVnqKEtL09r7M5gX9rcQLKICt+eQw6Ef/qzTHjLM8sRIlPeq7yxm8k8pdsDuWz6ZJOKlaX9420YFZpnS1YpZZkBnG0+g71Tv2k28HYPQd60JVDgMW6Vk6rPhS3PHAFNibsR6auy4Mi/K4NWLq5aRzsPf+lVrc4j45NVmkZMtnqcV0KNtjje7ZYNy4ypAY/Xisu+cGUkE7+47VPI+7GDyOvFUJSGmLZGTWi0FZoruwFx9zOOhzXoHgecNIN6gZxjn2NcJpaZLeack11nhnMNyATg5GAPxrKo+V3Cx6rGqo+YRg9QaS5DKskuAXIwc1Dp8uYuTk1daNngY120nzw0OV6M8tv7f7Hq8hP3XwcH1qa8QXFjLtUK4GVx161f8XRA7Tgh1PPFZlhOS+F+Yheh9K5WveZ3Qk5Rubl7qe7wLp+pxE+bC4hl456E/wCFcX4/V7LUI4ruQFpY92FI3AbV7fjWnoN3II73SGAaCVzKNwztOAKwvH0NxeeIFvnICmLy1z3+VR/Stb3Hy8uhxmoHdIWRnVMADI/WqU8c1sU8u4Z1kGGBA4q1foxVgrFnU45HTBqvKm6SBS3zZzjNCJkdt4dtBaaXAiDcZByT2610GnfOrDGMelZkalfJi4G1cYFdJo1ltgJZ+Sc1EmZuxxFroYkszAR845z61oDQ45UhRlBCVdtFck9s9zWtbx+Qu4nfmizvuQnYyE8P23mhpIMj3q1c6JpckBItPLZRjcMCtyAGRQzZDGtCFABh0yD0qNtiuY4MeEVuVBsrlgxPG49D+VQ3eh6xpLfvofOi/wCei16X9mjdflTbkepo+yzbNgfcvp1pNt7lqoebRXokQKecdz6+lXLeVfLIfkk966rUfDVtOpLIUkI6DNczqWh3emr5zJuhBAyucjP4VNjRTTHpJbhgkRzI3Y0+czKhiY/L6DtWdqOnMIorm2lZnYD5V6j/ADmrkBmUYYFSPUUJtF9DY07WP7OsDBBCjluoYdOtQSale6gNlw67V5C84AqnLBFPblZJAGXkc05Tbw2yMZNrjuKLsdkaui2KajdFEkCzL2NTX2p6hbyS2CJGdvHQ88f/AF6y5LaQwC5jcj26EioYjKrtKAQyjgdc0rDsWXe6azbzF2tnqO3NOs47tLbz5IzLGOpA/WpjYG+0wXbXawMp/wBTkZPNT2mpSWNsktoc/wB5MZzUvQq5Qlu4ymPOHP8AD6Uv2e2uEBlcFfan3RW7n3yQhHfnbzSafeRM7QyRMsi8dOtIYyO3kt1ZFcGE9D6VWmQxDMucD+IGrM1hh2bfwxzj0pj2clsAQ/mRY+ZRzxU7DRSlAnUMArEdPUVvaFFZ3WlTW91BuumIVSBzjNZHk2shZ4ZWiI/gYAZq9a3boFbbsKDAb1FJNoHtoaeraJc6BafYhcg6c3zMB1q9oSW8nh9bWJsBg53DtyazjqUsztIbVp4SP3hAJwPwqndixeRxpdw0SYBdMjr6dT71akk2yNXoyCeL7O0ls0gOGJGe/P8A9amxk7D24pzgxwCWVMqOB6mo/O823Lj5R6VCtsjToQzSLHEMnFc/qt/Fg9wOB9am1O9KxkSDAPVzwAK5fUpVu1SHTZPtM5P3IBvY/gK1pR5nqY1ZWWh1GnIY7TLvukk/QVXuCFn28YXgVn2/9qaM8cWuW5tPMHyOwI3e3zAehq1MW3huPwOa35Wmcy7jZzvDAHp6U0RBLcNj5v1pk0gMkY4PPNbCxo9um4dMGn1K3M2ygKSDtXQ6Od16Mj5gRg1Qs4Cd5Jzt5rS0lCZg24ZBrmqtgj0DS5CjAfeY8fpXQJICu3BzjnFcppbksXGMr68V0OnzlSzK4Un6V14OW6OWqtTC8VW7SafPIIx5bKQD3zivN9NuCE2ODuB2MfQCvVfEUplhWGN/unc3oa8nnuiNcuIY1AY8gHvyamrpPQ3oOyLujT+R4rU9YXjxz67hWX45kH7mWSRvkY8A/SpiiSavYPdSTxwNMN3loCOnrVn4rJDFcLZWsR8naHDfRQT/ADqlsbN62PNrmY5dgTtLcfnTtNUT6oiBNxAHI+pqJQHLRFf4mOfQA5FdX4M0/ev2xwMn5VPPpQ9rEPY63T7RRKGkGTxjNdfp0UezBXGBWFpwDONw5FdNa4CZFRbW5hJnFxQDyxuGO9X4ogAMEt+FLbRfLg4JrRS2CqDxVMCJQE2jHNaUYOFDLUMcIByevarUGQT0IBpJCuTEIQOSD9Ks2g2jd1z0yKYjqEwUBHripmOEBWm0kS2yxIgmXkKKgmso5YmV1DAjGDyKngBK1bjVQuTyOnNKUUxKTR5V4q8NalaObrS2LpnlD257c1jaXJd3UrIxBm6lW+U9u1e2XVsZoSigYPtXn3ifwtNBcNe6adk4OXxwD1/+tWbg0ddOqmrMxLWZPnjkX5x1z2p0E4tZWEtuJlJ454/lVHTphLcyQ3wEdx3z3rQidUk8phuj/vGpszdEsxle5J84eWf4BjAp0mwKoVwH785qI+Up3IpNOWKMEy7Se5oY7k0tqkVuk/ns0pP+rBIH88VJHkKPLTjv7VVjkWaTBB2j1q2kjK21V+WobGjRgvbee1aG7twtyv3HXv8AkKqyypFltqdgcAZpkYcXQG3j1qJrVXu2LSH1xmgaQy7juQ4aH542689Ka0VzMzCJtrr/AHuhq9N5hjH2JlUL1BotreS7j3K4Rk5K/wB4VDKRSjsyYma5xvH93j+XWmFI5IjGspyOikYNXTKiSbG5zwF96gJja7KmLEnZqncC34b1Q6beK4iEsZTbJGx68+4p+rtDfXcssdsLdHwfk7H8hVOW3RZA6tg+1Xzh4QMDI709xWV7mfnYAu7zB0CkYFZ+oSCAEONg7Y5FaF6NseEOHPQ+lYGqySpBsmy+e9EVcG9ClbTSQazBexwrcJCwPkucrIOOOQcflXa3viTwPc/8TK40WTTvEMUbRwiNZGTkY52qEPXuK5fQYYztyhJBPWrmpJG5bKrx7VvB8uxzVI8z1OIuLa6k8q41G4kutpBAeQnaPpmrkUxnQscA9gO1Wru0Vg4VgSe2KxFkNnOqSZBJGOa3WquRYtR4E+1id2RXR27AxIq+neudMo85CQBnp71twXAUICOoFSm72KS7llcAsY24NW9JIjlyG+bPIqrMkQcFWwOtSRSRopKHJHJrCrG7Ejr7KdijHO30wc1sRCRbfdkscdK4rQL77TOy7uBnv7V6BpsTFQTypHFOnJ03oZyRy+raluDISVZOvr7VwmtSwtqFtKJFjlz82euMeleieLtLD28klugjnT59+OGI6A4rlvsug654e+3+JEhsL9HaJTbL5ZfbwM8HNUnzscF0MDV5j9klYuViRdysBk59an8T3zaj4V07UGXErZQs/GRnHce1Z0kDzWk8Dy/ugSI29RjvRrk9zqPgCGwjgLyWcwdinHy5Yn9K3Rs9TmolBk3KuWL7Tn3OK9F0+1jt7G2hQ7SAG/HFcLpdv9pubdM4BIyvuK9Ihg3BdpzxjpU7mUzV00DcCAK34WCoM8fhWTp0AjGQQfrWzERsG4DNJ9jGRlxwbSCEHvV1FON/YdqeIxuzn8KkRd3A4FaJW0JuRxx7hknipYF2BwTnnrUkcYOAOMdaWNVDYboaVh3Jj80eCB0pLYllIPY4qTaCPwojQIBt7027IhFuNCFAzUuTt2+tRx7scHmrCqojJbrSWoXLCD91/tCq11amaLI556VPAd4POKmU7FG3mrsRezueS/EPw3MsiX1tH93hgo9uv6Vg6VP9ogZCx3LwVNe6XMEdxE8coBU9civJPHXhu702V77S/wDVk5KqO1c8oWO6lW5tGVo2RI9hIU1JFfIhVQQ655HrXP2morPCQ5+cHB5rTktCsavAQWyDwc5rNvobovSXG24xAgJccj0qb7SYINrqSw71kXErQMku7a/QirsbSSQ7sqT2FJs0LdrI10iyI7K2eeKkmEKtiUFnPUiqljdMD5UiBQO4q1uYMWQK/wBfSoeoEr26Nb5ilKn170yMSKgeFsyxqcZ6t3psLCZC5Xac9KgdFW7bziyBlwrKaQ1qW9Qnhljhka2MM54LAfep0O9lG4AD1NUlj6BmZghyCTmrMsyuu3cAR70tGAup4MDkfIwHaiwlMluoLZbp9aZKRNA+7kkcCn6RC6HJB61Am7Es9ozkeYMKa5vWVMZKV2dzE7r3GB2Fcj4i+Rcty2eePrVRIvcuaVYtBE00j/Iw4FZuqXMMUwY/MGJ6VrQypJphQMTIFrl5WkM21xvUHrjpWnN0El1G+ZHu3HIYmsPWkABcNlicjP0rdvMFQVABrB1LAUSZ3EHJX8K6KZE0V7O782MI4xInU1t2lwHQIy8jiuPa4/4mmFGFbqPXitu1n3gopCuO571co2aZMHc1XnCrnHH1qCS8IVvLdkXHOO9V5JGwSxBqKRGlUY9RmpY0dd4JjMiM4UkseD+Fe4afbmO2Tj+GvLfANvv+zxhMZGScf7Ney7AAoAwMVnCHM79jmrytoc/qFtvjdsfOK8X8faElzepIMxsG3DHqetfQF1ACj7e9eZ/EDTvMtJHi/wBYvIxUzXJO72HRlfQ8yt99v59rOTGYhjP96n+HUma61iOG6dZHtJCIeOcIef1qnBetJfyLfJ8w+Un1NXvDmB44gjRwHu7d7dePul9oH866Im+25T8HR7tQBdcsmQx9/mzXoVopymAcg84+lcp4Xtmtr3Vre4OZobqRCduMgOwz+NdjpmcMD3qXozORtWaGKP5kya0IhkZbg1BakbDv61Y68jpWbdjMiGN/NWVj+XPbtTPLAUMMVLAnOTyK6upmySJNuSSCaXyxI2e44oZeaWRBlcfjSSJuOCEYBNPjGW29hUZAAxxSwKEapk9bDWxajO05NS5DetMJ4HbFNJABJ71SViSeJ8KwNW7ch4Rz2qnbHHU8VdUhgAtUJgmzGT92o7u3S4tZIpFVo3HGRUjsEQ96jDLs9Kzb6DXc+dfiPo03hXW1nt1Y2U3XkYB5/wAKZoerpPArQTuMHGDk969u8XaNBrui3NnN3Qgfl/8AXr5duLaXRr6W2dM+W+3np2Pt61mocysdsKrsejSXEbt/pfzOfu4p0FzKjhQCDXKQXqMsYUjIAIzW3p2oldzSFd3cetZzgzdTTNzz3J3ScDuRVuJftBU2sp3DtzzWE2qeePkwo6bv8moTdCFhIp3SDncKztYtM6wymDMRA31TMjFHjuGOScqaxn1RJmXzGII69KnFwlyWVvuj7vqf85oY0zVWdpIiF+4BioY43ZiSeKdYcMi5+TP9a1rhI2QeXycVnqPmsR2ceGDOflBroI4lCB1xg4qrZWhIAkPSteBF8sqOMYoSMZMimBMAwO1efeIyUEqyevH516PNGVTK1wXiNFmuSrpjPG78TT2CJm27y29r5kQ8wOuKJo5mjVVVRG5yx9KsWYFnGsb/AL2M8bvSrTxED90xkjfnHpWkVcbdjm7m3lV8HoffrWLrUQiwgY/N1/Kun1ZJ1AIwB0x+dcrqjNKg3DDA44rWOgO1jOh00XqTSxnDwjJxxn/OKW1V1hBbG4nms67lCHC5xk8irdqT8m8cleK3lrExi7SsaFuxbaCc/Wrqgm4jjB68ms+1eONp2d1+QcHNbfh9IpZElKozP0IJrCo1FXRR6v8ADa3CyQ7vmAUf+g16hOVym3jNef8AgE7RGJFUBeP/AB2u9JGDiqwrTi2+5xYn4xkoHlkHpXIeJrbfC2wA11VxJt6Vy+uyklip7VFdp6BRvc8L1qxRNRmmDksDnZVOwZrfWLS/xs8qeNtw64DDP8q6fxQitcSleGYbc1zeiQg3H2ZkwQ4J9+aqnPRM69jtnVJrtrqEArPhy+OpPJ/nWxYgRk9CRWbDDsijVWztA4HQVo2hO9gPSh9zN6mxC3mYx3rXtIAykkmsrTomfHFdVaW+1B9KlLmM5uxgAtwD0zViEkOBjIqANuxjqD0qeH74bHGDzXWZlhyCOM1GqntzQevWlRzg5GCOxpOwDXQMclsY7VPbKOGznvxUTLuB4zmp7VdkfPpWcV7w+hI75yMYNKn3AKTg80IRv4NaEEi9DVu3wqZ6nFVB0IqZW2/Ke1PoDJ5JlA5XOfem7gwwFx+NQ5y2D0pZV+XK1mwGbgX9eK8A+MOnx2GqmWMZa4YfL74UV70TyNvXFeMfHOLztQ04rkgsen/AaUfiNqfY4GBG2pIVySNpH0FXYMhfmbK9hircensLdST06gVBLE0bbQCR+VVa5snbYsW0yRgI4wntT2uQGzA2RjoQKrbSVBkVvwNKY9uCqtz+tRymibJEuJgxIVWz6gCr0N0+074wv0qpEyCLoSfSlSeWTeoXG08fTFZuNylI6fTrsMqgpgjHBNbcV0gC7lH4GuEtbmUEB+MHOfxrbsL8SnD8+/SsnGxSZ3trMu0ru/Gr8LoCNpz61ytrOWJ2nNadtcsJOeuRxUE2OkLiRCrA4x271w3iZSJCVUbQf8a7S0lWQfMBnHSua8YQbIPNHCZznH1oYo6GNbRbIlcfczgrjJrTiWA7GHyqcgijSrhbae11DyPtEUbANCuPnGetdh4x0vR7/QDr2lyi3ljA3QjgEkgYx2PNaU1e5Mp2kovqebeISm4JGfofzrzrVjglwTwCB712+qjIhctk4Bb261wmsHEIA5JOK0he9i5OyMyOAy3dvEGXMxPU4qy0c0WoTWvy74jgbTnilgTDR3GwO8HIB/z7VqeDrJ9V1ie/uEOHk4A710TfLFs51rNHb+DfC8N3ZqtxAXdiM8kV203wugNsktjM0Ey8hCSQfzNdf4T0GC1t1lVcHjiunaIY4HauanTdRNyZnVxLi7RPLtGtrrSZ/slymZAchh0P+cV2UF4zgI64PvUusWJmj3KAJ15Vu9Z8N8JoGhuY9sqfxKOtZqEqcuVMJSVRc1iS6mV1yD0rldYugHYZ49c1s3VwPL6YYdq43XZ+HAHIGaJRbZpSicp4gxcOdhAbdk/lWd4bikl1yVmUBUGRjv0pmoPI08jK2fatrwnCEtmuJDlnOP1IqoaaFy0NhQMlsYz2rS06Nz8zLwap2cBkDE9S3A/Gum0yzIQbvrWkjNuyNHTLUqAa3Y12qKq2kZCjtV5RxzWkYpI5ZSuzkUIz2GfSnO7CPaDxmo1B3ZzxUp962e5puSx/cFSMoYjcAcetQ72B5p0nIBOeKmT0F1FG7coHTPWrKnZlTzUI6DHFSdAD3PelET1JN2TjHBpAqhs4pJmyoIPFEZ6YyTVCLBA7cU+Q7VC+nFQht34U7czMQc496GwJkbGQPSmMDnhuKb5gHAHNRyHPfFZvTUaGk5Z2Jworxn4h3cN7rcMHOYWzx/wE16trd7HZ6XPNIwUKCSc14JJc/b9Sub1jw7fIc46AD+lRDubwVjUYfISpxnHFMEygspGQKoNcOUwuSq9Dmpba6VkCuQp/vVoWW5hEFHOBTGZNw2tjA9eKrywp5Tt56sV5xmsCa/mmkMe0+UpwSKnlbHtqbc0sXls8kgRs4HPFVI9VATC9uh9azEi+fL7pA3T2qdwqNiNQRnrVci2YvaPoiabV2fpGcjFWbHWSMrsBJ7GquBFHudODnOOagBQ5MIIocIsaqPc6aHVruNy0bfKPercfi17dla4jZuRlh2/WuUS6WBeWyfSrA1NZMBovcd8/pWDo9zRVG9bHpui+LLe7mVYpEAIAOSM9K6O8dL638uYjy/Qd68VhRJm3IfLbgg5xXfeHtUMkcVvcMRKo4Y9652nF2LTUivYXc+j6g8bcxqwYBujD0rf13VtM1LSonigNteK2dgwA3T3qj4psPtVss8YOU5DKM5ri3uiFx5mXU4INXHbQmW9zS1WQfZWCkfN6Vxt1lSVLHIBb9K07nUDkAtyD3NYl7MDeBEy7Srt45xnAropL3jNvXQg0mzm1O+QksE3FWA6EZx/Svo34Y+ELNLGF/L6gHOPavOvh94ZknmghRDjIZ2wfUmvovR7FNL0+GJACMAcfSs5P2s7dEYVZuMb9WW47dYBsj4UVMFOPakj+Y1YVQF4rqikkcLZnXUIZea5a8ha3nLxcKetdlMM9a57VotqORnjmsKqW5vRlrY5y98pkYjAevO9eupInmV+/Qmuy1CfapyDuFcJ4jbzg24YwM5rJO+p6FNWOVkYuxaPO5vl4FdxplusNjBER8x5P5n/GuE0eOSS/t4CclnBPFeoRQhrmMKOFAFNaE1HYs6Ra7vm5GDXV20Q45J4rNsUEY2gYz1ratxgYHTFaQV9TlnItQkkCra8VUiwhAarSHPIq07GLOMUFTknip+NwPGKqEsTz0qzu+X3rU2LLFS+0gZ65xUUeWLgnoabFJklm5PSpUKsCy4564qZC2HjoKl2gx4bjpUf8A+lSRe9CVmSOZQQAFBHrQWCOqhetLgk4U9O1NJ4O7BIq7hclb5BlRTTNwMDnvTEcgfORz0pOG6jiokCJcqRk9arzy9NtPLYRgeBVCaQeWW54zWM30LijififqhjijsUfHnfewT0wa4FIoIY0jRdykEjjvV7xZdDUvEr5yUg7f5+tU4gokKx4P1rRaKzN1poQzsF3bdu3+7io4rc3KL5alc8+lattpjTP5kq4A5xxWjdrGtgjRJhxx9KLocbnKPp0isQZHDN2B4/nViHSGs4i0ygq/c4/xrorWzSKIyu249R7VoLoy6haHUNfnFjo8HL56v6Y600x8pwcssMJ8qNGZT1bZwPoalg04SRq4bhvWvXvE48Mv8KoE03TVh+3ELbO0ah2GAQ2R7CvPTBHZxeXFxkcK3UCr2ZC95XsYclubcYkbJb7o61XmjWytSSAWJyAKs6jKFYhmG7t7VRgjkumLTtlRwoqXJJXYJXG20YmkHmRkEnpium0/wANLcne3AHPb/Gr2gaXbXAzKuGH0rs9H0+OJmG0FTgYNefXxDTsmbqCRxUvhwCMyRsQqnHHr+dRwO9tMvnkqVPDev5V6z/ZUL2/lhAM89BXM+IfDGI2kTgjkDisI1bvUpWNXwpeW11Gba9ClJBtXcPWvMvid4fm8K6z58WXtbg5B7DJ+vvV+1nmsyqTyEAn5SD0Pausu54fFujf2Vegfa1XKOR6fn6V0U2KS1PHXk84Js6sM1XsZorXWoWucFXG0ZHAO5eaTVLaXS5pbW5G2aJsKT3FD6HfaoYjborYOMd+tdkWuUza7H1H8M9MtItEiniZXdxksPqa7nzRtCdh3rxz4MzXWmaUun3oZJE7N7lq9WikO0Z7muSjUik4rc5a8HzXZpQ7eoqYNxzVKOTC1IJRxXRGp1OZxJZcEZ71jaiu6Js46VpSSZFYt/LmOTtxU1KisaU4u5554kYxTOAcKcfyrhNVnEpeMtg4967nxiwSBWH3s815xdzeddnaOcYwayg7o9OGq1LPhWzjbVRM4OI16j1yK7+wQqN2OSa5jwxB5URZ8bnrq7VsKB3q0rGFR3Zr2+Sqkdc81qwHn6VlQnEQx1zV6EnAqk7M52aUS7j89ThgvA6VBDknBqbp1rTzMzjFTJ56U9ck8/hTAx6Y5709GA6HNbu1jR3JcY6Hg06M+WpA5yaiHXNTRgMc54FQwuixGwCgn8BUy4dcngVCAGIx0qblR8vSmiRqjDZBxTWUFt1IRznNJnt1zQ2rCFIB60xnC4UDd2+lLnBqJyA7Mud3p61lJ6FJCSMphO4kewrOvXWO1mdiQoXvVyTDeprnvGd/9l01kQcuNorK1zWKPMVDS6hc3AGVetXS7B5GDkBTngevNP062C2+Bgnq1a0Ai2oxYjaOMVpzJm1iJrO5PAIx6CpItIIgInfIbt6VoRyKDGFZmkkxhQM11Vvpcen266jrZ2ADMduOS/HfH+eKWsnZDvZHMW2hQ2VmL7VpHis4zvSIjDSY9qk+yN4vlj1DVwYNAtPmSDoGK9M+vIFa66bN4onGpeIJBaadAd0UKnsO2B+NZ/iTWfOZbezt/L0yHhV6bz6n+dXHReQrts5vWtafVL57iSHyLSECK2h9FBOD+Rrj9c1UTx4hTEn9714Na+s3EDIblsiRTgIBx/nmuVkxMi+Uu0gZwe9Na6jaK8aNdXcbHLMfvZro9NsnaTy1Xjgc1j6fKlucz/Lk8kc967TSiNsMiqXWTGGFc+Im0i6avudPo1uqlANpwMkZrp7J4i6pIMN1B7cVQ03T4SyMrH610FnbomAyhueteVKV2U3oWrdUf5geBUt5axzRFCM57VKLdEwyfd9KbO5QggArihbmLd3oeQeO9J+y7WhycuNqjk5rmYNSuLW6b5ngu4VB2kYJBr1PxbGZ7dpI9omiO9cjqRXlvjQz3UGn6qkaC4dmgkRcD7owK7sO1KOvQ15ixPo1x4teS92jchwVH+fevRvhj4SNtK09wNyqeM/UVk/CS2LxtBJuErklh27V7bbWK2kO2NRg+la8rqO3RGFeryK3VmTfWUcg3QqFdehFV7PWRbkw3y7CpwG9a3ntwUOB1rB1TT1ly0i5I6ZrKpT5JKUTKnJS0kbEd0snMZBHtUwkz1Nc9ao9sAFJIJ9a3ltjJEjQOGOPmFb04XViJxURJpcgsDx0xWNqUwERycepqa8leKYpjGOorE1OYNGwLEkUpwNKcNTjPG92r/u4m6Y/lXnqy4vELfdzgmun8Tb98jL0GOfwrmNOgN1dLEMks2c0RjaNjsSsj0WwjWSJSuFUCtKFstgDvVUItvDGq9cYqzaLhhn1qzlZq25xwBWlbKUbnkGqMKbcEnritKIjOT+FOKuzKRdh3huBVjr96q0chBqZicDcK02Mji1zvPBAIxTxHtAYUxN2Pm5BqVDtOTWj7mtx4Y46CpNx3DAwPT1qJX+Q09G+Vfbip3JLKPhR1zT1d9mSKiQ/lUgOeD0HSn0JHbspjvTOh5pofJxSsRsyahu5VgLCoyMAucnmkYjio2yW5OFrPcpEMsojTceAOa4LWbiXVdSaNWwiHitvxVq/k27W9vgu/GeOlZNg0VvCpbHmtyeeTQu5tFdR9taLCjgdMd6tabam+lS0sYvNuWYA46KM9TV3TvDd9qR+13kgsdJAy8sh2nHtkY/WprvxJBbxPpHhKPZGBiW9ODu9cfeHc/lTjGy5paIu99I7mxMdL8JxLHLGt5rZA2oBnZ+ePX9Ky4/tl7cSX2qzea7cqvaMegqnpVgqM8suXkkGSzdSecn9afPKYd1uGBB96HJS91LRFKLXqJePd3oKEsscf8PqKwtaM6gQof3ZX8qs3slzDPEyfdY4PHaq9zcBnfIx0prsO1jh70FYtuMnOT7VmXhZpVSMEHIBNdHqYUSuUGcnt9aybiAnbnjnrVp2Jsa2m6bb3VssdxEG9PzrqvBpjsrt9Mu1CoeYWNc5pMshnREGeK6iKw/tK2jBO25hbINcFW7NInd2lqbRyyjMValq6sxDdD0rltJmvY7cxSH94OORx/KraahcQkho8nIya4muonFnbaNPbebJHeLxnAJqHxbZW+mwfaYJiFf+CudtNVWNZ2kAywGPzrnNe1d2ZzIQy9gccVvdez5bamKpPnvczPEmriGPax+ZuuK4/R9OvNRuldNzxrIWVM8DJ5qS9klup9uNwY8HFesfDLRhDAlzIhPtzWtOL+FGs5cq5mdF4R0GKxgS4aMLIw5FdZCSynNS7o2ACrjFSRqOtenTpciseVObm7sgKEqRis69iJHTOK2yOKpXKZNZ1YdRwlZlH7NaXcapGdkwGMViTSXGl3LqGPH61o3WYpcgcjvVO8KzLknp1qG01dbnTTVtHsVJboTN5rsNzVg6jIP3mM4qzeHy2yvTNYOq34VH6FqyUr7nZGFtjkvE0o84oucHnH4VF4Jt0mumldRhSRmsnWNQD3Mi8b+AMc9RXY+F7YWukqWGJH5wadx1HZGpOSzALzitS0iAj3Hr2qtp8Jd8noa1IkycZ4FWlc5ZMsQYZF3DpVtSNtVY22HoSMcVLG5V/u1SVjIvRk5+lWUO5apQgt3FTqXGcEVe5DRyCPgDn3pzSEjkVXDHPpzUuT1BzV7lokjfgA/hUyMRwO1VQTnr+NTxZIY9xS21AnV2HB6EVOGJi7BumCarK3GDTt2BzQ9QSJRIcYKikMg4LDj0zUDN3zx0oDY3E44HNToOxKxy5/u9qytY1SO1g271Ep7Zpbq5uJ/3GnqXlPPPQf5xXM31jZ2t8L7xBe73X7sCk4P1/Wkl2Liu5RtEv9bvNtraFxuAMjcKPfOK6a2t9I8LztJq0327USoMcMeSFP4Eiqa6/dXlo1rpkS2NsTyyjDEfUVDYaZDHcNNcEyzMOGbk09IrTU0XnoW9X1fU9fsilwPs1oRxEmF/kBVG0hjtbdFVQka9W9eavXHmKvlZwtZVxcrMn2ZDhhz+P+TWUtXdmsUkrIu3N/IyqkecjoQO1VLgzs0TIST3p+mxTEkvjjjmtQW6xMA3I7ClfuPRFKRPNHznt6d6zLpZIQ3yg+ua6GWNF4A561j6snyFlOQSOlVfUi5zkkQErkjrzmsvU4xgMvX0A9jW3dSIYiAcP6fjWNdsSqjgk1V7bj66l7Q+xJAkrtNLPlLkkZPevPEvHtJ43CZycHFdVp+rxPEAw4A/KuOrGzaYXZ2UFyMFZDlvWqs+oiMOrt8p6VgNqWJM5OO1ULrUd4ZcEkCseRFJnQT6kHiJDYA75rldY1VZcbJM4+9z9ag3X18Alqj49hV2y8BajdypticBuTntTUIodyGNZBsn2/J0AHJr3TwDj+xo8nk8nNeU3fh3U9GRVlhZk7EdP513XgW9kghVZm4/lWsKnLUTZFePPT0PSYfvHirUfQetZdvc+Y2VI6VcjlzXqRmmtDypRZaqvPgZp2/HU1C0gzzyKipJBFGXqC5yawp2KufTk10l9D1kjO5QOlc1dtku3pXK9EdtLUxNZbEG5ep/xryPxBrM0U0kZfB6V6xrG77Kcf55FfOnjK4Y6vNmTAADKPXrU0488uU7U7K5veH4Dqet28atuVTvc5z0IxXq0cJ81UUDC8Y7V578KbFzby6k4P73hc+gJH9K9Q022LsXJ564q9L2MZyvqXLeJoockYNWogxUZBBpYhlCTz7VPEDwSOK2jGzOWUrjORjPGKfhwcmpflJORk04Lj72DQ1qSIm7PXFTq5UcmkER6g05YuOv5VXKI4mNuBlcg1JHwQxwfYVTgdumeKlj3biQTVF2Lyn2pckHg1HkDj86ex5HPP8AOkkJFhCNoPQ0Fv73FQljjoR+NRy3UUUfmSSLtAwOaljRachE3Ee9VbyeNbKW5klURr2B5NcnqvibzS8Vu2QRjKnI/lVC2lLwkzu7DOcFjj8qEUkaU2uXt3NH9gH2aJBtb1Yc1WS2t3hiMy75MZ3HvTo7sbuFXpgcVOriUg4A2+lJvoaLyJoWVGAjUA9KuK7BshBnFUwDKQV+U+1PdJGHmI2Np5yetS/MpErYkcqSQ7etQR6NtuFlVs+uDWpCqSSpKyqSR2NWM7IyEjeQnkhFJx+VZ3vsVzWKUKNFJggc8VcEbTMMsOKgu5RHGPkbf1ww2kVX0+8DzkPxzzzQ7oG7m/8A2RI9xGNyiMDk1yupeWstxCnzbWwD+NbepX7u6JE7LGeOD0Fc/cyqLplJG1ed3rQmJHKahFNDMzBDhjmsm5ZonUEHL85PauwvJjIjExv5ecBxGSCfrWJeW4ltwSgTIweOa0iu4SZzV1LJDMrsC0XUsO1XbPUowCyHOe2aY4a08yNkDxyAjkZ7f/Xrnm0yUXJa183aD9zk/wBav2aloyeax2kepC5xEuSSfvV3HhPQf7VlEaoSMDc2DVP4beC5dQjEmowtHECCCy4Pb3r2nTNOt9NiCWyAcY3Y61yRpub00Qp1OT1DQPDlpp9vGskSkgDn8K3DHBCuIEXPtVePcygEnAqykZAzXdCnGK0RwynKT1ZWv40uYfLmRWzXINpzWd1J5cZ8s85A6V27DI5+lU7lGiUsgDDuDWVemp2ZrRqOGgzTbHzbKKaOTnH3aljlZX2P8relRxarbQxKApV1/h5FU7m58+XzF6+1DjGMVYfK23c1jJgHJqFpTtPNZDXToCSab9sOzp+tZSepSpFu4uZLeIrGwO6sO8LFTk8nrViacu2D07VRu5gsLE9R71DlpY3pxsc34pvfs9mAGwx/xFfOfiB2vL5UiO6R8IP54r1f4i6uiqIw+CTjr71w3w80g6l4lE7gvb253ZPOSNv+NXRVryN5rTlPW9A05dO0aytoxgqvP4nNdVYJhRge9Z1vHkgr06fSti2PyED8KcO5z1HckRcCrMXPBFRIM9asxcY71qmYND0QAk45qRB/eFJETuPGB2q2i7k5FVvqSyGOMt7Cp1jxUiDngVIRinqQ3Y8oU7ExViLIKkjp1qp5qsAE6dan80ACqNy35gY8flU25WYYOKoq4Dbz0HJz0rE8TeI49JsnnKEqfTnHB96lvsCRp6/r0OkwtIMSsnzeWAecY4rA8a6voviPwFbatoly9jqUMmLi1+YbjwCOAB1NcNqGorqV2ty5by2z0H0pQlqnlSxKC78FgOR3pWDroW7JhAq+WcrWlDcuVPzYHpWUty0xwsfPY+tPmdkTbINo4OamVy9jdsLj5yHGe2R2rageNlVY+Tj5jXHQXSKhO4Vo2VwZIlEORxWbuUjqY22sXwQoHr3qfTrZ9QvIhMxECNl0XgkVmWssEcaLcSnDEBj6VaS7tbWTbZPunByJj1xSabKWh3N14U0qVJbvTtUkiEKEmFsnp+ArH0HxBd2VjJNaaZHdlWO52AyuCfUiuQuZpZ9Vknnn8yQjBx060601C+053+yTgJJ95O2KqL5fe2Eoaau50t/rf9tt5728MEgO0qqY/Wsu5jETlk4YjOKw769KBnBGWO4hfXOartqrPGiys6qx+bHWqs5aspaI05dUO4Qr80rcbRnn8a3rPwyBafafEE4tbdhkRDlz+Iz/ACrO1LxDpNvosdp4egH9oD790y859yDXKi9vriYSak5lkAxuYflii0YavUTbe2h3moeNNFs9JGk2mlqYEOBM6KSQO/QHPHpXBandmK3hmFpL5EgyrbevX/A1teAp9Ai1y8uPFZQwwKDbiXG3Ocd+/NWbn4z6vd2ZXTtFt2VWxHu3dMH0b1rRu+rZCjJO0UcXCTqLQ/uHjO75Q2Oea9P8K+A7SPyr29UNIwDBSFx/KuD0jWdT8S+KrSTVGEKo4IhBO3qP8K+g1AEEIXoFHSsZfvHyoKl4WJreMRR+XEgVPQACrcaM2AKrxY/vVbh4PXNaqSRyS1LMa9BVocDFVUbmrIORVKV9jNobIoUZ7VRuvXkfjV6Q7hg9qpXXcsenapmy6e5h37RzKF2hXHfHNUVumhYgndn1qe9KiQnPNYV8echua5pyaZ6NON1Y2jMrjryaAy7cZrm0uWRzycVN9sYjgmsee+5p7Lsa0syr1PJrmfEmqpBav8x46kZqW/v9sYYkV5b8QteO3yIWByfmx25FEU5MqMbanI+L9UOoXsm0sI4+uWPPJ6V6d8M9JGneHEeQL58/JIA9v8K8p0uyfV9YhtYyMONzfkxr6CghjiMcUQwirgfXNdElZcvQyk7ts0LVdqjj5avQnaDkcdKoxbsALjFaMSthd/SiL6GMiyi4A9+lTKuMc9OtRqCrAj1qyCpBzWqRi2WI8Mg3ADFTxjIOO1QwYKKKtRqA2O3etEjNsEwG9qkPPJoVAWwKtLGWUelapENniCSx+UAgIROFz3p7XqIPmUGs15dyBduMccVWlV5MBW21kzqUS6989zMYUBA6k4rjvFl2WnitVIaMKd49/wDJror+5TTLIyAbpcVxYk8+U3EqHc3QVnfXQtRuIWhFuqxxEcEGowqblPKir0Y3KMKABU0tpG6LkflxQ2yuQ0tIEJCfMp/Gtuaw89VPlKyexrmI7AKA0JYEdgavQ3GpRYCyNsHOCf8A69ZsFTaJr/wtHOm63LRSn1JxWSLPUdKZhKA6Lxletbtl4gfcY7uIjB4NXpJ4JlaRJNwfnae1G+4WaObj1GGUfvQVY9jxVqKRyd0BDcU27htJwcxYdecjiswXUdu+Q5GOOvSjlutATsTXV9NE4cxsSfQdat2stzcLvjifeeOhpukyLqV2ox8v+1Xc6UkcTlPLXgjnFFtBvTU5iy0DVLxssNik+ldRaeA3uYFFzMTnuOK6rTSGGQBx6VtQyAIENXCm5apmUqrWx5XrPw6vLMtLo8uR1Kk//rrnbnw54gJ2rCSe5A/+tXvcZ5JWpkAKkbQfwrT2L6MSxDS1PmfVvD2twpvurJ5U7BVPP6VDYtJAAhtpIvZlIwa+oAqSqVkjVlHQEVk6poWmXSsfs8aseuFHpUTpSWzuXHELqjxCyV47qC4jXDIwJ/PNe16DqC3mnRsx+YKM1zd/4bhtmyi/KfSp9JY2Q2r9wdq57yjI1naotDt7dg1W4mz9awrS6EgLRKzDvitOCeORQY2B9R0qkzkcbGqjjAqdGqjE4wCal8zONvQ9a0izJxLJcYJPSqF24cMKWSYYYZ+7Wbc3A8tgDgmlUmXThqY1422Vgf51m3DBhnvU985M3rWdPL8rHBG3/CuNu56UFZFYylLjBAAp004RXb5fpWFeagqTM7/w9q5bX/EogVyj/Ke1OMLs1atuXvFuu+Rbk8cjivLL2b7XcNNg9f1zU+p3095MBKT5fXrUCg3EkNrGu15JFUH1Ga7KdPkMJTvoegfC7S0U3GqSg7idiA/Qf416TbDcxPfNZOj2aWGk2lsuNyIob3O0DP6VtWan079aylvoZsv2ybgozg5zWmiHhT92qVumAprUjHGDzxV00YTYIpP0qeFcA801RhcVYRRtxWyRkySJR5a5q5EAOc8/WqyDgCrMaZX2FWiGSRgZ5qdOByTVUHaakDtitCbXPCCyqCDz6VDcXUdpbmSUrx0yap32o29qm55BnOOorjr7UH1O5ZRIQme2KxZ2pXJNQv5dTuc8CPPbpSsRGQF5GccVFHGsYC46frU9qDhwyk56GpN4luLDoCo6Y4Herm4GMdaporRlcA4PtV6PaRnI/OkUkXoxtjVVHbNWYmB4IA461lIxBLD19anV2cA7hx1oDl0LyW4wzMAw6YqtLbLuYrHs9T6VahkxHhiPzqRv+PctnIz2+lTYOVFFbLzFISTB6kZ/+tWVf6Kk2QCA2RXUr5flDy8Bsc0sUcQbMlLZicUc7ZmfSWTMPnD1Fdhp2o28wG9wjHHB7VUWNHPDce9KLdI24XO7v6VOxLgdrpDOceUyspA5zXQeTLECzI2z+9Xm9pJcW6jyZOD2rrtN8RXlnahLmPzkP04/StadWMNJHPUpu+hvwSIeMgVYjcICGIHpXPLrVk/JO1uuMirlvq9pMceYob3IH9a2VaLW5i6bNgyAEc9Rmq1zhjnsDzTFkSRAVkRh7EVHJOu0r0+tRKfVAokGrtHOirE2CBzmud6XBhJ256Me9ad4ww+0jn3rGuflkjcOGwQSK5r8zOykrKx1ehX50OeaKZomXOWYnjFWdev9Hmh+0abMsdyOqqR82a5y21W2/tJpbu3aS0kOGUZyPy5rZbTvB0zSPA7QSOuCWkbg49C1btpxtGxnKKUuaV7+RdsdUitrK3e6bdJLgdvQf41qXk0cTDeyiNhkYNcxdwaTBbQ2L3ZlXGUkBHHT0PtWe1s1oci8FxB2O4VE3yqweyUndHSyXSLG7BgVPSsPULk5BTk+1Z1zcSKcxkMvpmiNmlUOwwR2Nc0nc2hTUSQF3Ynqaq6k4hgcHkkf0q5I6QqzOVHGetcf4l1tI7fcjjv0I9DSSNUcl4k1AQPKCAd2cfpXDn947m4fKZJIrX1CX7bdu0ikjORio0tV35ZTt6966acUtyZyb2MZts8SRohU+uO1dJ8PtLjudcMkhLiAblOOhwf8KypkRGI6tjINdt8ObYRWU1x0Z+B/49Vyehnax2kDGacg8jpW5ZJjgL+NZOlRHaM/e6/pXRWaEKMCso22IkWoItqgdTVxB0FRqvQ1LjFapHO3ceoyeBUyA7ge+abEvy5xyasDBAxitLWIY5ME81YjJFQIu7joRTiH/hPFUSxzHnpmg7uMcUqjgE9aUsCOTii9wPkqWVrt2kckpngU+JUU5Ea5+lKEwmIgPXGKFVg3zAj3qDujoKImLZbO2rsJVVOwA/WiHa9ozscHtTrWPMWduQTUs0Ww/ccqT1NPiw0jD5sA9jUqoowTjOMUqJmUqi8+gFItMYXKtjPFWISu3JJJ9jiqsyMJT8pxS28gilw3T+VIpF6JpHVh6dOKvwPHHAsbkkkc59azIZBK+7OAD1qZZT5TGTk54PrQwa7GjIwUhouQetSmX5c8Y+lZVvcM0YjcEEnPStKNTsCgArgHNSxcpasdjqd3BqeUlkIAwB3qvGxHJX5adPKxRdoI/rS30JtcuRgrEpPbBqeW8cqNhIX0qgDJ5AI5AwasI4eFSFzUBYcWV2JcYHbHFVpNxb77A9tpxUx+dBj73pSOpIDADcKLXGh8d1d2uPLnkxjpuNaUOvOAkdwDk/xZ681nl9oGVptwFfYTz6ClYlxTNp7yOWN/JuF8z+6axtV1BIBCjtgnncPWqMtmGLOh2Ow4NU5o2lXyrkeZt70LQIxsaD6rOJl2jKnsOa02aVUWY7SHByDWHb4txsByexbtUE9xqM24ecBGpwACaOXSxd+h0Cag23y5Yiyjoc/1pJbp2CokuyMfwZzWIL66jgCEBsYBNVIdQYSt9oQxqD8riiwHZRvsAbcfm6ZNK2owIwQSbW75NcRB4gvDMQBvjXhCxPNVrtL65mMzsVDfwqam2gWOl1/XuP3ci474Nef6ley3cmyLJhPfHtWqdNYpiQ5z3z0qf7HHZwKqqME4yKcdB2ObtLCQB3RXOecE9PwqTyzvwflOOhFdDwrERMNoA5qhqQjI+YDd3NaqWtxcttTnLz5GZtoKnjpXoXhaIR6TAVUgEZHvXnt+zEwxLyCea9U0KEmwtlIIAUYpyvZGTOh0tQVDEHOMVv2y4UVk2KAKABzW3a4Zfl5xSgjCbLC9AKlWPPJBpqIThgKtoCTitkYXCJQVAOeKkUY6DpSKMdqetUmSOUHt3pSpXkE0FicBR9aVi3Yc09xCOelNALde1OUHvUiLxVWGfNo0dfMLAEDHNQfYGDkCPd6EGurMDeWAQOetV/szRTAggLis2jrjJnKLbkOyH7uelToojmBT7o/hHOalvNy3JC9CapSmSKRnjIwvrzipNUy4yES+Z36gelSqCSxjPzd/aqmnTtNM3mkEdKuWrRxXEgLHaTgUFLXYZsDxmQsMg9M1BKuThRz61dRUjLRlc55zmnLC/kSyIAyjH4UmUmVS3lx5Azgc9qWKYSDA4I7GkDbombIx3FFrbnymnIIwMnJpF3LShmQeSQGXrk9alS94VZlKe+OKppmWLzB8qA4yaWZlaNFAyRxRa49zYFxtkAHT0qSGXex3425qjl9gQL8/qae8V1BCm7GWOBUtC5TTkkYKAoOMdBU0LjywSQPas4LcQKu/5gRnip1kZod5xtPTJ5pNOwmi7bTrJ6A1Ljdk5wKo2+3cCDyavjAj68GpSJaJHbMQG3oOtQsY9gOeV61IVKj5myD2qu8I37uqkcjNOwCBopHT5uvTmopUZJJPL5ye9WIEiGCwBK9KdlX3jByaTVwKa23mKTmovs6KCGLZPNWVRkbAbrT2gLRlhjA680rDRSMRYbUIxUZt5QOVBH0p/lmFyzFhntUxkIHBOD70mmMz5VEQGE49hTGJZlPIq5NG6qfMIx9KqABmzuH0pPQaRFuJYgHimSQvGGaEs2eoPPFJqCNGgaPtTre5DRoG+/nBpjM2eVkY44J61XlZXjYsR+Na15FG0rDbwRmsfULcRjcp61cX1JZiLum1C0XuzjH517Jp0XlwQJzkKOPwryfQIVu/EFmv8K4JHvmvZbVMqhOAQBVSMJM0bQYbPcVtW53KCgAPese0TMgyeK17HC5HrxVQ0MJltD029auR5zk1UhAxz1q5GCUHPNaIxZLGoPJpyoAxpyKMYzQQQapIzF2dx3o2H2py8gZpwTJ64qkAwJmpAvFKo3D5adjFWgPFmVWBGRmq0iB02qDmr5IAw6FRnrVe7jZ1Hldc81idaOevLY/aE5GAevpVS5tjFbXDAxkHn6cVsR2kk95JFJgEL3+tUZ4wEkgBye/5Umi1I5sRMIw6HknpVpym1A+RJjmppIjGOvvVW9KtGjN98VJojWaRfJVSDuA6mtDTrtIbKaF0Zgw4I9cVyS3kglG7p0rftLoLCcgnPcUiyvZxJIkxIIYMfl9qnubkG2CNuCvyU71TuLgw3QaAYLHp61qW13DcNtljIlA5+v50FC+U1zYx28QWOMNuBNVJbU224Ntbb6VLeRtBG8yPuUdh2ptldrtDSD736UDXYdbuZowwkbzQehrotGkju5Ql25ynAz3rlrmONbwzW7fJUJv/AC3LZAcEFScUhtX0PWbbTbVosXIBJ+7gdvyrKvPC6XEr+RKUAPA/H6ViaH4jJgQSt5jDA4A4rpLa5iWZZPP4kGdvFO6M7NHKypJYuySAuE7r61Gt2S6liVU+vrW9qBJnO1AS1Up0t3XyZ/lYYPWk0aJkUMuMNJJu9MVNPcxwxoSGZm5wKoyiGKUBQSvTOKWWaFJQhI2noKmwWTNOOBZwrRkhiO9LOHVf3Yzt60xJolQrv2kDvSGRVYfvQd3HUUWJEZQyZ5wO9RyhVVcSke1ShJE+XHy1FIYRlQoYg8n0qUgQRu0ykyqpRehFOt1hkyBk47moonhdtiyLz2zTxBJHIfJHygdaHHuOxHcZkU7vu9qpfZo0YHORWi88DArIQD0qDygg3JyDUblIoMGIPH51SMGwrwdxYHjoBW9OwlVdgORxVN4mMoYg/Sl1GUZtsjPwVKgYz9Ky9RjLR5Y8CugmG7A9PSsTWBt3Aepq0rEMqeB7RH8R+cwwAvT8RXrVqo2c9K84+H0O67mlz0OK9Lhj24PXGK0OaRdtQBhiSPTNaUP3gRVKJd5G6r6jaR9aZjJ3Lqqu/PrV2MKOOappywxVxOCCa0TRiyYJtGeTTyA3I6URnIwetPRQQcHmrRAiA/hUpjU4+bHHenxhvLGRSoqt1qrCuNK7HCrxStGGPPWpX6ZNORcj5RmmtRHihjaRgHyfrTjHtIQY+uKmilCtmRevFJ8u/Bb8azOsoz2JG5o3Jb2NZFxp8jMSDtO38TW+x+YqGz6EVWmjaSRd4O0cZpFI5OW1kiZ1ZlKism/QkYiBMYzXb3lnERzySDWQ9kZD5caBOOrUi0zlEUMhB6jvT0kKxsQx3DjHrWlrOh6jaoZ1RWiPUisZ45VAfaSv8X1pWLUh0Zkjl83cx78mtaOYSok6n58ZYCsdHdtw4yO1S+f5UKKAS23n60mWjcW+ilBD4K455prRwrGDE2TjpWXarHK43NtJq5HIkT+QvP8AtUi1puNiaeNcbdynrS3BjK8AFiOeOlS5wGDHHFUiBvwufm70hx7DoCqggEqc9AcVuQaqtqqF9zt71heW0bDcwH1pqZjmYyP5i9sdqCrXPQn1KJolYjMr8fSntElzLGrLjjJP4Vw1rqBhuEaZvkU/dNbMOv7pgqfdYdewouKxvPGY5WXy8p2OKwdVuBY3aKYmaMjlthO2tiPUQ6hJJRkfrXR2F3ot/AIZngaYqcqRk9f/AK9FrivY5HT9OGpQtPY3QBUcq46n05+lV4Rf27tBe2skUxP7slCdw7dqtT+Hr97x5NKnW3CNujABwTnPP4102kXmvTqJPEFnbu1twjqn3scZ5NFhuWmhzZOrxo8ktrKy46hSMfpVKxupbzVrS1t4y7SyqkidwCwGfyNe8eHbmx1LTEkljjCsPmUjpS2Xw70Ia7Fq+njybqNtxCH5W6dR+FXKjK10cv1uEbqSsYOr/B6z1CxgudOupbK9VASSzOpOBnILfWvNNa03W/DFw0WoxNKudvnoDtNfVDK6wbVwWA4rzrxN4l0u2dNL8S2Yinn+4jgMH69D+BpzopLmTsYYbF1JvlkuZHikc8U6BHw2f4hxTlcwuNrhoz14pNbtba21Sc2SvFakjamenFV0m2Id20oe9c17q56mj1RorOACBjk+lQzqn97n/wCtVNZRvLE/LU0WJVLdv51IrdyF2GcAnIrE1ZG+bPqe9bZjDSEqQAKzNaG1CzYxiqiTLsTfD5Nvn567vyr0aLouOeleceAHLRyue7V6LbA7Rn2rU5ZmrB/rEyf84rUiwemKyYG3MNvbjNaVucDvirRhMuwD7p9Ktr16ZzVW2KlOvJq4uFAGckVSWpiyWMVImTkdKYhGOlSKQPx71diC1GR5YA7UpqFGwoHp+tP3iqsS0SZBFODbRxUKP6ipMbqYzxkyodoyDz0FPEYeUAfWqsYGc9x0pSzLPuBIOBWJ22LWFEhjVTn1pkTuS6DacetK5KkMOrcmm3KhTG68EjtQFiN7aNnO9xu7DNUr2CGQbTgsPSrN0BvU85OM8/Sop41EjEZz9aQ0ZrhvKEKyHb/cNZ9xZb8hkK46YFdF5MfkF9vzZ61XjObvYQCpB7UDOFuNPbzWHK4Pbp1qgQYp5InYYU4+tdzq0EXnEbBjn+dYN/awqzME5xmla5SfQxIlxMzfwYyKsG4jYAnAaq118km1enT9KgPOaRopXOgSeJsb8McdqbcOoAABL4OCB0rGsJH3uMn8a01kYsM4P4UixApkJ8zP1NRMCrc5P4Vbbr9aryMRIR9aQ12GPIW+8vX1pI5DE6uF+QGoZ3YrnPX0psBPk8nPJoKuaEd15lweoXHXFRi0mtbtdQjk245wDyef/rVCjEKR70zzXd03McA4xnigaaOu0/xY52oSyueg4zXT6B4suPtOy/X92O/HIrze1OZdxA3AcHFSyTSlgd7Zz60XaG4KR7lFrmj60ZIobyO3BX++o/rWlpupDTFlube/R448clhhq8EErgkKxXd1I4q+13cTWf2Z5pPKXkAMR371p7WXUweHja3Q+hl+Jum2tkkuocMR/AQa8a+JfiseNdYtp7aCaGytOVZgMluefyNYcUeQu55GAHAZye1VDM5WRM4UkjArOcnPR7FUMNTpS54LU2Hup5rUAo0sf9/HP6VDpmmwalOIXuxbk5I3EDkdKpaZcSQ3Cxo2U5+VuRUt7zcsw+Vs/wAPFZNdza1tC1qGnXmmT7byNJI/4JEyQakinjwB3xyB2rKe9uJ5vJllZ4xwATmp7AfvCpyRSSBo0JkTG5D71z+usXjcDI4ro7lFW2JA5xXM6kS8w3cgcfpVRRNrk/w/OIZQ3UN0r0m0bJXP3eK8y8CEs91ntIQPyFel2g+Ra0RyTNVWCHKAYrShYYxWPCx247ZrTU/MtaIxkrl6DaFO44qzbsGU47GqIGWUHoasD92QE4FUjJmgjcdeaeG5qspyoPepU5xmtERYsq2OtLvqHPzKKfQImXOanTOKqoTn8amZ2EYxVCZ//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martha Ann Keels, DDS, PhD, Duke Pediatric Dentistry.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24528=[""].join("\n");
var outline_f23_61_24528=null;
var title_f23_61_24529="Chest x-ray - Dilated cardiomyopathy in 13 yo boy";
var content_f23_61_24529=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Chest x-ray of 13-year-old boy with dilated cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 448px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest x-ray demonstrating cardiomegaly and pulmonary interstitial edema in a 13-year-old boy with dilated cardiomyopathy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24529=[""].join("\n");
var outline_f23_61_24529=null;
var title_f23_61_24530="Squamous papilloma Light";
var content_f23_61_24530=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F63595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F63595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Squamous papilloma of the head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of a squamous papilloma, which lacks the multiple cell types and microabscesses found in Schneiderian papillomas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24530=[""].join("\n");
var outline_f23_61_24530=null;
var title_f23_61_24531="Lunate fractures";
var content_f23_61_24531=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lunate fractures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24531/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/61/24531/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper extremity fractures are among the most common of the extremity injuries with carpal fractures accounting for 18 percent of hand fractures and 6 percent of all fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Of these, fractures to bones of the proximal row are most frequent. Lunate fractures occur less often than fractures of the scaphoid with a reported incidence of 0.5 to 6.5 percent of all carpal fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/3\">",
"     3",
"    </a>",
"    ]. Fractures of the lunate, particularly those that are not recognized and treated appropriately, may lead to osteonecrosis, also known as Kienb&ouml;ck's disease. Thus, detection of lunate fractures and appropriate early management are important goals which may reduce the likelihood of this complication of wrist injury.",
"   </p>",
"   <p>",
"    This topic will review issues related to lunate fractures in adults. A general overview of carpal fractures is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4886?source=see_link\">",
"     \"Overview of carpal fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lunate is well protected as it sits in a sulcus on the distal radius (lunate fossa) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70211 \" href=\"UTD.htm?37/16/38146\">",
"     image 1",
"    </a>",
"    ). The lunate can be appreciated by palpation on the dorsum of the wrist just distal to the radius and in line with the middle finger. Another landmark that can help to identify the location of the lunate is Lister's tubercle, a longitudinal bony prominence of the distal radius that is aligned with the third metacarpal. The lunate is made more prominent in this location with volar flexion of the wrist.",
"   </p>",
"   <p>",
"    The bone receives its blood supply on both the volar and dorsal aspects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/4\">",
"     4",
"    </a>",
"    ]. Despite the dual arterial sources, there is a high incidence of ischemic bone changes following fractures. Acute fracture of the lunate is an uncommon occurrence and many are unrecognized until avascular necrosis occurs, a condition known as Kienb&ouml;ck&rsquo;s Disease (osteonecrosis of the lunate). Associated risk factors include occupations or sports with repetitive pressure to the base of the hand with the wrist in extension (eg, gymnast, jack hammer operator), and those with ulnar shortening relative to the length of the radius, a condition referred to as \"ulna minus variance\" [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute lunate fractures most often occur as the result of a fall on an extended wrist or some other wrist hyperextension injury. A dorsal lip avulsion fracture can occur with a translational injury with force applied to the heel of the hand [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. All lunate fractures, except those of the corner fractures and dorsal or palmar horn, are prone to develop osteonecrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/6\">",
"     6",
"    </a>",
"    ]. However, osteonecrosis of the lunate is probably multifactorial and repetitive stress or trauma, in combination with the precarious blood supply, plays a role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SYMPTOMS AND EXAMINATION FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may not recall the specific incident, but typically present with pain in the wrist area that is aggravated by wrist motion or gripping. Because of the intracapsular location of the lunate, swelling may be minimal. Tenderness is generally present on the dorsum of the wrist just distal to Lister's tubercle (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Pertinent anatomy and risk factors'",
"    </a>",
"    above). There may be pain with axial loading of the third digit. If presentation is late, stiffness or decreased range of motion of the wrist may be the only complaint.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;AP, lateral, and oblique views of the wrist are obtained. A fracture line is often difficult to detect, but will show as a thin, lucent, typically transverse line (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83517 \" href=\"UTD.htm?3/11/3254\">",
"     image 2",
"    </a>",
"    ). The dorsal rim of the radius makes visualization difficult on AP view and the other carpus that are superimposed make detection difficult using the lateral view. If fracture is suspected clinically, CT scan or magnetic resonance imaging (MRI) is indicated for diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One should carefully examine the AP view to detect any widening of the scapholunate space (scapholunate dissociation) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52517 \" href=\"UTD.htm?14/30/14816\">",
"     image 3",
"    </a>",
"    ). The lateral view should be inspected for any abnormal position of the capitate and lunate indicative of a lunate or perilunate dislocation. This view also affords the best opportunity to evaluate for a dorsal lip avulsion which may be associated with scapholunate ligament injury and instability [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Scapholunate dissociation and lunate dislocation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/21/12632?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation of the adult with acute wrist pain\", section on 'Scapholunate dissociation, lunate dislocation, and related injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with later presentation will have radiographs that demonstrate a relatively mottled and radiodense area of the proximal lunate. This advances with sclerosis, cystic change, fragmentation, or eventually collapse of the lunate (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72808 graphicRef52781 \" href=\"UTD.htm?1/50/1829\">",
"     image 4A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGICAL REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the considerable potential for non-union and osteonecrosis, all patients with lunate fractures should be referred to a hand surgeon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be immobilized in a long arm cast or a double sugar tong splint (",
"    <a class=\"graphic graphic_figure graphicRef50501 \" href=\"UTD.htm?36/26/37281\">",
"     figure 1",
"    </a>",
"    ) with a well-molded wrist giving symmetric dorsal and volar support [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link\">",
"     \"Splinting of musculoskeletal injuries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"     \"Patient information: Cast and splint care (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of the patient with a lunate fracture will vary based upon the fracture, its potential for healing, or the stage of diagnosis of Kienb&ouml;ck's disease. Casting is often chosen for lunate lip fractures because of the good potential for healing.",
"   </p>",
"   <p>",
"    Optimal management for those patients with osteonecrosis at presentation is uncertain. In one retrospective study, operative intervention was not superior to a nonoperative approach and was associated with more limited wrist mobility [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24531/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;If immobilization is chosen as treatment, casting is maintained for up to 12 weeks or longer. The metacarpophalangeal joints should be incorporated in a flexed position to relieve compressive forces across the lunate. When immobilization is no longer required, referral to physical or occupational therapy can be very helpful in regaining range of motion and strength. Rigid bracing of the wrist should be continued until strength and range of motion are essentially equal to that of the contralateral side.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute lunate fractures are relatively uncommon. The usual mechanism is a fall onto an extended wrist. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pertinent anatomy and risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients typically present with wrist pain that is aggravated by motion or gripping. Swelling may be minimal. Tenderness is generally present on the dorsum of the wrist just distal to Lister's tubercle. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Symptoms and examination findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anteroposterior, lateral, and oblique x-rays of the wrist should be obtained if a fracture is suspected, but the fracture line is often difficult to detect. Look carefully for widening of the scapholunate space, abnormal position of the capitate and lunate, and dorsal lip avulsion fracture. Advanced imaging is needed if plain radiographs are negative but clinical suspicion persists. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Radiographic findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteonecrosis (Kienbock's Disease) is often apparent at initial presentation.",
"     </li>",
"     <li>",
"      Because of the high risk of osteonecrosis, and the potential for long-term sequelae, patients with lunate fractures should be referred for orthopedic management.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H292287\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editors would like to acknowledge Kevin E Burroughs, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Dobyns JH, Beckenbaugh RD, Bryan RS, et al. Fractures of the hand and wrist. In: Hand Surgery, 3rd, Flynn JE.  (Ed), Williams &amp; Wilkins, Philadelphia 1982.",
"    </li>",
"    <li>",
"     Eiff MP, Hatch RL, Petering RC. Chapter 5: Carpal fractures. In: Fracture Management for Primary Care, 3rd, Elsevier, Philadelphia 2012. p.84.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24531/abstract/3\">",
"      Hsu AR, Hsu PA. Unusual case of isolated lunate fracture without ligamentous injury. Orthopedics 2011; 34:e785.",
"     </a>",
"    </li>",
"    <li>",
"     Cooney WP III, Linscheid RL, Dobyns JH. Fractures and dislocations of the wrist. In: Rockwood and Green's Fractures in Adults, 4th, Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD.  (Eds), Lippincott-Raven, Philadelphia 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24531/abstract/5\">",
"      Geissler WB. Carpal fractures in athletes. Clin Sports Med 2001; 20:167.",
"     </a>",
"    </li>",
"    <li>",
"     Geissler W, Slade JF. Fractures of the carpal bones. In: Operative Hand Surgery, 6th, Green DP (Ed), Churchill Livingstone, Philadelphia 2011. p.639.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24531/abstract/7\">",
"      Dana C, Doursounian L, Nourissat G. Arthroscopic treatment of a fresh lunate bone fracture detaching the scapholunate ligament. Chir Main 2010; 29:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24531/abstract/8\">",
"      Imbuldeniya AM, Compson JC. Scaphoid fracture with an associated dorsal lip of lunate fracture - a sign of instability? J Hand Surg Eur Vol 2011; 36:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24531/abstract/9\">",
"      Delaere O, Dury M, Molderez A, Foucher G. Conservative versus operative treatment for Kienb&ouml;ck's disease. A retrospective study. J Hand Surg Br 1998; 23:33.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 192 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-95F309B6B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24531=[""].join("\n");
var outline_f23_61_24531=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERTINENT ANATOMY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SYMPTOMS AND EXAMINATION FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INDICATIONS FOR SURGICAL REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H292287\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/192\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/192|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/16/38146\" title=\"diagnostic image 1\">",
"      Normal adult wrist AP xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/11/3254\" title=\"diagnostic image 2\">",
"      X-ray and MRI lunate fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/30/14816\" title=\"diagnostic image 3\">",
"      Scapholunate dissociation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/22/1376\" title=\"diagnostic image 4A\">",
"      Lunate fracture and Kienbock",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/58/25504\" title=\"diagnostic image 4B\">",
"      Lunate fracture T2 MRI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/192|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/26/37281\" title=\"figure 1\">",
"      Distal sugar tong splint",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/21/12632?source=related_link\">",
"      Evaluation of the adult with acute wrist pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4886?source=related_link\">",
"      Overview of carpal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_61_24532="Dermatomyositis dilated capillary loops";
var content_f23_61_24532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dilated capillary loops at the proximal nail fold in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 415px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24532=[""].join("\n");
var outline_f23_61_24532=null;
var title_f23_61_24533="Nitric oxide and the kidney";
var content_f23_61_24533=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nitric oxide and the kidney",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24533/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24533/contributors\">",
"     Philip A Marsden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24533/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24533/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24533/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24533/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/61/24533/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitric oxide (NO) has a major role as a messenger molecule in most human organ systems [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/1\">",
"     1",
"    </a>",
"    ]. In the blood vessel wall, basal and calcium-agonist stimulated release of NO largely accounts for the bioactivity of endothelium-derived relaxing factor (EDRF) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/2\">",
"     2",
"    </a>",
"    ]. In the kidney, as well as other solid organs, physiologic concentrations of NO function as a tonic vasodilator, working essentially instantaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/3\">",
"     3",
"    </a>",
"    ]. However, higher concentrations can be toxic, damaging cellular constituents (such as DNA) and inducing hypotension in those with sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BASIC PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;NO, a molecular gas, is formed by the action of one of three isoforms of nitric oxide synthase (NOS). The isoforms were named based upon the cell types in which they were first isolated: neuronal NOS (nNOS or NOS1); inducible or macrophage NOS (iNOS, NOS2); and endothelial NOS (eNOS, NOS3) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/5\">",
"     5",
"    </a>",
"    ]. All three enzymes, which are cytochrome P450-like proteins, facilitate the addition of the guanidino nitrogen of the amino acid arginine to molecular oxygen, producing NO and water.",
"   </p>",
"   <p>",
"    The expression of the three NOS isoforms differs, resulting in varying amounts of NO production. In general, eNOS and nNOS are constitutively active, producing relatively low levels of NO, with the output varying with changes in the intracellular calcium concentration. By comparison, the transcriptional regulation of iNOS can be markedly induced, particularly by inflammatory cytokines, resulting in extremely large amounts of NO.",
"   </p>",
"   <p>",
"    NO is a paracrine mediator that works differently from endocrine mediators, such as angiotensin II and antidiuretic hormone. NO, which is produced and released by individual cells, readily penetrates the biological membranes of neighboring cells, modulating a number of signaling cascades. Since it has an extremely short half-life, it exerts its effects",
"    <strong>",
"     locally",
"    </strong>",
"    and",
"    <strong>",
"     transiently",
"    </strong>",
"    .",
"   </p>",
"   <p>",
"    The most recognized cellular target of NO is heme-containing soluble guanylate cyclase. The stimulation of this compound enhances the synthesis of cyclic GMP (cGMP) from guanosine triphosphate (GTP), increasing the cytosolic levels of cGMP. The effects of NO can be enhanced by inhibiting the breakdown of cGMP, a process catalyzed by a family of phosphodiesterases.",
"   </p>",
"   <p>",
"    Other cellular targets for NO also exist:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NO interacts with thiol groups on proteins and small molecules, resulting in the formation of S-nitrosothiols. The addition and removal of S-nitrosothiols is a highly regulated process.",
"     </li>",
"     <li>",
"      NO can target",
"      <span class=\"nowrap\">",
"       Fe/S",
"      </span>",
"      groups at the catalytic centers of proteins, including hemoglobin [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The formation of peroxynitrite from NO and superoxide radical has been implicated in cellular toxicity via the propensity of peroxynitrite to induce posttranslational changes in the tyrosine residues of proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the biologic effects of NO depend upon the concentration of NO produced as well as features specific to the local environment, particularly the presence and production of thiols and superoxide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Expression of nitric oxide in the kidney",
"    </span>",
"    &nbsp;&mdash;&nbsp;All three NOS isoforms can be expressed in the kidney. The renal pattern of isoform expression (whether in normals or in certain disorders) may be clinically important as perturbations in NO bioactivity have been described in a number of kidney-dependent pathologic states [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inconsistencies and controversies concerning the expression of NOS isoforms are due in part to variations in the methods of",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    product being detected (such as mRNA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    protein) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      nNOS is principally expressed in the macula densa and the inner medullary collecting duct.",
"     </li>",
"     <li>",
"      Although somewhat controversial, iNOS has been localized to several tubule segments (principally the thick medullary ascending limb but also the distal convoluted tubule and proximal tubule), glomerulus, and the interlobular and arcuate arteries.",
"     </li>",
"     <li>",
"      eNOS is expressed in the endothelium of glomerular capillaries, afferent and efferent arterioles, and intrarenal arteries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The greatest enzymatic activity for NO production in the kidney is found in the inner medullary collecting duct (IMCD). IMCD NOS activity is three to sixfold higher than that observed in the glomeruli [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     NITRIC OXIDE AND THE KIDNEY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insight into the role of NO in the kidney is primarily derived from experiments examining the altered expression of the NOS isoforms, the effects of inhibiting NOS (thereby lowering levels of NO), or the administration of NO donors. A large variety of actions on the kidney has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most important of actions of NO in the kidney are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Regulation of renal hemodynamics",
"     </li>",
"     <li>",
"      Modulation of fluid and electrolyte transport",
"     </li>",
"     <li>",
"      Regulation of damage in response to injury.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Renal hemodynamics",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, eNOS is expressed to a variable extent in endothelial cells of the afferent arteriole, glomerulus, and efferent arteriole [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/13\">",
"     13",
"    </a>",
"    ]. Endothelial-derived NO plays a major role in maintaining arteriolar dilation by participating in the paracrine control of renal glomerular vascular resistance and mesangial cell tone. In the rat, acute systemic NOS inhibition causes marked increases in afferent and efferent arteriolar resistances and a fall in glomerular capillary ultrafiltration coefficient [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, chronic systemic blockade of NO bioactivity in rats induced by pharmacologic inhibition of NOS enzyme activity results in significant glomerular capillary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/15\">",
"     15",
"    </a>",
"    ]. In these models, the marked increases in efferent arteriolar resistance also reflected important contributions from both angiotensin II and endothelin-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The systemic blood pressure is significantly affected by NO. In animal models, hypertension results from deletion of the genes for eNOS [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/17,18\">",
"     17,18",
"    </a>",
"    ] or from chronic inhibition of NO synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/15,19\">",
"     15,19",
"    </a>",
"    ], while hypotension occurs in transgenic mice that overexpress eNOS [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/20\">",
"     20",
"    </a>",
"    ]. With inhibition of NO synthesis or deletion of eNOS genes, significant reductions in renal plasma flow and glomerular filtration rate parallel the development of hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/17,19\">",
"     17,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some clinical settings, enhanced eNOS activity may be deleterious; it may, for example, contribute to the renal vasodilation and glomerular hyperfiltration observed in diabetic nephropathy. In a diabetic rat model, enhanced glomerular filtration and renal plasma flow were blocked by the administration of a nonselective NOS blocker [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/21\">",
"     21",
"    </a>",
"    ]. Increased protein levels of eNOS, but not iNOS, were observed in the glomeruli of these animals, suggesting that the hemodynamic effects were due to enhanced eNOS activity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Solute and water transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although many renal responses to NOS blockade are mediated by actions on the microcirculation, NO also effects solute and water transport by directly altering the function of specific segments of the nephron. In particular, NO appears to play a role in the moment-to-moment homeostatic control of renal sodium excretion and extracellular fluid volume:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrarenal NO synthesis is increased during periods of increased salt intake, thereby facilitating renal sodium excretion. The administration of NO donors also augments sodium elimination.",
"     </li>",
"     <li>",
"      By comparison, acute or chronic blockade of NO synthesis (with NOS inhibitors) impairs urinary sodium excretion, even at concentrations that do not affect renal glomerular or systemic hemodynamics. As an example, chronic administration of a NOS inhibitor in humans results in a 40 percent reduction in the fractional excretion of sodium [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, increased and decreased levels of NO enhance and impair the urinary excretion of sodium, respectively. This is due to effects on epithelial transporters located in specific nephronal segments. Specifically, NO inhibits sodium entry in the cortical collecting duct, Na-H exchange in the proximal tubule, the apical Na-K-2Cl cotransporter in the outer medulla, and Na-K-ATPase activity in varied nephronal segments [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. NO also impairs the responsiveness of the collecting tubule to antidiuretic hormone, facilitating the excretion of water [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Tubuloglomerular feedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some of the effects on NOS inhibition on body fluid homeostasis are thought to be mediated by changes in nNOS function expressed in the macula densa [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. NO synthesized by nNOS in the macula densa",
"    <strong>",
"     blunts",
"    </strong>",
"    the tubuloglomerular feedback (TGF) response in which increasing sodium chloride delivery to the macula densa lowers the glomerular filtration rate to maintain distal flow at a relatively constant level [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10985?source=see_link&amp;anchor=H4#H4\">",
"     \"Chapter 2D: Regulation of GFR and renal plasma flow\", section on 'Tubuloglomerular feedback'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, micropuncture experiments using NOS antagonists indicate that NO does not mediate TGF. Rather, NO release from the macula densa is a modulating factor that is augmented during increased sodium chloride delivery, thereby countering the afferent arteriole constriction elicited in the TGF response. Thus, changes in macula densa NO production may underlie the resetting of TGF that occurs when salt intake is varied; the response is appropriately blunted with a high salt diet, as maintenance of glomerular filtration promotes excretion of the excess salt [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Role in renal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of NO in the response to renal injury varies based upon the cell-type and NO isoform. The function of endothelial-derived NO as a tonic vasodilator as well as its ability to inhibit platelet activation and adhesion may help minimize injury in glomerulonephritis. This has been illustrated in mouse studies in which targeted inactivation of the eNOS gene increases the sensitivity to glomerular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/17,31\">",
"     17,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, NO generated by mesangial and tubular epithelial cells may exacerbate damage, due in part to the ability of these cells to induce the expression of iNOS in response to inflammatory stimuli [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/32\">",
"     32",
"    </a>",
"    ]. Although mesangial cells do not express appreciable amounts of any of the NOS isoforms under basal conditions, they can be induced to express iNOS, a feature that has been documented in human glomerulonephritis, animal models of glomerular injury, and in vitro experiments using inflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. As an example, exposure of mesangial cells to tumor necrosis factor-alpha (TNF-alpha) causes a 30-fold increase in cGMP content that is first evident at 8 hours and is maximal by 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With inflammatory stimuli, increased levels of NO may enhance injury by suppressing eNOS (resulting in vasoconstriction) and directly causing epithelial cell damage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24533/abstract/32\">",
"     32",
"    </a>",
"    ]. Cellular injury is most likely due to the formation of peroxynitrite from NO and superoxide radical.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17427384\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nitric oxide (NO) is produced from arginine and oxygen by one of three isoforms of nitric oxide synthase (NOS): neuronal NOS (nNOS or NOS1); inducible or macrophage NOS (iNOS or NOS2); and endothelial NOS (eNOS or NOS3). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Basic physiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NO, which is produced and released by individual cells, readily penetrates the biological membranes of neighboring cells, modulating a number of signaling cascades. Since it has an extremely short half-life, it exerts its effects locally and transiently. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Basic physiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important of actions of NO in the kidney are: regulation of renal hemodynamics; modulation of fluid and electrolyte transport; and regulation of damage in response to injury. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nitric oxide and the kidney'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      eNOS is expressed to a variable extent in endothelial cells of the afferent arteriole, glomerulus, and efferent arteriole, and endothelial-derived NO plays a major role in maintaining arteriolar dilation and glomerular filtration. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Renal hemodynamics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NO produced by iNOS in various tubular segments inhibits sodium entry in the cortical collecting duct, Na-H exchange in the proximal tubule, Na-K-2Cl cotransport in the thick ascending limb of the loop of Henle, and Na-K-ATPase activity in several nephronal segments, thereby facilitating sodium excretion. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Solute and water transport'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NO synthesized by nNOS in the macula densa promotes sodium excretion by blunting the tubuloglomerular feedback response, thereby countering the afferent arteriole constriction (and reduced glomerular filtration rate) elicited by increased sodium chloride delivery to the macula densa. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Tubuloglomerular feedback'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endothelial-derived NO may help minimize injury in glomerulonephritis. However, NO generated by iNOS in mesangial and tubular epithelial cells may exacerbate damage in response to inflammatory stimuli, due in part to the formation of peroxynitrite from NO and superoxide radical. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Role in renal injury'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/1\">",
"      Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 1997; 272:F561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/2\">",
"      Lane P, Gross SS. Cell signaling by nitric oxide. Semin Nephrol 1999; 19:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/3\">",
"      Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999; 31:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/4\">",
"      Marsden PA, Brenner BM. Nitric oxide and endothelins: novel autocrine/paracrine regulators of the circulation. Semin Nephrol 1991; 11:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/5\">",
"      Kone BC. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health. Semin Nephrol 2004; 24:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/6\">",
"      Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 1998; 391:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/7\">",
"      Ronson RS, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 1999; 44:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/8\">",
"      Bankir L, Kriz W, Goligorsky M, et al. Vascular contributions to pathogenesis of acute renal failure. Ren Fail 1998; 20:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/9\">",
"      Kone BC, Higham S. Nitric oxide inhibits transcription of the Na+-K+-ATPase alpha1-subunit gene in an MTAL cell line. Am J Physiol 1999; 276:F614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/10\">",
"      Kone BC. Localization and regulation of nitric oxide synthase isoforms in the kidney. Semin Nephrol 1999; 19:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/11\">",
"      Wu F, Park F, Cowley AW Jr, Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol 1999; 276:F874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/12\">",
"      Prabhakar SS. Regulatory and functional interaction of vasoactive factors in the kidney and extracellular pH. Kidney Int 2004; 66:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/13\">",
"      Marsden PA, Brock TA, Ballermann BJ. Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol 1990; 258:F1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/14\">",
"      Baylis C, Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int 1996; 49:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/15\">",
"      Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/16\">",
"      Qiu C, Baylis C. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Kidney Int 1999; 55:2390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/17\">",
"      Knowles JW, Reddick RL, Jennette JC, et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 2000; 105:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/18\">",
"      Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/19\">",
"      Qiu C, Muchant D, Beierwaltes WH, et al. Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension 1998; 31:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/20\">",
"      Ohashi Y, Kawashima S, Hirata Ki, et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 1998; 102:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/21\">",
"      Veelken R, Hilgers KF, Hartner A, et al. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/22\">",
"      Bech JN, Nielsen CB, Ivarsen P, et al. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol 1998; 274:F914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/23\">",
"      Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 1995; 6:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/24\">",
"      Kang DG, Kim JW, Lee J. EFFECTS OF NITRIC OXIDE SYNTHESIS INHIBITION ON THE Na,K-ATPase ACTIVITY IN THE KIDNEY. Pharmacol Res 2000; 41:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/25\">",
"      Evans RG, Fitzgerald SM. Nitric oxide and superoxide in the renal medulla: a delicate balancing act. Curr Opin Nephrol Hypertens 2005; 14:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/26\">",
"      Garc&iacute;a NH, Pomposiello SI, Garvin JL. Nitric oxide inhibits ADH-stimulated osmotic water permeability in cortical collecting ducts. Am J Physiol 1996; 270:F206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/27\">",
"      Blantz RC, Deng A, Lortie M, et al. The complex role of nitric oxide in the regulation of glomerular ultrafiltration. Kidney Int 2002; 61:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/28\">",
"      Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol 2002; 282:F777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/29\">",
"      Welch WJ, Wilcox CS, Thomson SC. Nitric oxide and tubuloglomerular feedback. Semin Nephrol 1999; 19:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/30\">",
"      Wilcox CS, Welch WJ. TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int Suppl 1996; 55:S9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/31\">",
"      Heeringa P, van Goor H, Itoh-Lindstrom Y, et al. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol 2000; 156:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/32\">",
"      Goligorsky MS, Noiri E. Duality of nitric oxide in acute renal injury. Semin Nephrol 1999; 19:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/33\">",
"      Cattell V. Nitric oxide and glomerulonephritis. Semin Nephrol 1999; 19:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/34\">",
"      Jansen A, Cook T, Taylor GM, et al. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994; 45:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/35\">",
"      Furusu A, Miyazaki M, Abe K, et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24533/abstract/36\">",
"      Marsden PA, Ballermann BJ. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 1990; 172:1843.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2300 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-89.218.100.194-DA315AB02B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24533=[""].join("\n");
var outline_f23_61_24533=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17427384\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BASIC PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Expression of nitric oxide in the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NITRIC OXIDE AND THE KIDNEY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Renal hemodynamics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Solute and water transport",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Tubuloglomerular feedback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Role in renal injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17427384\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10985?source=related_link\">",
"      Chapter 2D: Regulation of GFR and renal plasma flow",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_61_24534="Histol melan in situ sup spread";
var content_f23_61_24534=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F61083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F61083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant melanoma in situ, superficial spreading type",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power light micrograph of a superficial spreading malignant melanoma in situ, showing epidermal hyperplasia with associated proliferation of large malignant epithelioid melanocytes at all levels of the epidermis (the so-called pagetoid spread).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Roy King, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24534=[""].join("\n");
var outline_f23_61_24534=null;
var title_f23_61_24535="Erythema marginatum";
var content_f23_61_24535=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73233%7ERHEUM%2F50841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73233%7ERHEUM%2F50841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Erythema marginatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple annular and arcuate erythematous lesions are present on the lower legs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema marginatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image of the back of a patient with acute rheumatic fever shows the characteristic rash, erythema marginatum. Note the erythematous lesions with pale centers and rounded or serpiginous margins.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Binotto, MA, Guilherme, L, Tanaka, AC. Rheumatic fever. Images Paediatr Cardiol 2002; 11:12. Copyright &copy; 2002 Images in Paediatric Cardiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24535=[""].join("\n");
var outline_f23_61_24535=null;
var title_f23_61_24536="Late recurrent angina pectoris after coronary artery bypass graft surgery";
var content_f23_61_24536=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Late recurrent angina pectoris after coronary artery bypass graft surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Sary Aranki, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Rakesh M Suri, MD, DPhil",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     John A Bittl, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Stephan Windecker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24536/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/61/24536/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary artery bypass graft surgery (CABG) is performed in patients with stable angina and acute coronary syndromes to prolong life or to treat angina refractory to medical or percutaneous revascularization therapies. &nbsp;",
"   </p>",
"   <p>",
"    Angina may return after apparently successful CABG. The cause varies with the time when symptoms are first noted after surgery:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent angina during the early postoperative period is usually due to a technical problem with a graft or with early graft closure. This is indication for prompt coronary angiography with PCI, if feasible.",
"     </li>",
"     <li>",
"      Recurrent angina after the first few months, called late recurrent angina, can occur with the development of stenosis in a bypass graft or with progression of atherosclerosis in non-bypassed vessels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the management of late recurrent angina after CABG. Early ischemia due to graft occlusion, the technical aspects of percutaneous coronary intervention to treat saphenous vein graft stenosis, and determinants of long-term outcome after CABG are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=see_link\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26538?source=see_link\">",
"     \"Prevention, presentation, and management of saphenous vein graft stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=see_link\">",
"     \"Long-term outcome after coronary artery bypass graft surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND VESSEL INVOLVED",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of the development of late recurrent angina is not well studied; most series report on rates of repeat revascularization (either CABG or percutaneous coronary intervention [PCI]) rather than anginal rates.",
"   </p>",
"   <p>",
"    Long-term (more than 10 years) follow-up of patients who received CABG with saphenous vein grafts (SVGs) only in the 1970s and early 1980s showed repeat revascularization rates between 25 and 31 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In more contemporary reports, revascularization rates have come from studies which compare SVG to arterial grafts, CABG to PCI, or graft disease to native vessel disease. For example, in the SYNTAX trial that compared CABG to PCI in patients with three-vessel or left main disease, the rate of repeat revascularization at three years was 11 percent in the CABG group (and 21 percent in the PCI group) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Late recurrent angina can occur with the development of stenotic lesions in both saphenous vein grafts (SVGs) and arterial grafts. The need for repeat revascularization, and presumably the frequency of recurrent angina, is reduced with arterial grafts, since long-term patency is much higher compared to SVGs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. In a report that compared 2306 patients who underwent CABG with an internal thoracic artery (ITA) graft to the left anterior descending artery (alone or with one or more SVGs) to 3625 patients who received only SVGs, the 10-year rates of freedom from cardiac reoperation were 94.4 and 90.1 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=see_link&amp;anchor=H2#H2\">",
"     \"Long-term outcome after coronary artery bypass graft surgery\", section on 'Choice of graft'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Late recurrent angina after CABG can result from progressive atherosclerosis in a native vessel as well. Two studies performed before the routine use of arterial grafting found that SVG disease, as opposed to new native artery disease, was the cause of late recurrent angina in 54 and 80 percent of the cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In contrast, progression of native disease is most often the cause of late recurrent angina in patients who had received an ITA graft. This was illustrated in an analysis from the BARI trial of CABG versus PCI in patients with stable angina [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/9\">",
"     9",
"    </a>",
"    ]. On repeat coronary angiography at five years, 82 patients who underwent CABG showed evidence of increased jeopardized myocardium; progression of disease in previously untreated vessels accounted for two-thirds of this increase in myocardium at risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703118136\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of late recurrent angina correlates with male sex, increasing age, and risk factors for atherosclerotic cardiovascular disease such as hyperlipidemia, hypertension, cigarette smoking, and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\", section on 'Established risk factors for atherosclerotic CVD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H532659732\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late recurrent angina may occur at any time after the first few months from CABG and may present as stable or unstable angina. These patients often have symptoms similar to those present before CABG. However, a different presentation (including differing characteristics of pain or symptoms of exercise intolerance or dyspnea instead of pain) may occur, and clinicians should have a relatively low threshold for considering recurrent myocardial ischemia in a patient with prior CABG. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=see_link&amp;anchor=H6#H6\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\", section on 'History'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    While a physical examination directed at the cardiovascular system should be performed in any patient with a suspicion of recurrent angina, it cannot confirm the diagnosis of recurrent angina. Alternative causes of chest pain, such as chest wall tenderness or a herpes zoster rash can be found. A broader discussion of use of the physical examination in adults with chest pain is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnostic approach to chest pain in adults\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2201616\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late recurrent angina after CABG is diagnosed when a patient with symptoms consistent with angina is found to have evidence of myocardial ischemia on stress testing with imaging, significant obstructive coronary artery lesions on coronary arteriography, or evidence of an acute coronary syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25209?source=see_link&amp;anchor=H3#H3\">",
"     \"Criteria for the diagnosis of acute myocardial infarction\", section on 'Acute coronary syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the history may be strongly suspicious for recurrent angina, we recommend confirming the suspicion with diagnostic testing. As these patients have a high pretest probability of obstructive coronary artery disease, a positive test will likely confirm the diagnosis. Such testing will also provide prognostic information, which should be used to help formulate a reasonable management strategy.",
"   </p>",
"   <p>",
"    We recommend obtaining a 12-lead electrocardiogram (ECG) in all patients as soon as recurrent angina is suspected; it should be compared to prior ECGs. New findings of ST-segment or T wave changes representing ischemia, Q waves, bundle branch block, or arrhythmias should raise the possibility of an acute coronary syndrome (ACS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/52/16198?source=see_link\">",
"     \"ECG tutorial: ST and T wave changes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9317?source=see_link\">",
"     \"ECG tutorial: Myocardial infarction\"",
"    </a>",
"    .) ACS should be suspected in patients with symptoms of myocardial ischemia and one or more of these ECG abnormalities. For patients with possible ACS, including unstable angina, we recommend urgent coronary arteriography, as they may require urgent revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/7,14\">",
"     7,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H703120015\">",
"     'Indications for repeat revascularization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For patients who have a stable presentation, including a stable ECG, we recommend stress testing with imaging (either nuclear or echocardiographic). Such testing can accurately detect graft stenosis, even in patients with atypical symptoms, and can effectively localize the stenosis in some cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=see_link&amp;anchor=H23#H23\">",
"     \"Stress testing for the diagnosis of coronary heart disease\", section on 'Our approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20138?source=see_link&amp;anchor=H16#H16\">",
"     \"Role of stress testing after coronary revascularization\", section on 'Evaluation of patients after CABG'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar to patients without prior revascularization, any patient whose stress test results suggest a large area of myocardium at risk, or other high risk features, should be considered for diagnostic coronary angiography. The rationale for this recommendation is that the presence of a high grade lesion in a bypass graft(s) or in an unbypassed vessel(s), particularly the left anterior descending artery, supplying a large area of myocardium may be an indication for revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/51/9018?source=see_link&amp;anchor=H23#H23\">",
"     \"Medical therapy versus revascularization in the management of stable angina pectoris\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;It should be confirmed that patients with prior CABG are receiving appropriate secondary prevention therapies, including the prescription of antiplatelet and statin therapy, routine exercise (and referral to cardiac rehabilitation programs in some patients), glycemic and blood pressure control, and smoking cessation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients in whom repeat revascularization is not felt to be necessary, many can have their symptoms controlled with use of these preventative strategies as well as with the use of antianginal medication. In general, we suggest starting with an antianginal regimen that was previously effective for the patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=see_link\">",
"     \"Overview of the care of patients with stable ischemic heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following discussion will present the indications for revascularization and outcomes with either percutaneous coronary intervention (PCI) or repeat coronary artery bypass graft surgery (CABG).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H370156579\">",
"    <span class=\"h2\">",
"     Post CABG angina in patients with diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discussion of post CABG angina in patients with diabetes is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=see_link&amp;anchor=H27#H27\">",
"     \"Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease\", section on 'Post-CABG angina'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703120015\">",
"    <span class=\"h2\">",
"     Indications for repeat revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with prior CABG, revascularization with either CABG or PCI is indicated to either improve survival or symptoms, similar to the broad population of patients with coronary artery disease.",
"   </p>",
"   <p>",
"    We suggest repeat revascularization for the following groups of stable patients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Those for whom revascularization is likely to improve survival. Similar to patients who have not previously undergone CABG, this benefit is likely limited to patients with obstruction of blood flow to the proximal left anterior descending artery (LAD) territory and demonstrable extensive anterior ischemia on noninvasive testing or significant disease in multiple other vessels. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42343?source=see_link&amp;anchor=H4#H4\">",
"       \"Management of significant proximal left anterior descending coronary artery disease\", section on 'Indications for revascularization'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The lack of benefit of revascularization in patients without significant proximal LAD obstruction was demonstrated in an observational study of over 4600 patients with prior CABG who had a patent LITA bypass graft to the LAD but significant disease in another territory [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/15\">",
"       15",
"      </a>",
"      ]. There was no significant difference in mortality during 20-year follow-up between those who continued with medical therapy and those who received either CABG or PCI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with bothersome angina after a trial of medical therapy. Revascularization may be undertaken if there is a reasonable likelihood of procedural success and the patient understands the possibility of recurrent angina.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar to the broad group of patients with an acute coronary syndrome (ACS), most patients with an ACS after CABG should be referred for diagnostic coronary arteriography with a view toward early revascularization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link&amp;anchor=H34#H34\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'Early angiography'",
"    </a>",
"    .) Patients with an unstable presentation after CABG are at increased risk for significant coronary events, including death or myocardial infarction, compared to those without prior CABG. In an analysis of the PURSUIT trial (glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitor versus placebo), patients with prior CABG had significantly higher 30-day mortality rates [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=see_link&amp;anchor=H37#H37\">",
"     \"Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease\", section on 'Eptifibatide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2201170\">",
"    <span class=\"h2\">",
"     Repeat PCI versus CABG",
"    </span>",
"    &nbsp;&mdash;&nbsp;We prefer PCI to CABG in:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with limited areas of ischemia-causing symptoms and in whom there are suitable targets",
"     </li>",
"     <li>",
"      Patients with a patent LITA graft to the LAD artery",
"     </li>",
"     <li>",
"      Patients with poor CABG targets",
"     </li>",
"     <li>",
"      Patients with comorbid conditions for whom repeat CABG will not prolong life and in whom the benefit to risk ratio is not favorable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the approximately three- to fourfold increase in mortality after repeat CABG (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Repeat CABG'",
"    </a>",
"    below), this procedure should be reserved for patients who cannot undergo PCI for technical reasons or for patients who will likely have a survival benefit from left internal thoracic artery grafting to the left anterior descending artery. For these patients with significant left anterior descending artery (LAD) stenosis, we prefer CABG with a LITA graft to the LAD to PCI. If repeat CABG cannot be performed, for example, due to a high risk of reoperation, PCI of the LAD is a reasonable option.",
"   </p>",
"   <p>",
"    There is no high quality evidence that can be used to support a choice of CABG or PCI in patients for whom either procedure is reasonable and technically feasible. Early comparative studies are not particularly helpful, as balloon angioplasty was performed without stenting in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/17-20\">",
"     17-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More studies suggest comparable long-term mortality between PCI and CABG, but the potential for bias in the choice of procedure limits our ability to draw strong conclusions from these studies:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A retrospective study of 2191 patients with prior CABG who underwent multivessel revascularization between 1995 and 2000 evaluated outcomes in the 1487 who had repeat CABG and the 704 who underwent PCI (77 percent with at least one stent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/21\">",
"       21",
"      </a>",
"      ]. The most important factors involved in the choice of repeat CABG were more diseased or occluded grafts, absence of a prior MI, lower left ventricular ejection fraction, longer interval from first CABG (15 versus 6 years), more total occlusions in native coronary arteries, and the absence of a patent thoracic artery graft. There was no difference in 30-day mortality with CABG compared to PCI (2.8 versus 1.7 percent, respectively). At five years, unadjusted cumulative survival was similar with CABG and PCI (79.5 versus 75.3 percent). After adjustment, PCI was associated with a nonsignificant increase in mortality risk (hazard ratio 1.47, 95% CI 0.94-2.28).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The AWESOME trial randomly assigned 454 patients with angina refractory to medical therapy and one of five high risk features including prior CABG to either CABG or PCI [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Among the 142 patients with refractory post-CABG ischemia (a high risk feature), there was no significant difference in the three-year survival rates (73 and 76 percent, respectively). Interpretation of these results is limited by the small number of patients and the fact that stents were used in only 54 percent of PCIs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Repeat CABG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients for whom repeat CABG is being considered need to be informed of the higher perioperative mortality with a second procedure. Multiple observational studies have shown an approximate three- to fourfold increase in the risk of death with repeat CABG, with rates of 4.8 and 1.8 found in a 2009 report [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/8,22,23\">",
"     8,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who undergo repeat CABG, the principles guiding the choice of arterial or venous graft are similar to initial CABG. If the LAD territory is being revascularized, placement of an arterial conduit is preferred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=see_link&amp;anchor=H41023269#H41023269\">",
"     \"Long-term outcome after coronary artery bypass graft surgery\", section on 'Summary'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the increased early mortality with repeat CABG, it has been proposed that there may be an advantage to minimally invasive CABG in this setting, particularly in patients with a patent left internal thoracic artery graft in whom the occluded vessels are inaccessible to PCI. Data are limited on this issue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37031?source=see_link&amp;anchor=H965600082#H965600082\">",
"     \"Off-pump and minimally invasive direct coronary artery bypass graft surgery: Outcomes\", section on 'MID CABG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     PCI",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with recurrent angina after CABG undergoing PCI, decisions need to be made regarding whether to intervene on the native coronary circulation, a saphenous vein graft(s), an arterial graft(s), or some combination. PCI of the bypassed native artery has been preferred to PCI of a bypass graft (when technically feasible) because of the higher risk of distal embolization during bypass graft PCI than during native-vessel PCI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/24\">",
"     24",
"    </a>",
"    ]. However, the use of embolic protection devices has significantly lowered the risk of bypass graft intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. A detailed discussion of the periprocedural aspects of PCI for saphenous vein graft stenosis is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26538?source=see_link&amp;anchor=H8#H8\">",
"     \"Prevention, presentation, and management of saphenous vein graft stenosis\", section on 'Percutaneous coronary intervention'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p>",
"    Left main PCI in the setting of an occluded bypass conduit to either the left circumflex or left anterior descending arteries is a reasonable option if the bypass to the opposite vessel is patent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=see_link&amp;anchor=H27#H27\">",
"     \"Management of left main coronary artery disease\", section on 'Protected lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Internal thoracic artery grafts are less prone than saphenous vein grafts to develop atherosclerosis, but may develop a proliferative lesion, most frequently at the distal anastomosis site and less commonly at the ostium or within the shaft [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Some of these are thought to represent a technical complication of the operation, such as a reaction to suturing. These lesions can be treated by PCI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/28,30-32\">",
"     28,30-32",
"    </a>",
"    ]. The efficacy of this approach was illustrated in a review of 174 patients with 202 lesions: Anastomotic (distal) lesions were mostly treated with balloon angioplasty, while ostial lesions were more frequently treated with stents [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/28\">",
"     28",
"    </a>",
"    ]. The procedural success was 97 percent, there were no cases of MI, in-hospital mortality was 0.6 percent, and the rate of urgent CABG was 0.6 percent. At one year, mortality was 4.4 percent, MI occurred in 2.9 percent, and target vessel revascularization was performed in 7.4 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/22/17770?source=see_link&amp;anchor=H7#H7\">",
"     \"Use of intracoronary stents for specific coronary lesions\", section on 'Ostial lesions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=see_link&amp;anchor=H15134962#H15134962\">",
"     \"Long-term outcome after coronary artery bypass graft surgery\", section on 'Internal mammary versus saphenous vein grafts'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H370156746\">",
"    <span class=\"h2\">",
"     Unstable patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with an acute coronary syndrome, we recommend early angiography and urgent revascularization as opposed to a conservative strategy. While there are no studies that directly compare these approaches in patients with prior CABG and an ACS, we believe the benefits to this approach are similar to those in patient without prior CABG. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link&amp;anchor=H34#H34\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'Early angiography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most cases we prefer PCI, if technically feasible, to CABG. This is based on the relative delay to revascularization if CABG is carried out and the increased mortality associated with repeat CABG. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Repeat CABG'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients with ST-elevation myocardial infarction after CABG,&nbsp;we and others recommend culprit-vessel only PCI in the absence of cardiogenic shock [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/33\">",
"     33",
"    </a>",
"    ]. The decision regarding the need for revascularization of other significant lesions can be deferred until the patient is stable. In patients with non-ST elevation acute coronary syndromes, we prefer culprit-vessel only PCI if a single culprit lesion can be identified. We are concerned about large contrast volumes or high radiation doses with multivessel PCI in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/33\">",
"     33",
"    </a>",
"    ]. PCI is preferred to CABG in most cases due to the rapidity with which revascularization with PCI can be achieved, and the increased mortality seen with repeat CABG. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Repeat CABG'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H170115537\">",
"    <span class=\"h2\">",
"     Recommendations of others",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our recommendations are generally in agreement with those made in the 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart Association CABG guideline and the 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Society",
"    </span>",
"    for Cardiovascular Angiography and Interventions PCI guideline [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24536/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The former document suggests that the decision to treat medically refractory ischemia with repeat CABG should consider the following variables: those with vessels unsuitable for PCI, number of diseased bypass grafts, availability of the internal thoracic artery for grafting, chronically occluded coronary arteries, and good distal targets for bypass graft placement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angina that develops after the first few months following coronary artery bypass graft surgery (CABG) is called late recurrent angina. It may be caused by both graft disease and by progression of atherosclerosis in non-bypassed vessels. Late recurrence can be manifested as either stable or an acute coronary syndrome. These patients often have symptoms similar to those present before CABG. (See",
"    <a class=\"local\" href=\"#H532659732\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We make the following recommendations for management of patients with recurrent angina after CABG (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Management'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For stable patients in whom there is a suspicion of late recurrent angina, we recommend diagnostic testing using stress testing with imaging. Such testing allows confirmation of the diagnosis and provides prognostic information that may be useful for management. Patients for whom this testing is not diagnostic may need to proceed to coronary angiography.",
"     </li>",
"     <li>",
"      Recurrent angina with an unstable presentation is associated with significantly worse outcome compared with patients without prior CABG. For these patients, diagnostic testing with urgent coronary angiography is indicated. (See",
"      <a class=\"local\" href=\"#H2201616\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients should have optimal management of their cardiovascular disease, including the use of antiplatelet therapy, statin, routine exercise (and referral to cardiac rehabilitation programs in some patients), glycemic control and blood pressure control, and smoking cessation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link\">",
"       \"Secondary prevention of cardiovascular disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with an acute coronary syndrome, we recommend urgent revascularization of the culprit lesion or lesions as opposed to a conservative approach (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H703120015\">",
"       'Indications for repeat revascularization'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      In patients with ACS, we recommend percutaneous coronary intervention (PCI), if technically feasible, instead of CABG (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). If PCI is performed, we prefer to revascularize only the culprit lesion at the time of the initial procedure. (See",
"      <a class=\"local\" href=\"#H370156746\">",
"       'Unstable patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a stable presentation, the management strategy will depend on the findings of diagnostic testing (see",
"      <a class=\"local\" href=\"#H703120015\">",
"       'Indications for repeat revascularization'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with obstruction of blood flow to the proximal left anterior descending artery and demonstrable extensive anterior ischemia or significant disease in other vessels, we recommend revascularization rather than medical therapy to improve survival (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For patients with obstructive disease but without extensive anterior ischemia, we suggest medical therapy rather than initial revascularization (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For patients who are not satisfied with the quality of their lives after a trial of medical therapy, we suggest PCI if it is technically feasible rather than CABG (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/1\">",
"      Peduzzi P, Kamina A, Detre K. Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina. Am J Cardiol 1998; 81:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/2\">",
"      Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 1994; 73:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/3\">",
"      Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/4\">",
"      Cameron AA, Green GE, Brogno DA, Thornton J. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cardiol 1995; 25:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/5\">",
"      Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/6\">",
"      Muneretto C, Negri A, Manfredi J, et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg 2003; 125:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/7\">",
"      Chen L, Th&eacute;roux P, Lesp&eacute;rance J, et al. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol 1996; 28:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/8\">",
"      Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/9\">",
"      Alderman EL, Kip KE, Whitlow PL, et al. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2004; 44:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/10\">",
"      Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/11\">",
"      DeBakey ME, Glaeser DH. Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up. Am J Cardiol 2000; 85:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/12\">",
"      Voors AA, van Brussel BL, Kelder JC, Plokker HW. Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation. Am J Cardiol 1997; 79:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/13\">",
"      Solymoss BC, Nadeau P, Millette D, Campeau L. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988; 78:I140.",
"     </a>",
"    </li>",
"    <li>",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/15\">",
"      Subramanian S, Sabik JF 3rd, Houghtaling PL, et al. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. Ann Thorac Surg 2009; 87:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/16\">",
"      Labinaz M, Kilaru R, Pieper K, et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2002; 105:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/17\">",
"      Stephan WJ, O'Keefe JH Jr, Piehler JM, et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 1996; 28:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/18\">",
"      Cole JH, Jones EL, Craver JM, et al. Outcomes of repeat revascularization in diabetic patients with prior coronary surgery. J Am Coll Cardiol 2002; 40:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/19\">",
"      Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 2001; 38:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/20\">",
"      Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002; 40:1951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/21\">",
"      Brener SJ, Lytle BW, Casserly IP, et al. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur Heart J 2006; 27:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/22\">",
"      Yau TM, Borger MA, Weisel RD, Ivanov J. The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg 2000; 120:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/23\">",
"      Yap CH, Sposato L, Akowuah E, et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg 2009; 87:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/24\">",
"      Hoffmann R, Hamm C, Nienaber CA, et al. Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis 2007; 18:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/25\">",
"      Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/26\">",
"      Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation 2008; 117:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/27\">",
"      Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003; 108:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/28\">",
"      Gruberg L, Dangas G, Mehran R, et al. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. J Am Coll Cardiol 2000; 35:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/29\">",
"      Hosono M, Ueda M, Suehiro S, et al. Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J Thorac Cardiovasc Surg 2000; 120:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/30\">",
"      Shimshak TM, Giorgi LV, Johnson WL, et al. Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft. J Am Coll Cardiol 1988; 12:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/31\">",
"      Dimas AP, Arora RR, Whitlow PL, et al. Percutaneous transluminal angioplasty involving internal mammary artery grafts. Am Heart J 1991; 122:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/32\">",
"      Najm HK, Leddy D, Hendry PJ, et al. Postoperative symptomatic internal thoracic artery stenosis and successful treatment with PTCA. Ann Thorac Surg 1995; 59:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/33\">",
"      Blankenship JC, Moussa ID, Chambers CC, et al. Staging of multivessel percutaneous coronary interventions: an expert consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012; 79:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/34\">",
"      Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58:e123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24536/abstract/35\">",
"      Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:2574.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1588 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-1.234.2.38-35693F307E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24536=[""].join("\n");
var outline_f23_61_24536=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND VESSEL INVOLVED",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H703118136\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H532659732\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2201616\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H370156579\">",
"      Post CABG angina in patients with diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H703120015\">",
"      Indications for repeat revascularization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2201170\">",
"      Repeat PCI versus CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Repeat CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PCI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H370156746\">",
"      Unstable patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H170115537\">",
"      Recommendations of others",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=related_link\">",
"      Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25209?source=related_link\">",
"      Criteria for the diagnosis of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=related_link\">",
"      Diagnostic approach to chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9317?source=related_link\">",
"      ECG tutorial: Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/52/16198?source=related_link\">",
"      ECG tutorial: ST and T wave changes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=related_link\">",
"      Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=related_link\">",
"      Long-term outcome after coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=related_link\">",
"      Management of left main coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42343?source=related_link\">",
"      Management of significant proximal left anterior descending coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/51/9018?source=related_link\">",
"      Medical therapy versus revascularization in the management of stable angina pectoris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37031?source=related_link\">",
"      Off-pump and minimally invasive direct coronary artery bypass graft surgery: Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=related_link\">",
"      Overview of the care of patients with stable ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26538?source=related_link\">",
"      Prevention, presentation, and management of saphenous vein graft stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20138?source=related_link\">",
"      Role of stress testing after coronary revascularization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/22/17770?source=related_link\">",
"      Use of intracoronary stents for specific coronary lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_61_24537="Cross-cultural care and communication";
var content_f23_61_24537=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cross-cultural care and communication",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Joseph R Betancourt, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Alexander R Green, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24537/contributors\">",
"     J Emilio Carrillo, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24537/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/61/24537/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of sociocultural factors, race, ethnicity, and limited-English proficiency on clinical care is increasingly important in the delivery of quality healthcare and is the focus of a growing literature [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]. Sociocultural background influences a patient's perspectives, values, beliefs, and behaviors regarding health and well-being. These factors give rise to variation in recognition of symptoms, thresholds for seeking care, comprehension of management strategies, expectations of care (including preferences for or against diagnostic and therapeutic procedures), and adherence to preventive measures and medications.",
"   </p>",
"   <p>",
"    Sociocultural differences between patients and providers influence communication and clinical decision making. Evidence clearly links clinician-patient communication to patient satisfaction, adherence, and health outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Lower quality care may result when clinicians fail to recognize and understand sociocultural differences between their patients and themselves [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The field of cross-cultural care focuses on the ability to communicate effectively and provide quality health care to patients from diverse sociocultural backgrounds. There is no empirical literature comparing the effectiveness of different models of cross-cultural care and communication. There is excellent empirical evidence showing that efforts to educate health care clinicians in cross-cultural care improve knowledge and good evidence that they improve attitudes and skills [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/11\">",
"     11",
"    </a>",
"    ]. Accreditation groups for undergraduate and graduate medical education in the United States require training in cultural competency and",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    disparities and a curriculum guide has been developed for trainees and practitioners in primary care [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/12\">",
"     12",
"    </a>",
"    ]. The Joint Commission introduced cultural competency guidelines and standards, which include training of clinical staff practicing in the hospital environment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/13\">",
"     13",
"    </a>",
"    ]. The Hospital Consumer Assessment of Health Care Providers and Systems (HCAHPS) will impact hospital Medicare reimbursements by measuring clinician-patient communication as a major determinant of satisfaction scores [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/14\">",
"     14",
"    </a>",
"    ]. The development of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Cultural Competence Item Set promotes efforts to study the impact of cultural competency on patient satisfaction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will identify the key issues faced when caring for patients from diverse backgrounds, and provide a framework for an effective clinical encounter. These recommendations are based on a combination of expert opinion and when possible, evidence from related literature such as the field of physician-patient communication. Other issues related to the patient-provider relationship are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19831?source=see_link\">",
"     \"A patient-centered view of the clinician-patient relationship\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17609?source=see_link\">",
"     \"Literacy and patient care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/3/8249?source=see_link\">",
"     \"Patient-centered interviewing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINING CULTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Culture is a system of beliefs, values, rules, and customs that is shared by a group and is used to interpret experiences and direct patterns of behavior. Culture plays a large role in shaping each individual's health-related values, beliefs, and behaviors, and clearly impacts clinical care.",
"   </p>",
"   <p>",
"    In a survey of United States (US) residency programs in multiple specialties, 96 percent of the responding physicians rated consideration of a patient's culture \"moderately important\" or \"very important,\" impacting patient compliance, clinician testing behaviors, and overall quality of care [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When a clinician interacts with a patient, three cultures are juxtaposed: the patient's, the clinician's, and the culture of medicine. All three cultures influence the outcome of the encounter. To understand patients, it is first necessary to recognize our own cultural beliefs, values, and behaviors, as well as personal life experiences that have influenced the way we think about health care and make clinical decisions. In addition, the culture of medicine has its own particular beliefs, values, and customs (eg, the idea of patient autonomy and the value placed on scientific evidence). Finally, the patient's social and cultural background affect the quality of understanding and communication that occurs in the clinical encounter.",
"   </p>",
"   <p>",
"    The core values necessary for providing effective cross-cultural care are values fundamental to the practice of medicine: empathy, curiosity, and respect [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CROSS-CULTURAL CARE AND COMMUNICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several issues have put the field of cross-cultural care and communication in the spotlight: an increasingly diverse population, recognition of the need for effective communication to achieve quality healthcare, evidence of the disparity in healthcare provided to patients from differing racial and ethnic backgrounds, and new accreditation standards and quality measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Increasingly diverse population",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2010 US Census reported that there are 39.9 million foreign-born residents living in the United States and about 55.4 million residents (19.7 percent of the total population) who speak a language other than English at home. In some states, such as California, the figure is as high as 42.6 percent of the population.",
"   </p>",
"   <p>",
"    Clinicians increasingly see patients who may hold beliefs and values that differ from their own [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Effective communication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective clinician-patient communication is directly linked to improved patient satisfaction, adherence, and subsequently, health outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/9\">",
"     9",
"    </a>",
"    ]. However, patients, particularly those from minority backgrounds, are often dissatisfied with their ability to communicate with their physician. A large telephone survey of people with a recent medical visit inquired whether patients had trouble understanding their doctor, whether they felt their doctor did not listen, and if they had medical questions during the visit that they felt they couldn't ask [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/18\">",
"     18",
"    </a>",
"    ]. The survey found that 19 percent of all patients experienced one or more of these problems; by ethnicity, problems were experienced by 16 percent of whites, 23 percent of African-Americans, 33 percent of Hispanics, and 27 percent of Asian-Americans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Racial and ethnic disparities in healthcare",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two reports from the Institute of Medicine highlighted the importance of patient-centered care and effective cross-cultural communication as a means of improving quality, achieving equity, and eliminating the significant",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    disparities in health care that persist today [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Some representative findings indicating these disparities follow:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      African-Americans are less likely than non-Hispanic whites to be referred for cardiac catheterization for coronary artery disease [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hispanics with isolated long bone fractures were twice as likely as non-Hispanic whites to receive no pain medication in the emergency department, in a study from one US academic medical center [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/22\">",
"       22",
"      </a>",
"      ]. Despite an increase in the past decade in opioid use for pain-related diagnoses visits in US emergency departments, disparity in pain treatment between ethnic groups has not decreased [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/23\">",
"       23",
"      </a>",
"      ]. Compared to white patients, the odds ratios for black, Hispanic, or Asian patients to receive opioid treatment were 0.66, 0.67, and 0.79 respectively.",
"     </li>",
"     <li>",
"      The risk of an African-American developing end stage renal disease requiring dialysis is four times greater than a European-American [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/24\">",
"       24",
"      </a>",
"      ]. Once on dialysis, African-American patients are only 70 percent as likely to be referred for evaluation for renal transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      African-Americans with hyperlipidemia, compared to non-Hispanic whites, are less likely to achieve target lipid levels, less likely to be using medication to control lipids, and less likely to be taking high efficacy statin drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Asian-Americans, compared to non-Hispanic whites, have lower rates of cancer screening (colorectal and breast), adjusting for access to care and socioeconomic status [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/27\">",
"       27",
"      </a>",
"      ]. Foreign-born Asians, on survey, believed that cancer screening should be a response to symptoms and declined tests because of lack of symptoms.",
"     </li>",
"     <li>",
"      Minorities in the United States are less likely to seek mental health treatment when indicated than are White Americans; mental health providers (psychiatrists, psychologists and social workers) are less likely than general medical practitioners to be Hispanic, black, Asian, or native American [",
"      <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most of these studies account for potential confounding factors such as socioeconomic status, insurance status, and disease severity, and still the",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    disparities remain. Multiple factors contribute to racial disparity in healthcare, including barriers to effective clinician-patient interactions (eg language and literacy issues, and different cultural beliefs), systems barriers (eg lack of interpreter services or ethnically diverse clinicians), and clinician biases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/29\">",
"     29",
"    </a>",
"    ]. It is unlikely any single intervention to improve treatment adherence or screening rates, for example, will address the variety of issues across different populations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The studies cited above largely address patients within the health care system. Many patients never receive care due to lack of access, or their social environments impact their health in other ways. These social determinants may have an even greater detrimental effect on the health of minorities and the poor than disparities in health care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Accreditation standards and quality measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Joint Commission, which accredits healthcare organizations, and the National Quality Forum, have all developed new standards and measures in the area of cultural competence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/31-33\">",
"     31-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Skills for cross-cultural care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cross-cultural care is based on universal principles of patient-centered care. Until recently, many have thought that cross-cultural care simply entails addressing language barriers in the clinical encounter, and learning the norms of specific cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/34\">",
"     34",
"    </a>",
"    ]. While the former remains a key component of cross-cultural care, the latter is more problematic. Previous efforts in cross-cultural education have aimed to teach about attitudes, values, beliefs, and behaviors of certain cultural groups (eg, the key practice \"do's and don'ts\" in caring for the \"Latino\" patient) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Learning about a particular local community or cultural group can be helpful in certain situations. Following the principles of community-oriented care, it is important to explore the beliefs, values, and customs, as well as the historical experiences, of the cultural groups most frequently seen in a given medical practice. This may be especially important for new immigrant groups, who may reside in the same neighborhood and share the immigration experience.",
"   </p>",
"   <p>",
"    This approach, however, can lead to stereotyping and oversimplification of culture without respect for its complexity. Balancing knowledge of an individual and knowledge about groups is one of the tightropes of cross-cultural health care. As an example, Latinos may have some commonalities (eg, the Spanish language) but represent many subgroups from different countries, ethnicities, and cultures. Diversity also exists within subgroups, based on factors such as social status, acculturation, age, local environment, and individuality.",
"   </p>",
"   <p>",
"    Components of cross-cultural care include effective use of interpreters, familiarity with differences in disease epidemiology, and comfort level in working with patients who are culturally different than oneself. Additionally, cross-cultural care goes beyond learning about patients based on their racial, ethnic, or cultural background, to focusing on the skills required to follow the principles of patient-centered care [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient-centeredness encompasses qualities of compassion, empathy, and responsiveness to the needs, values, and expressed preferences of the individual patient. Cross-cultural care aims to take this a step further to include skills that are especially useful in cross-cultural interactions, but remain vital to all clinical encounters.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     THE PATIENT-BASED APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient-based approach is derived from research in cross-cultural care and communication, medical anthropology and sociology, as well as medical interviewing [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/17\">",
"     17",
"    </a>",
"    ]. This framework allows the clinician to learn from the individual patient the social and cultural factors that influence his or her health values, beliefs, and behaviors, and offers strategies to negotiate for the best health outcome possible.",
"   </p>",
"   <p>",
"    The patient-based approach to cross-cultural care and communication entails four components: assessing core cross-cultural issues; exploring the meaning of the illness; determining the social context; and engaging in negotiation. Time constraints will likely make it difficult to address in detail all of these components in a single visit; clinicians should tailor their exploration to aspects pertinent to the specific patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Assess core issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Misunderstandings between patients and health care clinicians often reflect inherent differences in cultural values and expectations. These misunderstandings can lead to outcomes ranging from mild discomfort to a major lack of trust that disintegrates the therapeutic relationship.",
"   </p>",
"   <p>",
"    The vast number of cultural and ethnic groups that may be encountered in a clinical practice make it impractical, if not impossible, to learn specific aspects of each that could influence the medical encounter. Fortunately, certain core cross-cultural issues tend to recur across cultures. As an example, one study found a lower level of patient autonomy, and an emphasis on the role of the family in medical decision-making among both Korean and Hispanic patients compared to African-Americans and European-Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rather than attempt to learn an encyclopedia of culture-specific issues, a more practical approach is to recognize a set of common problems that occur in cross-cultural medical encounters. Five core cross-cultural issues that should be taken into account are: styles of communication; mistrust and prejudice; decision-making and family dynamics; traditions, customs, and spirituality; and sexual and gender issues (",
"    <a class=\"graphic graphic_table graphicRef65015 \" href=\"UTD.htm?0/17/283\">",
"     table 1",
"    </a>",
"    ). Once a potential core issue is recognized, it can be explored further by inquiring about the patient's own belief or preference, which may be quite different than the \"cultural norm.\"",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Styles of communication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Differences in styles of communication between patient and clinician, which can lead to discomfort and miscommunication, include both verbal and non-verbal communication: eye contact, touch, and personal space. Direct eye contact may be avoided in some cultures, while in others it is a sign of respect. Providers should be aware of their own tendencies and should be sensitive to the preferences of their patients.",
"   </p>",
"   <p>",
"    Another key aspect of communication is level of assertiveness, which may range from deferent to aggressive. It should not be assumed that a quiet patient agrees with the plan outlined by the provider. A deferent patient may simply be hesitant to voice a conflicting view, making it crucial to ask for the patient's input and encourage verbalization of any disagreement.",
"   </p>",
"   <p>",
"    Communication issues become more complex when preferences around relating \"bad news\" to a patient need to be considered. Providers may incorrectly assume that patients should be informed of results and diagnoses, just as providers themselves would wish such news delivered. Personal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cultural preferences for a direct or indirect approach vary and should be elicited from patients, ideally before ordering an important test. This technique is often used in HIV pretest counseling, and an abbreviated version can be adapted prior to a colonoscopy or CT scan.",
"   </p>",
"   <p>",
"    Techniques for adapting to different communication styles and customs are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Get a sense for the patient's general communication style and adapt your style of communicating to fit best with",
"      <span class=\"nowrap\">",
"       hers/his.",
"      </span>",
"     </li>",
"     <li>",
"      Try to draw out indirect or reserved patients by making them feel comfortable and asking open-ended questions. Do not assume that lack of resistance means agreement with your plan or recommendations.",
"     </li>",
"     <li>",
"      Determine how the patient prefers to receive information about results of testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"I am going to check the report of your sonogram tomorrow and would like to let you know the results. Some of my patients want to be told directly, no matter what the test shows, even over the phone. While I don't suspect that there will be anything serious, I would like to know how you prefer to hear the results.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Get a sense for whether the patient is more stoic or expressive of pain and symptoms. Avoid judging patients based on your own cultural perspective.",
"     </li>",
"     <li>",
"      Pay attention to cultural differences in personal space, eye contact, body language. Try to be flexible, and not to be misled by misinterpretation of communication cues.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Trust",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trust is a crucial element in the therapeutic alliance between patient and health care provider. It correlates directly with adherence to physician recommendations and patient satisfaction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Mistrust of the health care system also affects patient's use of services, and results in inconsistent care, doctor shopping, self-medicating, and an increased demand for referrals and diagnostic tests by patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A national telephone survey in 2000 found significant mistrust for the health care system among minority populations: of the individuals surveyed (n = 3884), 35 percent of African-Americans and 36 percent of Hispanics (compared to 15 percent of whites) felt they had been treated unfairly in the health care system, and 65 percent of African-Americans and 58 percent of Hispanics (compared to 22 percent of whites) were afraid of being treated unfairly in the future based on their race and ethnicity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    African-Americans in particular may be mistrustful of providers, based on a history of discrimination, segregation, and medical experimentation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/41\">",
"     41",
"    </a>",
"    ]. The exploitation by the US Public Health Service during the Tuskegee study left a legacy that persists even today [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The provider should be aware of cues that may indicate some degree of mistrust. Patients may express concerns about whether a particular test is necessary, or they may mention a bad experience in the past. These should lead to direct efforts at reassurance and trust-building. Suggestions for building trust with patients, especially across cultures, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Discuss mistrust openly. If the patient seems open to it, discuss why they might feel mistrustful of doctors or medical care. Reassure them of your intentions to help.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"You've mentioned that you don't really like coming to doctors. Was there anything in particular that led you to feel that way? (Any bad experiences or concerns?)\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Explore the patient's perspective. Ask what's important for",
"      <span class=\"nowrap\">",
"       her/him.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"What are your thoughts about having this operation?\"",
"     </li>",
"     <li>",
"      \"What were you hoping that I could do for you today?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Provide focused reassurance. After determining the patient's perspective and concerns, focus reassurance on those concerns.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"You've told me that the pain is what you're really worried about so I'm going to make absolutely sure that you'll have enough pain medication after the operation.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Build a partnership. Many mistrustful patients respond well to being given options and some control over their health care decisions.",
"     </li>",
"     <li>",
"      Communicate clearly. Listen carefully, avoid medical jargon, and check in regularly for feedback from the patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Family dynamics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians in the US may take for granted that patients wish to make decisions about their own medical care, based on information and guidance provided by their health care providers. Autonomy is not the norm in all cultures, however, and family members or others may be very involved in the decision-making process. The family may look to a specific authority figure, determined by gender, position in the family, or level of acculturation, as the decision-maker.",
"   </p>",
"   <p>",
"    Families may even wish to exclude the patient from decisions, to avoid what they perceive as undue stress for the patient. A common issue occurs when a family asks the health care team to withhold a terminal diagnosis from a patient. In this situation, the family as a unit is trying to do what they feel is best for the individual patient. However, this conflicts with our own medical ethics which places great value on patient autonomy and the \"right to know.\" A negotiation might lead to accord in these situations, if the patient herself agrees to allow her family to make medical decisions on her behalf.",
"   </p>",
"   <p>",
"    Techniques for understanding cultural differences in decision-making and family dynamics include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Introduce yourself respectfully to the patient and others in the room and determine their relation to the patient, keeping in mind that in some cultures it is appropriate to speak only to certain individuals.",
"     </li>",
"     <li>",
"      Find out if the patient prefers autonomy, or would want the family, or someone in particular, to be involved in medical decision-making.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"How much do you want your family to be involved in making decisions regarding your health care (such as tests or medications)?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Find out if there is an authority figure in the family, community or religious group, to consult and involve in important decisions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"Is there anyone in particular whom we should talk to about your health care besides you, someone who makes decisions in your family (or community)?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consider allowing a patient to waive their right to know (legal documents can be signed in this case) when the family wants to withhold information.",
"     </li>",
"     <li>",
"      When a dominant family member is not allowing direct communication with the patient, explain the situation tactfully. If this fails, try ways to obtain information directly from the patient without offending the relative. However, if there is any concern for domestic abuse, laws protecting the patient should supersede issues of cultural sensitivity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"I appreciate what you're saying Mr.------, your input is very important. From a medical standpoint, though, it's also very important for me to hear a description of the problem from the patient herself, so I can make a more accurate diagnosis.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Realize that in many cultures it is typical (and important) for family members (as many as 5 or 10) to stay with the patient in the hospital at all times. If this leads to difficulty for the staff, it should be negotiated openly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Traditions, customs, and spirituality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the myriad of traditions and customs that help to shape a persons cultural environment have a significant relation to health and illness, including issues relating to dietary practices, folk remedies, and certain religious customs. It is not possible to describe even a fraction of these medically relevant traditions and customs. It is important to have an awareness of their importance, as well as openness and skills to explore them further with individual patients.",
"   </p>",
"   <p>",
"    Many of these health-based traditions and customs are directly related to the patient's world-view, religion, or spiritual beliefs. Illness and death are among the most powerful and mysterious phenomena in our existence, and people often seek meaning in these experiences through spirituality. Physicians may undervalue the importance of addressing spiritual concerns with patients in the primary care setting [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/44\">",
"     44",
"    </a>",
"    ]. Patient expressions of spirituality should be discussed when appropriate and relevant to the clinical interaction.",
"   </p>",
"   <p>",
"    Questions for clinicians about customs, religion and, spirituality include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Can you tell me anything about your customs that might affect your health care? What about your diet?",
"     </li>",
"     <li>",
"      How important is religion (or spirituality) in your life?",
"     </li>",
"     <li>",
"      Some patients have spiritual or religious beliefs that prevent them from having certain tests or treatments, such as blood transfusions. Do you have any specific concerns?",
"     </li>",
"     <li>",
"      How important are these beliefs to you, and do they influence how you care for yourself or what type of care you might receive?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Sexual and gender issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many parts of the world, including the Middle East, Africa, and South Asia, gender roles are strictly defined and enforced. The male role is commonly seen as that of protector and spokesperson for the family. Cultural differences in attitudes towards sexuality and gender roles can be \"hot button\" issues and should be negotiated with tact and respect to maintain the therapeutic relationship.",
"   </p>",
"   <p>",
"    Difficult situations may arise due to the patient and provider being of different (or the same) gender: discomfort with genital, breast, or rectal exams, or shame in discussing sexual issues. Health care providers should keep sexual and gender issues in mind when dealing with patients of all cultures, but especially when the patient is traditional or conservative, to promote a trusting relationship.",
"   </p>",
"   <p>",
"    Techniques for understanding sexual and gender issues, customs, and taboos include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Be aware of the different ways that patients and families view gender roles and try to accommodate them when feasible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"Unfortunately, we have no female obstetricians in clinic today, but if you are willing to reschedule your appointment, I can make sure that your wife will see a female doctor next week.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A judgmental attitude toward patients is unlikely to change behaviors and values, but may compromise the clinician-patient relationship and the ability to provide good health care.",
"     </li>",
"     <li>",
"      Ask",
"      <span class=\"nowrap\">",
"       patients/family",
"      </span>",
"      what is acceptable to them, rather than making assumptions based on limited information (name, clothing, etc).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"I perform breast examinations on all of my female patients to look for signs of breast cancer or other problems. Is this okay with you?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Be particularly sensitive to patients' views on discussing sexual issues openly. State that you will be asking about some personal issues and explain why, especially in interactions where you are unfamiliar with the patient's cultural background.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"I generally ask all patients about some very personal matters at this point, which are important for doctors to know about. Are you comfortable talking about these things with me?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recognize that patients' views and language regarding sexuality and sexual orientation may differ. Ask whether patients have had sexual partners who are men or women rather than whether they are gay, bisexual, etc.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Explore the meaning of illness",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     The explanatory model",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients seeking care for a medical issue come with certain beliefs about the cause of their symptoms, concerns about their illness, and expectations about potential treatment. Their overall conceptualization of their illness has been called the patient's explanatory model [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The explanatory model represents the \"meaning of the illness\" for the patient, or how they understand and explain their condition. Patients' explanatory models can range broadly, from the mundane to the exotic, and may be more complex than what is initially apparent. Understanding these models is useful for all patient encounters, but particularly so for patients whose perspectives on health and illness may differ significantly from the Western model of biomedicine.",
"   </p>",
"   <p>",
"    Common sense and lay health beliefs are the most typical type of explanatory model. Limited education, low health literacy, lack of information, or mistrust of medicine may lead people to develop their own ideas about the causes, consequences, and appropriate treatment of their illness. Sometimes beliefs are simply misunderstandings about medical information, such as the idea that diabetes can be controlled by avoiding sugar.",
"   </p>",
"   <p>",
"    There is individual variation in how tightly people adhere to their beliefs. Some will be happy to learn \"the truth\" from a physician. Others will ignore whatever they are told if it doesn't take into account their own particular perspective and respect their common sense.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Belief systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are often initially hesitant to reveal their beliefs and fears. Respectful questioning and reassurance may overcome this resistance. Focusing on what others may believe, or on hypothetical situations, may help relieve the patient's discomfort.",
"   </p>",
"   <p>",
"    The following questions can be adapted for use in various contexts besides illness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/1\">",
"     1",
"    </a>",
"    ]. As an example, they may be used to explore the meaning of a particular procedure or treatment for a patient, such as a breast biopsy or chemotherapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      What do you think may have caused the problem? &mdash; This question gets at the patient's beliefs about the cause of the illness, the most fundamental and important aspect of the explanatory model. Clinicians have developed their own personal styles and phrasing, modified to suit the particular situation, to address this question.",
"     </li>",
"     <li>",
"      What do you call the problem? &mdash; This question may be especially useful when you suspect the patient believes a particular folk illness to be causing the symptoms. Another way to phrase this would be, \"Do you have a name for this sickness (in your language)?\"",
"     </li>",
"     <li>",
"      Why do you think it started when it did? &mdash; This can help link the illness to certain events in the patient's life that may be important elements of the explanatory model. A related question is, \"What was going on in your life at the time that this illness started?\"",
"     </li>",
"     <li>",
"      What do you know about the illness and how it works? &mdash; This gets at the patient's deeper understanding of the illness and how it affects him or her. Patients may not be able to answer this, just as patients who believe that viruses cause colds most often would not be able to describe how this works.",
"     </li>",
"     <li>",
"      How severe is the illness? How worried are you about it? &mdash; Patients may be very worried about an illness while the physician is not, when symptoms do not suggest a concerning disease. The opposite may also be true, when the patient feels the illness to be minor and does not fully believe the physician's diagnosis. This is important to discuss as openly as possible.",
"     </li>",
"     <li>",
"      What kind of treatment do you think you should receive? What are the most important results you hope to get from this treatment? &mdash; Part of the patient's understanding of their illness has to do with their beliefs about its treatment. Traditional and alternative healers and remedies play a large role in many patients' perspective on health and illness. They may also have opinions on Western medical therapy as well, which should be taken into consideration.",
"     </li>",
"     <li>",
"      What are the chief problems the sickness has caused? &mdash; This is a good way to discuss the effect that the illness has had on the patient's life and daily routine. Understanding this allows better insight into the patient's unique illness experience. Other ways to phrase this include, \"How has this illness affected your life?\" or \"What has changed in your life since this illness started?\"",
"     </li>",
"     <li>",
"      What do you fear most about the sickness? &mdash; This is a crucial question; it allows the physician to tailor his or her explanation of the illness and its treatment to the patient's concerns. This can also be extremely helpful to understand a patient's perspective on a particular medication or procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Alternative therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of traditional remedies, healing practices or other forms of alternative therapy is widespread both in patients in the US mainstream as well as those from other cultures. The Institute of Medicine Report on Complementary and Alternative Medicine found that over a third of Americans rely on unconventional practices either in conjunction with medications or in place of them [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/4/20554?source=see_link\">",
"     \"Overview of herbal medicine and dietary supplements\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/13/40154?source=see_link\">",
"     \"Complementary and alternative therapies for cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7513?source=see_link\">",
"     \"Complementary and alternative remedies in rheumatic disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Techniques to understand the patients use of",
"    <span class=\"nowrap\">",
"     complementary/alternative",
"    </span>",
"    medicine include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ask patients in a non-judgmental, open-minded way about non-medical, alternative practices (can be asked after \"medications\" in the medical history).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"A lot of my patients use other forms of treatment, like home remedies, herbs, or acupuncture, that can be helpful. Besides the medications that you mentioned, have you used any other types of therapy?\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Check to see whether alternative therapies are safe and look for any interactions with medications.",
"     </li>",
"     <li>",
"      Negotiate the use of alternative therapies along with standard medicine when safe and important to the patient, and discuss reasons to discontinue any dangerous ones.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Determine the social context",
"    </span>",
"    &nbsp;&mdash;&nbsp;The manifestations of a person's illness are inextricably linked to the individual's social environment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/46\">",
"     46",
"    </a>",
"    ]. This social context is not limited to socioeconomic status, but encompasses migration history, social networks, literacy, and other factors. There is a vast literature defining the relationship of these social factors to health status and elucidating the effects of social class barriers between patient and doctor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three specific aspects of the patient's social text have particular relevance to the cross-cultural clinical encounter: change in environment (such as migration); literacy and language; and life control, social stressors, and supports [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Environment change",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environment change refers to any migration, whether from a different country, town, or even neighborhood, that requires adaptation to new physical and social surroundings. Adaptation to a new way of life often poses an enormous stress on the individual.",
"   </p>",
"   <p>",
"    The reasons for the migration, ranging from fleeing political persecution or torture to attending a university, may be crucial in understanding past and present stresses. A change in economic and professional status (eg, from physician to lab technician) may also be relevant. Mental illness and psychosomatization are potential consequences of this stress and should be recognized and managed with awareness of the social context.",
"   </p>",
"   <p>",
"    There may be difficulty negotiating the unfamiliar medical system, especially for patients accustomed to a very different health system. Understanding the patient's unique migration experience can help the health care provider build rapport and trust, allay certain concerns (such as fear of deportation), acknowledge sources of distress which may be causing psychological or psychosomatic problems, and focus on interventions which facilitate the patient's transition.",
"   </p>",
"   <p>",
"    Questions regarding environment change include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Where are you from originally? When did you come and why did you decide to come?",
"     </li>",
"     <li>",
"      How have you found life here compared to life in your country (city, town)?",
"     </li>",
"     <li>",
"      What was medical care like there compared to here?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Language and literacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the 2010 US Census, 55.4 million United States residents speak languages other than English at home. This represents 19.7 percent of the total population (up from 18 percent in 2000), and in some states, such as California, the figure is as high as 42.6 percent. Nearly half of these individuals have difficulty speaking and understanding English.",
"   </p>",
"   <p>",
"    Language barriers affect quality of care in several ways. Studies have found that Spanish-speaking patients discharged from the emergency room are less likely than English-speaking patients to understand their diagnosis, medication plans, special instructions, and plans for follow-up care; less likely to be satisfied with their care or willing to return if they had a problem; more likely to report problems with their care; and less satisfied with the patient-clinician relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Hispanics who spoke Spanish at home, compared to those who spoke English at home, were less likely to receive recommended health services in a representative household survey of health care utilization in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with limited English proficiency (LEP) and",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    minorities are more likely than their English-speaking white counterparts to suffer from adverse events, and these adverse events tend to have greater clinical consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/52\">",
"     52",
"    </a>",
"    ]. Communication problems are the most frequent cause of serious adverse events as recorded by the Joint Commission [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/53\">",
"     53",
"    </a>",
"    ]. Effective communication is compromised by language barriers, cultural differences, and low health literacy, all of which are particularly important issues for patients of",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    minority [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interpreter services are often unavailable, family member interpreters (especially children) are often inaccurate and unreliable, and physicians are rarely trained in how best to work with interpreters [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. Assessing a patient's language proficiency is essential for delivering care to immigrant populations. Four factors should be considered in determining need for an interpreter: the clinical situation, the degree of language gap, available resources, and patient preferences [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/57\">",
"     57",
"    </a>",
"    ]. When an interpreter is needed and a professional interpreter is not readily available, options include telephone interpretation systems, or a family member or friend who has been briefed on the expectations of interpretation. Children should not be used as interpreters except in emergency situations where there are no alternatives.",
"   </p>",
"   <p>",
"    More than 30 percent of the US population is functionally illiterate and innumerate, and approximately 45 percent have low health literacy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/58\">",
"     58",
"    </a>",
"    ]. Health literacy is the degree to which an individual can understand medical terms about symptoms and illness, follow directions for procedures and therapies, and ask pertinent questions. Immigrant patients may be illiterate in both English and their native language. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17609?source=see_link\">",
"     \"Literacy and patient care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians need to identify patients with language and literacy barriers, and refer them to appropriate resources. Questions to be asked regarding language and need for interpretative services are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How well do you speak English: Not at all, not well, well, or very well?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the patient responds \"not at all\" or \"not well,\" an interpreter is appropriate; if the response is \"very well,\" interpretation is not necessary; if the response is \"well,\" a second question should be asked:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In what language do you prefer to receive your medical care?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A study of 300 patients in a California clinic found that these two sequential questions had a sensitivity of 99 percent and specificity of 92 percent to identify patients who would prefer to discuss their medical concerns in Spanish [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Questions that may be asked to evaluate literacy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Do you have trouble reading your medication bottles, instructions, or other patient information?",
"     </li>",
"     <li>",
"      Do you have trouble with reading in general?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Life control, stress, and support",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient's lack of control over their environment can clearly impact their health seeking behavior and symptom threshold. Some patients will present at the earliest stages of their disease, while others will tolerate a great deal of symptomatic distress before presenting for care. While part of this variation may be cultural or characterological, there is undeniably a socioeconomic component related to being able to take time from work or family responsibilities, or being able to pay medical fees. Awareness helps the health care provider develop a plan that may include accessing available financial supports and social services.",
"   </p>",
"   <p>",
"    Social stressors and supports may have strong impact on a patient's illness experience. A socially isolated patient may manifest more symptomatology related to a given illness than a patient with a broader set of social supports.",
"   </p>",
"   <p>",
"    Questions helpful to gain understanding of issues related to life control, social stressors and supports include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      What is causing the most stress in your life? How do you deal with this (ie, family, friends, activities, religion)?",
"     </li>",
"     <li>",
"      Do you ever feel that you're not able to afford food, medications, or other medical expenses?",
"     </li>",
"     <li>",
"      Do you feel that you have the ability to affect your own health (or particular medical condition) or is it out of your control?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Engage in negotiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the emphasis of cross-cultural communication has to do with exploring patients' perspectives. Even when sociocultural backgrounds are similar, substantial differences may exist in expectations, agendas, and values between patients and clinicians. There is no simple answer to the problems that arise when patient views differ and conflict with our own. The process of cross-cultural negotiation can be helpful in acknowledging different explanatory models or agendas and developing management strategies.",
"   </p>",
"   <p>",
"    Negotiation is not about trying to convince patients who are refusing medical treatment that they should accept what we say. It requires getting beyond the notion that whatever we think as medical professionals is right for everyone. It is about teaching people what we know in a way that they can understand and that also values their system of beliefs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24537/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following steps are helpful in the negotiation process:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Step 1: Explore the patient's perspective &mdash; Ask open-ended questions about the patient's understanding and concerns about the illness and its treatment.",
"     </li>",
"     <li>",
"      Step 2: Explain your perspective &mdash; Provide the patient with an explanation in terms that are understandable and familiar, sharing what you hope will be beneficial for them if they follow your recommendations.",
"     </li>",
"     <li>",
"      Step 3: Acknowledge the difference in opinion &mdash; Do this in a way that is non-judgmental and accepting of difference.",
"     </li>",
"     <li>",
"      Step 4: Create common ground &mdash; This may mean offering a compromise or asking the patient what they are willing to do. This often requires some back and forth discussion in an environment where the patient feels they can be open.",
"     </li>",
"     <li>",
"      Step 5: Settle on a mutually acceptable plan &mdash; Once a plan is developed, check in with the patient again to make sure that it is acceptable. Look for any sign of hesitation on the part of the patient and discuss this openly. Ensure that the patient understands and has retained the plan that has been negotiated and articulated by the provider in language that is plain, simple, and understandable to the patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If conflict remains after initial negotiation, it may be helpful, if the patient is willing, to involve other individuals who the patient trusts. When a mutually agreeable plan or understanding cannot be reached with a competent adult patient, it is important to document the negotiation process in the medical record and acknowledge that the patient has the ultimate decision in his or her health care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sociocultural differences between patient and provider influence communication and clinical decision-making. Lower-quality care may result when clinicians fail to recognize and understand sociocultural differences between their patients and themselves. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cross-cultural care is based on universal principles of patient-centered care, and does not entail simply \"learning\" the norms of specific cultures. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cross-cultural care and communication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Core cross-cultural issues that should be explored, when relevant to care, are: styles of communication, mistrust and prejudice, decision-making and family dynamics, traditions and spirituality, and sexual and gender issues. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Assess core issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The explanatory model represents how the patient understands his or her illness: its cause, meaning, and consequence. Understanding a patient's explanatory model allows the clinician to adapt communication and treatment recommendations to the patient's concerns and perspectives. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Explore the meaning of illness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The patient-based approach to providing quality cross-cultural care entails four basic components: assessing core cross-cultural issues, exploring the patient's explanatory model, understanding the social context (environmental change, language, literacy, stressors, and social supports), and negotiating for a mutually acceptable approach to treatment. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'The patient-based approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/1\">",
"      Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978; 88:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/2\">",
"      Hill RF, Fortenberry JD, Stein HF. Culture in clinical medicine. South Med J 1990; 83:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/3\">",
"      Berger JT. Culture and ethnicity in clinical care. Arch Intern Med 1998; 158:2085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/4\">",
"      Pachter LM. Culture and clinical care. Folk illness beliefs and behaviors and their implications for health care delivery. JAMA 1994; 271:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/5\">",
"      Einbinder LC, Schulman KA. The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev 2000; 57 Suppl 1:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/6\">",
"      Flores G. Culture and the patient-physician relationship: achieving cultural competency in health care. J Pediatr 2000; 136:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/7\">",
"      Epner DE, Baile WF. Patient-centered care: the key to cultural competence. Ann Oncol 2012; 23 Suppl 3:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/8\">",
"      Eisenberg JM. Sociologic influences on decision-making by clinicians. Ann Intern Med 1979; 90:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/9\">",
"      Stewart M, Brown JB, Boon H, et al. Evidence on patient-doctor communication. Cancer Prev Control 1999; 3:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/10\">",
"      Betancourt JR, Carrillo JE, Green AR. Hypertension in multicultural and minority populations: linking communication to compliance. Curr Hypertens Rep 1999; 1:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/11\">",
"      Beach MC, Price EG, Gary TL, et al. Cultural competence: a systematic review of health care provider educational interventions. Med Care 2005; 43:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/12\">",
"      Smith WR, Betancourt JR, Wynia MK, et al. Recommendations for teaching about racial and ethnic disparities in health and health care. Ann Intern Med 2007; 147:654.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.jointcommission.org/assets/1/6/ARoadmapforHospitalsfinalversion727.pdf (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     https://www.cms.gov/hospitalqualityinits/30_hospitalhcahps.asp (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/15\">",
"      Clancy C, Brach C, Abrams M. Assessing patient experiences of providers' cultural competence and health literacy practices: CAHPS Item Sets. Med Care 2012; 50:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/16\">",
"      Weissman JS, Betancourt J, Campbell EG, et al. Resident physicians' preparedness to provide cross-cultural care. JAMA 2005; 294:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/17\">",
"      Carrillo JE, Green AR, Betancourt JR. Cross-cultural primary care: a patient-based approach. Ann Intern Med 1999; 130:829.",
"     </a>",
"    </li>",
"    <li>",
"     Commonwealth Fund Health Care Quality survey, 2001. Available at: www.cmwf.org/surveys (Accessed on March 15, 2006).",
"    </li>",
"    <li>",
"     Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. National Academies Press; Washington, CT 2001.",
"    </li>",
"    <li>",
"     Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academy Press; Washington, DC 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/21\">",
"      Buckley RS, Kaul S, Jayaweera AR, et al. Quantification of mitral regurgitation in the cardiac catheterization laboratory with contrast echocardiography. Am Heart J 2000; 139:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/22\">",
"      Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993; 269:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/23\">",
"      Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008; 299:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/24\">",
"      Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/25\">",
"      Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med 1999; 341:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/26\">",
"      Clark LT, Maki KC, Galant R, et al. Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med 2006; 21:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/27\">",
"      Kandula NR, Wen M, Jacobs EA, Lauderdale DS. Low rates of colorectal, cervical, and breast cancer screening in Asian Americans compared with non-Hispanic whites: Cultural influences or access to care? Cancer 2006; 107:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/28\">",
"      Miranda J, McGuire TG, Williams DR, Wang P. Mental health in the context of health disparities. Am J Psychiatry 2008; 165:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/29\">",
"      Green AR, Carney DR, Pallin DJ, et al. Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med 2007; 22:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/30\">",
"      Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 2008; 168:1317.",
"     </a>",
"    </li>",
"    <li>",
"     National Quality Forum. Endorsing a framework and preferred practices for measuring and reporting cultural competency (ongoing Project). Accessed at: www.qualityforum.org/projects/ongoing/cultural-comp/ (Accessed on March 15, 2006).",
"    </li>",
"    <li>",
"     Wilson-Stronks A, Galvez E. Exploring Cultural and Linguistic Services in the Nation's Hospitals: A Report of Findings. The Joint Commission; Oakbrook Terrace, IL 2007.",
"    </li>",
"    <li>",
"     Wilson-Stronks A, Lee KK, Cordero C, et al. One size does not fit all: Diverse populations pose special health needs. The Joint Commission and California Endowment; 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/34\">",
"      Donini-Lenhoff FG, Hedrick HL. Increasing awareness and implementation of cultural competence principles in health professions education. J Allied Health 2000; 29:241.",
"     </a>",
"    </li>",
"    <li>",
"     Paniagua FA. and Treating Culturally Diverse Clients: A Practical Guide, Sage Publications, Thousand Oaks, CA 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/36\">",
"      Blackhall LJ, Murphy ST, Frank G, et al. Ethnicity and attitudes toward patient autonomy. JAMA 1995; 274:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/37\">",
"      Petersen LA. Racial differences in trust: reaping what we have sown? Med Care 2002; 40:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/38\">",
"      Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract 1997; 44:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/39\">",
"      Safran DG, Taira DA, Rogers WH, et al. Linking primary care performance to outcomes of care. J Fam Pract 1998; 47:213.",
"     </a>",
"    </li>",
"    <li>",
"     Race, Ethnicity and Medical Care, A Survey of Public Perceptions and Experiences (KFF) Kaiser Family Foundation. Available at: www.kff.org (Accessed on March 11, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/41\">",
"      Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 1997; 87:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/42\">",
"      Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation. Am J Med Sci 1999; 317:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/43\">",
"      Brandt AM. Racism and research: the case of the Tuskegee Syphilis Study. Hastings Cent Rep 1978; 8:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/44\">",
"      Puchalski CM. The role of spirituality in health care. Proc (Bayl Univ Med Cent) 2001; 14:352.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Complementary and Alternative Medicine in the US. National Academies Press; Washington, DC 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/46\">",
"      Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998; 129:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/47\">",
"      Feinstein JS. The relationship between socioeconomic status and health: a review of the literature. Milbank Q 1993; 71:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/48\">",
"      Green AR, Betancourt JR, Carrillo JE. Integrating social factors into cross-cultural medical education. Acad Med 2002; 77:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/49\">",
"      Crane JA. Patient comprehension of doctor-patient communication on discharge from the emergency department. J Emerg Med 1997; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/50\">",
"      Carrasquillo O, Orav EJ, Brennan TA, Burstin HR. Impact of language barriers on patient satisfaction in an emergency department. J Gen Intern Med 1999; 14:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/51\">",
"      Cheng EM, Chen A, Cunningham W. Primary language and receipt of recommended health care among Hispanics in the United States. J Gen Intern Med 2007; 22 Suppl 2:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/52\">",
"      Divi C, Koss RG, Schmaltz SP, Loeb JM. Language proficiency and adverse events in US hospitals: a pilot study. Int J Qual Health Care 2007; 19:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/53\">",
"      Schyve PM. Language differences as a barrier to quality and safety in health care: the Joint Commission perspective. J Gen Intern Med 2007; 22 Suppl 2:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/54\">",
"      Flores G, Ngui E. Racial/ethnic disparities and patient safety. Pediatr Clin North Am 2006; 53:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/55\">",
"      Flores G. Language barriers to health care in the United States. N Engl J Med 2006; 355:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/56\">",
"      Lee KC, Winickoff JP, Kim MK, et al. Resident physicians' use of professional and nonprofessional interpreters: a national survey. JAMA 2006; 296:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/57\">",
"      Schenker Y, Lo B, Ettinger KM, Fernandez A. Navigating language barriers under difficult circumstances. Ann Intern Med 2008; 149:264.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Report brief. Health literacy: a prescription to end confusion. Available at: www.iom.edu/CMS/3775/3827/19723/19726.aspx (Accessed on June 12, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/59\">",
"      Karliner LS, Napoles-Springer AM, Schillinger D, et al. Identification of limited English proficient patients in clinical care. J Gen Intern Med 2008; 23:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24537/abstract/60\">",
"      Botelho RJ. A negotiation model for the doctor-patient relationship. Fam Pract 1992; 9:210.",
"     </a>",
"    </li>",
"    <li>",
"     Katon W, Kleinman A. Doctor-patient negotiation and other social science strategies in patient care. In: The Relevance of Social Science for Medicine, Eisenberg L, Kleinman A (Eds), D Reidel Publishing Company, 1980.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2753 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-18C9BB78CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24537=[""].join("\n");
var outline_f23_61_24537=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINING CULTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CROSS-CULTURAL CARE AND COMMUNICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Increasingly diverse population",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Effective communication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Racial and ethnic disparities in healthcare",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Accreditation standards and quality measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Skills for cross-cultural care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      THE PATIENT-BASED APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Assess core issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Styles of communication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Trust",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Family dynamics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Traditions, customs, and spirituality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Sexual and gender issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Explore the meaning of illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - The explanatory model",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Belief systems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Alternative therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Determine the social context",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Environment change",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Language and literacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Life control, stress, and support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Engage in negotiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2753\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2753|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/17/283\" title=\"table 1\">",
"      Core cross cultural issues",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19831?source=related_link\">",
"      A patient-centered view of the clinician-patient relationship",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7513?source=related_link\">",
"      Complementary and alternative remedies in rheumatic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/13/40154?source=related_link\">",
"      Complementary and alternative therapies for cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17609?source=related_link\">",
"      Literacy and patient care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/4/20554?source=related_link\">",
"      Overview of herbal medicine and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/3/8249?source=related_link\">",
"      Patient-centered interviewing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_61_24538="Fever and rash in HIV-infected patients";
var content_f23_61_24538=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Fever and rash in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Fred A Lopez, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Charles V Sanders, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24538/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/61/24538/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/61/24538/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatologic manifestations affect 80 to 90 percent of individuals infected with the human immunodeficiency virus (HIV) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The frequency of cutaneous manifestations was illustrated in a review of 684 HIV-infected patients who were followed for almost three years; 540 patients (79 percent) were given one or more (average 3.7) dermatologic diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Importantly, a higher number of mucocutaneous diseases in HIV-infected patients has been shown to correlate with poor prognosis and a shorter time to the development of AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rash can occur as a manifestation of HIV infection, another infection, some neoplasms, and frequently as a reaction to a drug. The defect in cell-mediated immunity that results from HIV infection predisposes infected individuals to certain bacterial, fungal, mycobacterial, and viral infections, many of which have skin manifestations. In addition, many immune reconstitution inflammatory syndrome-associated events are dermatological and warrant consideration in the HIV-infected individual who has recently started highly active antiretroviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic fever and rash syndromes in the HIV-infected patient will be reviewed here. The diagnosis and treatment of the individual diseases as well as the epidemiology, etiology, and diagnostic approach to fever and rash in non-HIV infected immunocompromised hosts and in the normal host are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=see_link\">",
"     \"Infectious causes of fever and rash in non-HIV immunocompromised hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29098?source=see_link\">",
"     \"Fever and rash in the immunocompetent patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACTERIAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with HIV infection have an increased incidence of bacterial infections that is related to both deficiencies in T cell function and dysregulation of humoral immunity in advanced disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staphylococcus aureus is a common cause of skin infection and bacteremia in patients with the acquired immunodeficiency syndrome (AIDS). Risk factors for S. aureus bacteremia include nasal colonization with S. aureus, injection drug use (IDU), lymphedema due to Kaposi sarcoma (KS), neutropenia, and indwelling vascular catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/9\">",
"     9",
"    </a>",
"    ]. Colonization with S. aureus is increased in HIV-infected individuals and an increasing number of isolates are methicillin-resistant [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. History of prior MRSA infection, recent systemic antibiotic use or hospitalization (ie, within last six months), lower CD4 count, and prior incarceration have been reported as MRSA risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. HIV infection also appears to increase the risk for community-associated MRSA skin and soft tissue infections [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, HIV infection is an independent risk factor for recurrence of infection due to Staphylococcus aureus in patients with a history of S. aureus bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The varied skin manifestations of S. aureus infection include impetigo, folliculitis, cellulitis, abscesses, ulcerations, or ecthyma gangrenosum (",
"    <a class=\"graphic graphic_picture graphicRef63238 \" href=\"UTD.htm?25/9/25744\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef75659 \" href=\"UTD.htm?35/13/36050\">",
"     picture 2",
"    </a>",
"    ). Progression of staphylococcal infections can lead to cutaneous botryomycosis, a plaque-like, nodular, or papular lesion that clinically resembles a fungal infection and is characterized by aggregates of bacteria in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33365?source=see_link\">",
"     \"Botryomycosis\"",
"    </a>",
"    .) Secondary staphylococcal infections of underlying skin disorders such as herpetic ulcers,",
"    <span class=\"nowrap\">",
"     abrasions/trauma,",
"    </span>",
"    eczema, adverse cutaneous drug eruptions, and other dermatoses should also be considered.",
"   </p>",
"   <p>",
"    Therapy with antibiotics and debridement or drainage, when indicated, is imperative because these sites can serve as portals of entry for disseminated disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link\">",
"     \"Impetigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=see_link\">",
"     \"Folliculitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bacillary angiomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacillary angiomatosis, a vascular skin lesion that can mimic KS (",
"    <a class=\"graphic graphic_picture graphicRef76323 \" href=\"UTD.htm?40/4/41025\">",
"     picture 3",
"    </a>",
"    ), and pyogenic granuloma, is usually seen in HIV-infected patients when the CD4 cell count is less than 100",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    These cutaneous lesions result from proliferation of small blood vessels. The etiologic agents of this disease, Bartonella henselae and Bartonella quintana, can also cause bloodstream, liver, lymph node, lung, bone, bone marrow, brain, and heart valve infection. Cat and flea exposure have been associated with B. henselae infections and body louse exposure with B. quintana.",
"   </p>",
"   <p>",
"    The skin lesions associated with Bartonella, which may be isolated or multiple, are typically hemangiomatous, small, and papular before becoming larger, nodular, and potentially friable. Occasional lesions are subcutaneous in location (with or without overlying erythema) and appear cyst-like or manifest as a small mass. Intermittent fever is often associated with Bartonella bacteremia and should be considered in patients with AIDS and fever of unknown origin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Neisseria gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients have an increased rate of gonococcal infection that is related more to sexual behavior than to immunosuppression. Fever, rash, tenosynovitis, and polyarthralgia are typically part of disseminated gonococcal infection (DGI). The rash typically consists of painless lesions, often between two and ten in number, often located over trunk, extremities, or",
"    <span class=\"nowrap\">",
"     soles/palms.",
"    </span>",
"    The lesions are usually pustular or vesiculopustular, although hemorrhagic macules, papules, or nodules rarely occur (",
"    <a class=\"graphic graphic_picture graphicRef71303 \" href=\"UTD.htm?18/49/19219\">",
"     picture 4",
"    </a>",
"    ). Pustular or vesicular skin lesions are often transient and, even without treatment, may only last for three to four days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syphilis is important to recognize because of its important public health implications, including its association with increased HIV acquisition and seroprevalence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The skin manifestations of syphilis are often an important diagnostic clue and, although they may be altered in the setting of HIV infection, usually present in a manner similar to HIV-uninfected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/25\">",
"     25",
"    </a>",
"    ]. There remains a need for more large well-designed studies to evaluate effect of HIV status on presentation and course of syphilis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Primary syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first, or primary stage of syphilis, presents as a chancre usually two to three weeks after sexual contact with an infected partner. A painless papule forms at the mucosal surface where Treponema pallidum, the causative agent of syphilis, was inoculated (",
"    <a class=\"graphic graphic_picture graphicRef75291 \" href=\"UTD.htm?17/16/17664\">",
"     picture 5",
"    </a>",
"    ). The papule can grow to 0.5 to 2 cm in diameter, and ulcerate to form a clean-based, well-demarcated lesion with firm and indurated margins. Associated non-tender regional lymph nodes are often seen. Although chancres are usually solitary, multiple chancres can occur, particularly in the setting of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37017?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Secondary syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rash is the most characteristic finding in secondary syphilis, occurring in more than 80 percent of patients. Secondary syphilis occurs three to six weeks after the primary stage resolves and is characterized by hematogenous dissemination of treponemes. Additional symptoms and signs include malaise, low grade fever, sore throat, lymphadenopathy, alopecia, arthralgias, and headache.",
"   </p>",
"   <p>",
"    Skin manifestations of secondary syphilis can present in a variety of forms including a nonpruritic macular, maculopapular, papular, papulosquamous, plaque-like, erythema multiforme-like or pustular rash; vesicular lesions are notably absent. An uncommon but severe ulceronodular presentation of secondary syphilis known as lues maligna has also been reported in patients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/29\">",
"     29",
"    </a>",
"    ]. The rash usually begins on the trunk and extremities. When lesions are seen on the palms and soles, secondary syphilis should be strongly considered (",
"    <a class=\"graphic graphic_picture graphicRef68877 \" href=\"UTD.htm?9/3/9279\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In most patients with syphilis, the primary chancre resolves prior to the presentation of secondary syphilis. However, overlap of the primary and secondary stages of syphilis has been reported in HIV-infected patients (9 of 21 in one report) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tertiary syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gummatous lesions of late benign syphilis can involve any organ, including the skin. Often solitary, gummas can present as ulcerative, nodular, or papulosquamous lesions, usually located over the trunk, extremities, and face. HIV-infected patients are reported to have a shorter interval to the development of destructive localized gummatous lesions than HIV-seronegative patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/48/776?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of late syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=see_link\">",
"     \"Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pneumococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV infection is a common risk factor for invasive Streptococcus pneumoniae disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. The incidence of bacteremic pneumococcal disease appears to be decreasing in the HAART era when compared to the pre-HAART era [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/37\">",
"     37",
"    </a>",
"    ]. A decrease has also been noted in HIV-infected adults since the introduction of the pneumococcal conjugate vaccine for children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/38\">",
"     38",
"    </a>",
"    ]. Skin manifestations of disseminated pneumococcal infection can include cellulitis and purpura fulminans (",
"    <a class=\"graphic graphic_picture graphicRef63897 \" href=\"UTD.htm?28/55/29567\">",
"     picture 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Helicobacter cinaedi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Helicobacter cinaedi can cause recurrent cellulitis or erythema nodosum-like lesions, fever, arthritis, and bacteremia in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. The organism is fastidious and requires special growth conditions. Thus, this infection may be missed if the laboratory is not notified to use special testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MYCOBACTERIAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous tuberculous manifestations include scrofuloderma and gummatous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/43\">",
"     43",
"    </a>",
"    ]. Cutaneous disease may be a clue to underlying disseminated mycobacterial infection. Cutaneous miliary tuberculosis, an unusual manifestation, has been reported in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. Microscopic examination of the skin lesions will demonstrate numerous acid-fast bacilli. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atypical mycobacteria, including Mycobacterium avium intracellulare and M. kansasii, may also present as isolated cutaneous disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. M. haemophilum, an uncommon cause of mycobacterial infections, primarily presents as cutaneous or subcutaneous disease in the setting of immunocompromise [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lesions associated with mycobacterial infections are polymorphous, highlighting the need to isolate the etiologic agent in culture in order to direct therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. Mycobacterial-associated immune reconstitution inflammatory syndrome may also present with cutaneous manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     VIRAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions due to viral infections are common in HIV-infected patients, including acute HIV infection itself.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Acute HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin rash can be one manifestation of the acute retroviral syndrome, a mononucleosis- or flu-like syndrome that occurs after primary HIV infection in up to 75 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/57\">",
"     57",
"    </a>",
"    ]. Additional signs and symptoms include fever, night sweats, fatigue, malaise, generalized lymphadenopathy, sore throat, arthralgias, myalgias, headache,",
"    <span class=\"nowrap\">",
"     nausea/vomiting,",
"    </span>",
"    and diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=see_link\">",
"     \"Acute and early HIV infection: Pathogenesis and epidemiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A generalized skin eruption typically occurs 48 to 72 hours after the onset of fever and persists for five to eight days. The upper thorax, neck, and face are most often involved though the scalp and extremities, including the palms and soles, may be affected. The lesions are characteristically small (5 to 10 mm), well-circumscribed, oval or round, pink to deeply red colored macules or maculopapules [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/60\">",
"     60",
"    </a>",
"    ]. Vesicular, pustular, and urticarial eruptions have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/59,61\">",
"     59,61",
"    </a>",
"    ] but are not nearly as common as a maculopapular rash. Pruritus is unusual and only mild when present. Oropharyngeal enanthems and ulcerations can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute HIV infection should be considered in the differential diagnosis of a patient presenting with a mononucleosis-like illness. In a retrospective study of 563 serum samples obtained from patients with suspected mono-like illness with negative heterophile antibody tests, 11 (2 percent) were positive for HIV-1 RNA and four had greater than 100,000",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    of HIV-1 viral RNA, consistent with acute HIV-1 infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link&amp;anchor=H30#H30\">",
"     \"Infectious mononucleosis in adults and adolescents\", section on 'Primary HIV infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Genital herpes virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary episode of genital herpes simplex virus (HSV) infection usually presents with fever, headache, and malaise, in association with localized symptoms of pain and pruritus in the area of the vesicular lesions. However, most genital HSV infections occurring in HIV-infected patients reflect reactivation syndromes, and the appearance of lesions is usually not accompanied by fever. Rates of reactivation appear to be inversely correlated with CD4 counts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/63\">",
"     63",
"    </a>",
"    ]. In addition, immune reconstitution inflammatory syndrome (IRIS)-associated events involving genital herpes virus infection appear to be more common than other manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=see_link\">",
"     \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical presentation of symptomatic HSV episodes may include extensive mucocutaneous involvement, a variable appearance of genital lesions, and the development of chronic nonhealing and recurrent ulcers. Tumor-like lesions have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/64\">",
"     64",
"    </a>",
"    ]. Recurrences are often more frequent, more extensive, and of longer duration than in immunocompetent patients (",
"    <a class=\"graphic graphic_picture graphicRef59219 \" href=\"UTD.htm?1/17/1297\">",
"     picture 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72032 \" href=\"UTD.htm?12/59/13232\">",
"     picture 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef55663 \" href=\"UTD.htm?15/38/15970\">",
"     picture 10",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Of note, herpes simplex virus type 2 infections may increase the risk of HIV acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/65-68\">",
"     65-68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Varicella zoster virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactivation of endogenous latent Varicella zoster virus (VZV) infection within the sensory ganglia results in herpes zoster or \"shingles\", a syndrome characterized by a painful, unilateral vesicular or vesiculobullous eruption in a restricted dermatomal distribution. The incidence of varicella zoster virus (VZV) infections is higher in HIV-infected patients compared with those without concomitant HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/69\">",
"     69",
"    </a>",
"    ]. The risk of VZV infections increases as CD4 T-cell counts fall [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. Recurrent herpes zoster, which has been reported in up to 22 percent of HIV-infected patients, appears to be more common than in non-HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. Like HSV infections, chronic (greater than one month) mucocutaneous infections with varicella zoster virus in HIV-infected individuals are well described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/74\">",
"     74",
"    </a>",
"    ]. Of note, one study conducted in the era of highly active antiretroviral therapy reported that having a CD4 count of 50 to 200",
"    <span class=\"nowrap\">",
"     cells/mm",
"    </span>",
"    and being on HAART were associated with an increased risk of herpes zoster when compared with a CD4 count below 50",
"    <span class=\"nowrap\">",
"     cells/mm",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/75\">",
"     75",
"    </a>",
"    ]. Similarly, other studies have shown that increased incident cases of zoster are associated with use of ART [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'HIV-infected patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In cohort studies of patients with immune reconstitution, varicella-zoster infections are not uncommon, usually occurring at least four weeks after initiation of ART [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/8,55\">",
"     8,55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=see_link\">",
"     \"Immune reconstitution inflammatory syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atypical presentations of VZV include verrucous varicella, which has been mainly reported in the setting of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/71,78\">",
"     71,78",
"    </a>",
"    ]. This diagnosis should be considered in the patient with multiple, chronic, wart-like lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/78,79\">",
"     78,79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Parvovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parvovirus B19 can cause fever, arthralgia and a lacy reticular rash on the trunk and extremities in both immunocompetent and immunocompromised individuals. Cutaneous vasculitis due to human parvovirus B19 has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/80\">",
"     80",
"    </a>",
"    ]. However, in the setting of HIV, severe, chronic anemia may persist due to impaired humoral responses in those with advanced immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of shared routes of transmission, HIV-infected patients may also acquire hepatitis B through unprotected intercourse with a chronically infected partner or through injection drug use. Acute hepatitis B infection may be heralded by a serum sickness-like syndrome manifested as fever, skin rash, arthralgia and arthritis, which usually subside with the onset of jaundice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30122?source=see_link\">",
"     \"Clinical manifestations and natural history of hepatitis B virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     FUNGAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions may be the initial sign of a systemic fungal infection. Endemic fungi must be considered in any HIV-infected patient with skin lesions and systemic disease. Fungi can disseminate when cell-mediated immunity falls, either during the acute stage of infection or as a result of reactivation of prior disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/83-85\">",
"     83-85",
"    </a>",
"    ]. HIV-infected patients may harbor more than one fungus responsible for systemic infection and associated cutaneous manifestations, underscoring the importance of histopathologic and microbiologic evaluation of suspicious skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cryptococcosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryptococcus neoformans is an encapsulated yeast that is found around the world. It is a common opportunistic infection in immunosuppressed AIDS patients.",
"   </p>",
"   <p>",
"    Approximately 10 percent of HIV-infected patients who develop cryptococcal infection have cutaneous manifestations of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/87\">",
"     87",
"    </a>",
"    ]. Skin lesions secondary to C. neoformans may represent the sentinel clue to underlying disseminated infection.",
"   </p>",
"   <p>",
"    The skin lesions of cryptococcosis may be quite diverse, but ulcers,",
"    <span class=\"nowrap\">",
"     nodules/papules,",
"    </span>",
"    pustules, or molluscum contagiosum-like centrally umbilicated vesicular lesions are commonly described (",
"    <a class=\"graphic graphic_picture graphicRef52777 \" href=\"UTD.htm?15/17/15635\">",
"     picture 11",
"    </a>",
"    ). Presentations can also mimic cellulitis or cutaneous malignancies such as basal cell or squamous cell carcinoma(s). Lesions are frequently located on the head and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/88\">",
"     88",
"    </a>",
"    ]. Since cryptococcal skin infection can mimic molluscum contagiosum, a helpful diagnostic clue for cryptococcosis is the finding of a small hemorrhagic center in the lesion and a rapid onset of development of the papules (",
"    <a class=\"graphic graphic_picture graphicRef69214 \" href=\"UTD.htm?34/15/35058\">",
"     picture 12",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/89\">",
"     89",
"    </a>",
"    ]. Cryptococcal-associated IRIS has been reported and commonly includes lymphadenitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Histoplasmosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histoplasmosis is a dimorphic fungus concentrated in the Ohio and Mississippi River valleys in the United States. It is also found in the Caribbean, Central America, South America, Cuba, Southeast Asia, and Africa.",
"   </p>",
"   <p>",
"    HIV-infected patients can acquire primary histoplasmosis infection when visiting areas of endemicity, or can develop reactivation disease many years later, particularly in the setting of advanced immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/91\">",
"     91",
"    </a>",
"    ]. Skin lesions appear to be more common in patients with disseminated histoplasmosis who have acquired immunodeficiency syndrome when compared to those not coinfected with human immunodeficiency virus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 10 percent of HIV-infected patients with disseminated histoplasmosis have mucocutaneous manifestations including oropharyngeal ulcerations, macules, papules, pustules, plaques (can be verrucous), nodules, or vesicles [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/93,94\">",
"     93,94",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef67641 graphicRef68101 \" href=\"UTD.htm?22/3/22585\">",
"     picture 13A-B",
"    </a>",
"    ). Cutaneous histoplasmosis can mimic erythema-multiforme, molluscum contagiosum, pyoderma gangrenosum, vasculitic, exfoliative dermatitis, herpetic, acneiform, and psoriatic-like lesions (",
"    <a class=\"graphic graphic_picture graphicRef74799 graphicRef67381 \" href=\"UTD.htm?13/20/13641\">",
"     picture 14A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/93-96\">",
"     93-96",
"    </a>",
"    ]. Lesions are commonly located over the face, chest, and upper extremities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/6/43112?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of disseminated histoplasmosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Blastomycosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blastomyces dermatitidis is a dimorphic fungus seen in the south-central and Midwestern United States, Canada, and Africa. Blastomycosis can present with severe disseminated disease with central nervous system involvement in the HIV-infected patient, usually in the setting of advanced immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/4/79?source=see_link\">",
"     \"Mycology, pathogenesis, and epidemiology of blastomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A retrospective survey of 15 HIV-infected patients with blastomycosis included eight patients with disseminated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/97\">",
"     97",
"    </a>",
"    ]. All of these individuals had CD4 lymphocyte counts below 200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    and three had evidence of cutaneous disease. Possible dermatologic manifestations of blastomycosis include papules, pustules, deep ulcers, and papulopustular and papulonodular ulcers, or verrucoid lesions (",
"    <a class=\"graphic graphic_picture graphicRef78481 \" href=\"UTD.htm?42/17/43280\">",
"     picture 15",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef71630 \" href=\"UTD.htm?31/4/31810\">",
"     picture 16",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/97,98\">",
"     97,98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Coccidioidomycosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dimorphic fungus Coccidioides immitis is endemic in the southwestern United States, including California, Arizona, New Mexico, Utah, Nevada, and Texas and also in Central and South America (particularly Argentina). A prospective study of HIV-infected patients in a highly endemic area in Arizona reported the development of active Coccidioides infection in approximately 25 percent of this cohort during 3.5 years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/99\">",
"     99",
"    </a>",
"    ]. In another analysis, one percent of AIDS patients residing in counties of the United States endemic for this fungus had coccidioidomycosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/100\">",
"     100",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=see_link\">",
"     \"Manifestations and treatment of extrapulmonary coccidioidomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hematogenous dissemination of this organism often manifests cutaneously. Skin lesions in this disease may take many forms, including pustules, nodules, ulcers, verrucous plaques, and papules; though nonspecific, these lesions are usually hemorrhagic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/101\">",
"     101",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef78978 \" href=\"UTD.htm?28/44/29378\">",
"     picture 17",
"    </a>",
"    ). A thorough travel history should be obtained, since presentations of fungal disease may be due to reactivation of prior infection. Of note in one report of persons with AIDS and disseminated coccidioidomycosis, only about one-half of all cases resided in C. immitis-endemic countries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Sporotrichosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sporothrix schenckii is a dimorphic fungus that is ubiquitous in warmer areas of the world. Cutaneous manifestations of infection may occur from direct inoculation through the skin as a localized, lymphocutaneous infection, classically following trauma with a rose thorn. Less commonly, sporotrichosis presents with extensive cutaneous involvement (ulcerated and crusted nodules) in patients with advanced AIDS consistent with underlying disseminated disease (",
"    <a class=\"graphic graphic_picture graphicRef67553 \" href=\"UTD.htm?19/58/20384\">",
"     picture 18",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. These atypical ulcerations are often described as \"punched-out\" [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/104\">",
"     104",
"    </a>",
"    ]. Following dissemination, bone or joint infection can occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"     \"Clinical features and diagnosis of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Penicillium marneffei",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penicillium marneffei is an emerging, endemic dimorphic fungal pathogen in Southeast Asia, India, and China [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. The clinical presentation often includes weight loss, fever, respiratory symptoms, and anemia. Disease usually occurs when the CD4 cell count is less than 50",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    and most commonly involves the skin, blood, bone marrow, lymph nodes, liver, and lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/107\">",
"     107",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33302?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Penicillium marneffei infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one series of 80 HIV-infected patients in Thailand with disseminated P. marneffei infection, 71 percent had skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/108\">",
"     108",
"    </a>",
"    ]. In another series of 46 patients in India with disseminated P. marneffei infection, skin lesions were reported in 81 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/109\">",
"     109",
"    </a>",
"    ]. Papular skin lesions often with central umbilication are typically located on the trunk and face and may resemble molluscum contagiosum (",
"    <a class=\"graphic graphic_picture graphicRef62477 \" href=\"UTD.htm?26/21/26961\">",
"     picture 19",
"    </a>",
"    ). Genital and oral ulcerations have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/110,111\">",
"     110,111",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Pneumocystis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumocystis jirovecii (formerly P. carinii) most commonly causes pneumonia in immunocompromised patients including those with AIDS, but extrapulmonary disease including cutaneous manifestations have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/112\">",
"     112",
"    </a>",
"    ]. Skin findings include macular, papular, polypoid, nodular, and molluscum contagiosum-like lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/113-115\">",
"     113-115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     PARASITIC INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, parasitic infections with cutaneous manifestations are not common in HIV-infected patients with the exception of scabies, which has a worldwide distribution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Scabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In HIV-infected patients, scabies can be widespread, presenting as a diffuse erythematous papulosquamous eruption [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/116\">",
"     116",
"    </a>",
"    ]. Lesions typically involve the extremities, and, less commonly, the ears, face, scalp, back, and nailfold areas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/117\">",
"     117",
"    </a>",
"    ]. Psoriatic-like lesions, a maculopapular dermatitis, and red papules have also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/118\">",
"     118",
"    </a>",
"    ]. These highly infectious lesions contain thousands of organisms and are a source for nosocomial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/119\">",
"     119",
"    </a>",
"    ]. They can become secondarily infected with bacteria, leading to fever and bacteremia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Leishmaniasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leishmaniasis can be classified geographically into New World versus Old World disease and infections by the various species can be divided into cutaneous, mucocutaneous, or visceral disease. In patients with AIDS, this emerging infectious disease represents the second most common tissue-associated protozoan infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/120,121\">",
"     120,121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some Leishmania species are primarily dermatotropic, while others are mainly viscerotropic. It has become increasingly clear however, that some species frequently associated with visceral leishmaniasis can produce skin lesions, and conversely, species usually found in the skin can disseminate viscerally. This was illustrated in a report of 32 HIV-infected patients with visceral leishmaniasis, six of whom had cutaneous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/122\">",
"     122",
"    </a>",
"    ]. The cutaneous findings included macular, papular, nodular, and plaque-like lesions. A full discussion of the dermatologic presentations associated with the various forms of leishmaniasis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21161?source=see_link\">",
"     \"Clinical manifestations and diagnosis of visceral leishmaniasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./clinical-manifestations-and-diagnosis-of-cutaneous-leishmaniasis?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cutaneous leishmaniasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     KAPOSI SARCOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;KS, although not often a cause of fever, has been convincingly linked to human herpes virus (HHV)-8 infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/123\">",
"     123",
"    </a>",
"    ]. In the United States, the incidence, mortality and morbidity of KS has declined significantly since the introduction of highly active antiretroviral therapy and associated improved CD4 counts. KS is no longer the most common HIV-associated tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/124\">",
"     124",
"    </a>",
"    ]. In fact, in the ART era, the most common cutaneous cancers in patients with HIV infection are non-AIDS-defining cancers, particularly basal cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/125\">",
"     125",
"    </a>",
"    ]. Kaposi sarcoma presenting within eight weeks after initiation of ART is well recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/126\">",
"     126",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral lesions are classically found on the hard palate, although the tonsils, gingiva (",
"    <a class=\"graphic graphic_picture graphicRef81245 \" href=\"UTD.htm?2/60/3008\">",
"     picture 20",
"    </a>",
"    ), soft palate, tongue, or lips may be involved. Cutaneous lesions occur most commonly on the trunk (",
"    <a class=\"graphic graphic_picture graphicRef51962 \" href=\"UTD.htm?26/18/26914\">",
"     picture 21",
"    </a>",
"    ), the extremities, and the face. Initially papular or patch-like KS lesions later develop into plaques or nodules. The color of these lesions changes with time from light brown or pink to a darker violet. Other cutaneous variants are described as patch-like, exophytic, keloidal, telangiectatic, infiltrative, lymphangioma-like, cystic-like, bullous, lymphadenopathic or ecchymotic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/127\">",
"     127",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The lesions can be confused with cutaneous Bartonella. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Bacillary angiomatosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     DRUG REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug reactions, particularly cutaneous manifestations, are common in HIV-infected patients and appear to be directly related to the degree of immunocompromise [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/3,128-131\">",
"     3,128-131",
"    </a>",
"    ]. A morbilliform rash (74 percent) has been most frequently described (particularly with the use of nonnucleoside reverse transcriptase inhibitors), followed by urticarial eruptions (17 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/3\">",
"     3",
"    </a>",
"    ]. Fever may be a prominent part of the clinical presentation.",
"   </p>",
"   <p>",
"    Among patients with HIV infection,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/41/20118?source=see_link\">",
"     sulfadiazine",
"    </a>",
"    , trimethoprim-dapsone, and amino penicillins have been associated with the highest incidence of adverse cutaneous drug reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/3\">",
"     3",
"    </a>",
"    ]. Amprenavir,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/31/506?source=see_link\">",
"     atazanavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/63/31734?source=see_link\">",
"     abacavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/12/18633?source=see_link\">",
"     nevirapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/10/27816?source=see_link\">",
"     delavirdine",
"    </a>",
"    are antiretroviral agents that are most commonly associated with hypersensitivity reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/132-134\">",
"     132-134",
"    </a>",
"    ]. Other anti-HIV agents including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/33/19992?source=see_link\">",
"     tipranavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/0/13320?source=see_link\">",
"     etravirine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/27/10678?source=see_link\">",
"     raltegravir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    have also been associated with adverse cutaneous reactions of various types [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/129\">",
"     129",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7205?source=see_link\">",
"     Enfuvirtide",
"    </a>",
"    , a fusion inhibitor, almost always results in a local injection site reaction, which includes",
"    <span class=\"nowrap\">",
"     pain/discomfort,",
"    </span>",
"    induration, erythema,",
"    <span class=\"nowrap\">",
"     nodules/cysts,",
"    </span>",
"    pruritus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ecchymosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/135\">",
"     135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/63/31734?source=see_link\">",
"     Abacavir",
"    </a>",
"    causes a well-described hypersensitivity reaction in approximately 5 percent of patients within six weeks of beginning this antiretroviral nucleoside reverse transcriptase inhibitor. This hypersensitivity reaction consists of rash (typically maculopapular or urticarial in appearance), fever, constitutional symptoms, respiratory symptoms, and GI complaints. Patients at risk for developing this reaction can be identified by pharmacogenetic screening for the human leukocyte antigen (HLA) HLA-B(*)5701 allele [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/136,137\">",
"     136,137",
"    </a>",
"    ]. Resolution of symptoms typically occurs within three days of discontinuation of the agent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/138\">",
"     138",
"    </a>",
"    ]. Resuming abacavir therapy after the development of this drug hypersensitivity syndrome is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21049?source=see_link\">",
"     \"Abacavir hypersensitivity reaction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe cutaneous reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN) are described more frequently in HIV-infected patients compared to HIV-seronegative patients and are commonly associated with sulfa-based drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/139,140\">",
"     139,140",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23594?source=see_link\">",
"     \"Sulfonamide allergy in non HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, risk for adverse cutaneous drug reactions secondary to antituberculous therapy is increased in the setting of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/141\">",
"     141",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immune reconstitution syndrome is reported in up to 25 percent of patients who begin ART [",
"    <a class=\"abstract\" href=\"UTD.htm?23/61/24538/abstract/8\">",
"     8",
"    </a>",
"    ]. Cutaneous manifestations are common and can be secondary to viral, fungal, mycobacterial and parasitic infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30755863\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with chronic HIV infection have a defect in cell-mediated immunity that predisposes them to certain bacterial, fungal, mycobacterial, and viral infections, many of which have cutaneous findings. Rash can also occur secondary to a drug reaction, underlying Kaposi sarcoma, or as a manifestation of acute HIV infection itself. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with HIV infection have an increased incidence of bacterial infections that is related to both deficiencies in T cell function and dysregulation of humoral immunity in advanced disease. One of the most common infections is Staphylococcus aureus, which can present as impetigo, folliculitis, cellulitis, abscesses, ulcerations, or ecthyma gangrenosum. Bartonella infection occurs in patients with advanced immunosuppression and usually presents with cutaneous lesions that are violaceous in appearance due to the vascular nature. Rash is the most characteristic finding in secondary syphilis, occurring in more than 80 percent of patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Bacterial infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rash related to herpes viruses (eg, herpes simplex virus or varicella zoster virus) usually represents reactivation disease. Parvovirus B19 can cause fever, arthralgia, and a lacy reticular rash on the trunk and extremities in both immunocompetent and immunocompromised individuals, although HIV-infected patients with advanced immunosuppression are at risk for chronic anemia. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Viral infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endemic fungi must be considered in any HIV-infected patient with skin lesions and systemic disease. Fungi can disseminate when cell-mediated immunity falls, either during the acute stage of infection or as a result of reactivation of prior disease. One of the most common fungal infections in HIV-infected patients includes cryptococcosis, which can present with a variety of cutaneous lesions including ulcers,",
"      <span class=\"nowrap\">",
"       nodules/papules,",
"      </span>",
"      pustules, or molluscum contagiosum-like centrally umbilicated vesicular lesions. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Fungal infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the United States, parasitic infections with cutaneous manifestations are not common in HIV-infected patients with the exception of scabies, which has a worldwide distribution. Among HIV-infected patients, scabies can be widespread, presenting as a diffuse erythematous papulosquamous eruption. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Parasitic infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Kaposi sarcoma may present with oral or cutaneous involvement. Papular or patch-like KS lesions later develop into plaques or nodules. The color of these lesions changes with time from light brown or pink to a darker violet. Kaposi sarcoma is a manifestation of human herpes virus-8, but is rarely associated with fever. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Kaposi sarcoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drug reactions, particularly cutaneous manifestations, are common in HIV-infected patients and appear to be directly related to the degree of immunocompromise. Fever and a diffuse morbilliform or urticarial rashes have been reported along with fever. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Drug reactions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/1\">",
"      Uthayakumar S, Nandwani R, Drinkwater T, et al. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol 1997; 137:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/2\">",
"      Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989; 125:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/3\">",
"      Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/4\">",
"      Gottschalk GM. Pediatric HIV/AIDS and the skin: an update. Dermatol Clin 2006; 24:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/5\">",
"      Zancanaro PC, McGirt LY, Mamelak AJ, et al. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 2006; 54:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/6\">",
"      Jensen BL, Weismann K, Sindrup JH, et al. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study. Acta Derm Venereol 2000; 80:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/7\">",
"      Goh BK, Chan RK, Sen P, et al. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Int J Dermatol 2007; 46:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/8\">",
"      Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/9\">",
"      Jacobson MA, Gellermann H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 1988; 85:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/10\">",
"      Miller M, Cespedes C, Vavagiakis P, et al. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/11\">",
"      B&auml;r A, Hantschke D, Mirmohammadsadegh A, Hengge UR. Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci. AIDS 2003; 17:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/12\">",
"      Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/13\">",
"      Melles DC, Pauw E, van den Boogaard L, et al. Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients. Microbes Infect 2008; 10:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/14\">",
"      Skiest D, Brown K, Hester J, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 2006; 7:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/15\">",
"      Cenizal MJ, Hardy RD, Anderson M, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr 2008; 48:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/16\">",
"      Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/17\">",
"      Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/18\">",
"      Popovich KJ, Weinstein RA, Aroutcheva A, et al. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010; 50:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/19\">",
"      Kreisel K, Boyd K, Langenberg P, Roghmann MC. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis 2006; 55:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/20\">",
"      Patterson JW, Kitces EN, Neafie RC. Cutaneous botryomycosis in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1987; 16:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/21\">",
"      Ahdoot D, Rickman LS, Haghighi P, Heard WU. Botryomycosis in the acquired immunodeficiency syndrome. Cutis 1995; 55:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/22\">",
"      Koehler JE, Sanchez MA, Tye S, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 2003; 37:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/23\">",
"      Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis 2000; 27:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/24\">",
"      Zetola NM, Bernstein KT, Wong E, et al. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr 2009; 50:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/25\">",
"      Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/26\">",
"      Farhi D, Dupin N. Management of syphilis in the HIV-infected patient: facts and controversies. Clin Dermatol 2010; 28:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/27\">",
"      Dowell D, Polgreen PM, Beekmann SE, et al. Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis 2009; 49:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/28\">",
"      Rompalo AM, Joesoef MR, O'Donnell JA, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis 2001; 28:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/29\">",
"      Sands M, Markus A. Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review. Clin Infect Dis 1995; 20:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/30\">",
"      Hutchinson CM, Hook EW 3rd, Shepherd M, et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994; 121:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/31\">",
"      Rompalo AM, Lawlor J, Seaman P, et al. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001; 28:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/32\">",
"      Collis TK, Celum CL. The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men. Clin Infect Dis 2001; 32:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/33\">",
"      Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/34\">",
"      Frankel RE, Virata M, Hardalo C, et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/35\">",
"      Jordano Q, Falc&oacute; V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/36\">",
"      Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007; 20:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/37\">",
"      Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/38\">",
"      Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/39\">",
"      Rodriguez Barradas MC, Musher DM, Hamill RJ, et al. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis 1992; 14:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/40\">",
"      Capdevila O, Grau I, Vadillo M, et al. Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 2003; 22:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/41\">",
"      Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med 1994; 121:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/42\">",
"      Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 1995; 20:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/43\">",
"      Terranova M, Padovese V, Fornari U, Morrone A. Clinical and epidemiological study of cutaneous tuberculosis in Northern Ethiopia. Dermatology 2008; 217:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/44\">",
"      Daikos GL, Uttamchandani RB, Tuda C, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases. Clin Infect Dis 1998; 27:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/45\">",
"      Antinori S, Bini T, Galimberti L, et al. Cutaneous miliary tuberculosis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1997; 25:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/46\">",
"      Montejo M, Goicoetxea J, Agesta N, et al. Cutaneous infection by Mycobacterium lentiflavum in a patient with HIV. Dermatology 2006; 213:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/47\">",
"      High WA, Evans CC, Hoang MP. Cutaneous miliary tuberculosis in two patients with HIV infection. J Am Acad Dermatol 2004; 50:S110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/48\">",
"      Taylor CR, Bailey EM. Red nodule on the forearm of an HIV-positive man. Isolated cutaneous Mycobacterium avium-intracellulare infection. Arch Dermatol 1998; 134:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/49\">",
"      Brown T, Yen A. Isolation of Mycobacterium avium complex from erythema multiforme. J Am Acad Dermatol 1998; 39:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/50\">",
"      Nomura Y, Nishie W, Shibaki A, et al. Disseminated cutaneous Mycobacterium kansasii infection in an patient infected with the human immunodeficiency virus. Clin Exp Dermatol 2009; 34:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/51\">",
"      Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996; 9:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/52\">",
"      Fari&ntilde;a MC, Gegundez MI, Piqu&eacute; E, et al. Cutaneous tuberculosis: a clinical, histopathologic, and bacteriologic study. J Am Acad Dermatol 1995; 33:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/53\">",
"      Zanelli G, Webster GF. Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome. Clin Dermatol 1995; 13:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/54\">",
"      Groves R. Unusual cutaneous mycobacterial diseases. Clin Dermatol 1995; 13:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/55\">",
"      Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007; 4:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/56\">",
"      Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 2005; 41:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/57\">",
"      Valenti WM. Acute retroviral syndrome: a challenge for primary care. AIDS Read 2008; 18:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/58\">",
"      Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med 2001; 134:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/59\">",
"      Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis 2004; 38:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/60\">",
"      Lapins J, Gaines H, Lindb&auml;ck S, et al. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDS 1997; 11:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/61\">",
"      Calabrese LH, Proffitt MR, Levin KH, et al. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med 1987; 107:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/62\">",
"      Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N Engl J Med 1999; 340:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/63\">",
"      Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 2004; 11 Suppl 1:36A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/64\">",
"      Mosunjac M, Park J, Wang W, et al. Genital and perianal herpes simplex simulating neoplasia in patients with AIDS. AIDS Patient Care STDS 2009; 23:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/65\">",
"      Brown JM, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 2007; 21:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/66\">",
"      Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006; 164:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/67\">",
"      Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/68\">",
"      de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J Immunol 2010; 185:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/69\">",
"      Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992; 166:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/70\">",
"      Veenstra J, Krol A, van Praag RM, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995; 9:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/71\">",
"      Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 1995; 21:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/72\">",
"      Tappero JW, Perkins BA, Wenger JD, Berger TG. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Clin Microbiol Rev 1995; 8:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/73\">",
"      Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis 1988; 157:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/74\">",
"      Wauters O, Lebas E, Nikkels AF. Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. J Am Acad Dermatol 2012; 66:e217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/75\">",
"      Gebo KA, Kalyani R, Moore RD, Polydefkis MJ. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 2005; 40:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/76\">",
"      Mart&iacute;nez E, Gatell J, Mor&aacute;n Y, et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998; 27:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/77\">",
"      Domingo P, Torres OH, Ris J, Vazquez G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 2001; 110:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/78\">",
"      Nikkels AF, Snoeck R, Rentier B, Pierard GE. Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects. Clin Exp Dermatol 1999; 24:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/79\">",
"      Zampogna JC, Flowers FP. Persistent verrucous varicella as the initial manifestation of HIV infection. J Am Acad Dermatol 2001; 44:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/80\">",
"      Martinelli C, Azzi A, Buffini G, et al. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. AIDS 1997; 11:1891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/81\">",
"      Clarke J, Lee JD. Primary human parvovirus B19 infection in an HIV infected patient on highly active antiretroviral therapy. Sex Transm Infect 2003; 79:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/82\">",
"      Morelli P, Bestetti G, Longhi E, et al. Persistent parvovirus B19-induced anemia in an HIV-infected patient under HAART. Case report and review of literature. Eur J Clin Microbiol Infect Dis 2007; 26:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/83\">",
"      Minamoto GY, Rosenberg AS. Fungal infections in patients with acquired immunodeficiency syndrome. Med Clin North Am 1997; 81:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/84\">",
"      Johnson RA. HIV disease: mucocutaneous fungal infections in HIV disease. Clin Dermatol 2000; 18:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/85\">",
"      Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis 2007; 45:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/86\">",
"      Myers SA, Kamino H. Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. J Am Acad Dermatol 1996; 34:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/87\">",
"      Aftergut K, Cockerell CJ. Update on the cutaneous manifestations of HIV infection. Clinical and pathologic features. Dermatol Clin 1999; 17:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/88\">",
"      Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Dermatol 1996; 132:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/89\">",
"      Sandler B, Potter TS, Hashimoto K. Cutaneous Pneumocystis carinii and Cryptococcus neoformans in AIDS. Br J Dermatol 1996; 134:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/90\">",
"      Skiest DJ, Hester LJ, Hardy RD. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. J Infect 2005; 51:e289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/91\">",
"      Fredricks DN, Rojanasthien N, Jacobson MA. AIDS-related disseminated histoplasmosis in San Francisco, California. West J Med 1997; 167:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/92\">",
"      Tob&oacute;n AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/93\">",
"      Dover JS, Johnson RA. Cutaneous manifestations of human immunodeficiency virus infection. Part II. Arch Dermatol 1991; 127:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/94\">",
"      Johnson PC, Khardori N, Najjar AF, et al. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/95\">",
"      Laochumroonvorapong P, DiCostanzo DP, Wu H, et al. Disseminated histoplasmosis presenting as pyoderma gangrenosum-like lesions in a patient with acquired immunodeficiency syndrome. Int J Dermatol 2001; 40:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/96\">",
"      K Ramdial P, Mosam A, Dlova NC, et al. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol 2002; 29:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/97\">",
"      Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/98\">",
"      Witzig RS, Hoadley DJ, Greer DL, et al. Blastomycosis and human immunodeficiency virus: three new cases and review. South Med J 1994; 87:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/99\">",
"      Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/100\">",
"      Jones JL, Fleming PL, Ciesielski CA, et al. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis 1995; 171:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/101\">",
"      Prichard JG, Sorotzkin RA, James RE 3rd. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis 1987; 39:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/102\">",
"      Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol 1999; 40:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/103\">",
"      al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis 1998; 26:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/104\">",
"      Kauffman CA. Sporotrichosis. Clin Infect Dis 1999; 29:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/105\">",
"      Borradori L, Schmit JC, Stetzkowski M, et al. Penicilliosis marneffei infection in AIDS. J Am Acad Dermatol 1994; 31:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/106\">",
"      Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996; 23:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/107\">",
"      Ungpakorn R. Cutaneous manifestations of Penicillium marneffei infection. Curr Opin Infect Dis 2000; 13:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/108\">",
"      Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/109\">",
"      Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect 2002; 45:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/110\">",
"      Annam V, Inamadar AC, Palit A, et al. Genital ulcer caused by Penicillium marneffei in an HIV-infected patient. Sex Transm Infect 2007; 83:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/111\">",
"      Tong AC, Wong M, Smith NJ. Penicillium marneffei infection presenting as oral ulcerations in a patient infected with human immunodeficiency virus. J Oral Maxillofac Surg 2001; 59:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/112\">",
"      Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev 1997; 10:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/113\">",
"      Coulman CU, Greene I, Archibald RW. Cutaneous pneumocystosis. Ann Intern Med 1987; 106:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/114\">",
"      Hennessey NP, Parro EL, Cockerell CJ. Cutaneous Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome. Arch Dermatol 1991; 127:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/115\">",
"      Praveen CV, Terry RM, Elmahallawy M, Horsfield C. Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient. J Laryngol Otol 2002; 116:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/116\">",
"      Guggisberg D, de Viragh PA, Constantin C, Panizzon RG. Norwegian scabies in a patient with acquired immunodeficiency syndrome. Dermatology 1998; 197:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/117\">",
"      Perna AG, Bell K, Rosen T. Localised genital Norwegian scabies in an AIDS patient. Sex Transm Infect 2004; 80:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/118\">",
"      Schlesinger I, Oelrich DM, Tyring SK. Crusted (Norwegian) scabies in patients with AIDS: the range of clinical presentations. South Med J 1994; 87:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/119\">",
"      Leone PA. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2007; 44 Suppl 3:S153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/120\">",
"      Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis 2007; 45:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/121\">",
"      Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008; 21:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/122\">",
"      Postigo C, Llamas R, Zarco C, et al. Cutaneous lesions in patients with visceral leishmaniasis and HIV infection. J Infect 1997; 35:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/123\">",
"      Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 2006; 1:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/124\">",
"      Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/125\">",
"      Crum-Cianflone N, Hullsiek KH, Satter E, et al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med 2009; 169:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/126\">",
"      Bower M, Nelson M, Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005; 23:5224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/127\">",
"      Schwartz RA. Kaposi's sarcoma: an update. J Surg Oncol 2004; 87:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/128\">",
"      Stern RS. Epidemiology of skin disease in HIV infection: a cohort study of health maintenance organization members. J Invest Dermatol 1994; 102:34S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/129\">",
"      Borr&aacute;s-Blasco J, Navarro-Ruiz A, Borr&aacute;s C, Caster&aacute; E. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. J Antimicrob Chemother 2008; 62:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/130\">",
"      Introcaso CE, Hines JM, Kovarik CL. Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors. J Am Acad Dermatol 2010; 63:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/131\">",
"      Introcaso CE, Hines JM, Kovarik CL. Cutaneous toxicities of antiretroviral therapy for HIV: part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome. J Am Acad Dermatol 2010; 63:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/132\">",
"      Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/133\">",
"      Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol 2002; 46:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/134\">",
"      Davis CM, Shearer WT. Diagnosis and management of HIV drug hypersensitivity. J Allergy Clin Immunol 2008; 121:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/135\">",
"      Luther J, Glesby MJ. Dermatologic adverse effects of antiretroviral therapy: recognition and management. Am J Clin Dermatol 2007; 8:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/136\">",
"      Hughes CA, Foisy MM, Dewhurst N, et al. Abacavir hypersensitivity reaction: an update. Ann Pharmacother 2008; 42:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/137\">",
"      Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/138\">",
"      Lucas A, Nolan D, Mallal S. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. J Antimicrob Chemother 2007; 59:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/139\">",
"      Porteous DM, Berger TG. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Arch Dermatol 1991; 127:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/140\">",
"      Harris B, Harris K, Penneys NS. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis. J Am Acad Dermatol 1992; 26:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/61/24538/abstract/141\">",
"      Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003; 167:1472.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3703 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.1.191.153-3A23DB03CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24538=[""].join("\n");
var outline_f23_61_24538=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30755863\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACTERIAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bacillary angiomatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Neisseria gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Syphilis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Primary syphilis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Secondary syphilis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tertiary syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pneumococcus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Helicobacter cinaedi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MYCOBACTERIAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      VIRAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Acute HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Genital herpes virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Varicella zoster virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Parvovirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FUNGAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cryptococcosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Penicillium marneffei",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Pneumocystis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      PARASITIC INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      KAPOSI SARCOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      DRUG REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30755863\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3703\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3703|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/9/25744\" title=\"picture 1\">",
"      Impetigo in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/13/36050\" title=\"picture 2\">",
"      Insertion site infection in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/4/41025\" title=\"picture 3\">",
"      Bacillary angiomatosis in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/49/19219\" title=\"picture 4\">",
"      Gonococcal skin lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/16/17664\" title=\"picture 5\">",
"      Penile chancre in syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/3/9279\" title=\"picture 6\">",
"      Rash in secondary syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/55/29567\" title=\"picture 7\">",
"      Purpura in pneumococcal sepsis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/17/1297\" title=\"picture 8\">",
"      Chronic herpes simplex in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/59/13232\" title=\"picture 9\">",
"      Chronic HSV ulcer in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/38/15970\" title=\"picture 10\">",
"      Ear lesion of chronic HSV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/17/15635\" title=\"picture 11\">",
"      Cryptococcal papular skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/15/35058\" title=\"picture 12\">",
"      Disseminated cryptococcosis - papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/18/32034\" title=\"picture 13A\">",
"      Erythematous nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/35/30262\" title=\"picture 13B\">",
"      Dome shaped papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/12/27842\" title=\"picture 14A\">",
"      Skin in disseminated histo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/51/12086\" title=\"picture 14B\">",
"      Biopsy specimen histo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/17/43280\" title=\"picture 15\">",
"      Eyelid lesion in blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/4/31810\" title=\"picture 16\">",
"      Verrucous lesion in blasto",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/44/29378\" title=\"picture 17\">",
"      Nodules in coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/58/20384\" title=\"picture 18\">",
"      Skin lesions sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/21/26961\" title=\"picture 19\">",
"      Penicillium marneffei in an AIDS patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/60/3008\" title=\"picture 20\">",
"      Gingival infiltration in KS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/18/26914\" title=\"picture 21\">",
"      Follicular pattern in KS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21049?source=related_link\">",
"      Abacavir hypersensitivity reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=related_link\">",
"      Acute and early HIV infection: Pathogenesis and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33365?source=related_link\">",
"      Botryomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./clinical-manifestations-and-diagnosis-of-cutaneous-leishmaniasis?source=related_link\">",
"      Clinical manifestations and diagnosis of cutaneous leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21161?source=related_link\">",
"      Clinical manifestations and diagnosis of visceral leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30122?source=related_link\">",
"      Clinical manifestations and natural history of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=related_link\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33302?source=related_link\">",
"      Epidemiology and clinical manifestations of Penicillium marneffei infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3865?source=related_link\">",
"      Epidemiology, clinical presentation, and diagnosis of syphilis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29098?source=related_link\">",
"      Fever and rash in the immunocompetent patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=related_link\">",
"      Folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=related_link\">",
"      Immune reconstitution inflammatory syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=related_link\">",
"      Infectious causes of fever and rash in non-HIV immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=related_link\">",
"      Manifestations and treatment of extrapulmonary coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/4/79?source=related_link\">",
"      Mycology, pathogenesis, and epidemiology of blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/6/43112?source=related_link\">",
"      Pathogenesis and clinical manifestations of disseminated histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37017?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of early syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/48/776?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of late syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=related_link\">",
"      Prevention of sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23594?source=related_link\">",
"      Sulfonamide allergy in non HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_61_24539="Contraindications to bronchoprovocation testing";
var content_f23_61_24539=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contraindications to bronchoprovocation challenge testing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Absolute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe airflow limitation (FEV1 &lt;50 percent predicted or &lt;1 L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction or stroke in last three months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncontrolled hypertension (systolic BP &gt;200 or diastolic BP &gt;100)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Known aortic aneurysm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Relative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate airflow limitation (FEV1 &lt;60 percent predicted or &lt;1.5 L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inability to perform acceptable-quality spirometry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nursing mothers",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FEV1: forced expiratory volume in one second.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American Journal of Respiratory and Critical Care Med 2000; 161:309. Official journal of the American Thoracic Society. Copyright &copy; 2000 American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24539=[""].join("\n");
var outline_f23_61_24539=null;
var title_f23_61_24540="Marine toxins";
var content_f23_61_24540=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Marine toxins",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Toxin associated disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fish affected",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciguatera",
"       </td>",
"       <td>",
"        Most originate in tropics/subtropics",
"       </td>",
"       <td>",
"        More than 400 species; predominantly reef dwelling tropical",
"fish such as barracuda, moray eel, amberjack, grouper, mackerel, parrot",
"fish, red snapper",
"       </td>",
"       <td>",
"        Gastroenteritis, neurologic, cardiovascular, fatigue and malaise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scombroid",
"       </td>",
"       <td>",
"        Worldwide",
"       </td>",
"       <td>",
"        Most commonly tuna, mackerel, skip-jack, bonito, mahi mahi, bluefish, amberjack",
"       </td>",
"       <td>",
"        Resemble allergic reaction with flushing, rash, palpitations, tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paralytic shellfish poisoning",
"       </td>",
"       <td>",
"        Primarily temperate climates, northeast and northwest coasts in United States",
"       </td>",
"       <td>",
"        Most commonly bivalve molusks such as clams, oysters, and mussels",
"       </td>",
"       <td>",
"        Neurologic - can progress to paralysis and respiratory failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotoxic shellfish poisoning",
"       </td>",
"       <td>",
"        Southeast coast of United States, Gulf of Mexico, northern Spain, eastern Mediterranean, Japan, New Zealand",
"       </td>",
"       <td>",
"        Shellfish",
"       </td>",
"       <td>",
"        Gastrointestinal, neurologic, pulmonary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrheic shellfish poisoning",
"       </td>",
"       <td>",
"        Worldwide; major outbreaks in Japan, Scandinavia, France, Spain, Chile, Uruguay, Nova Scotia",
"       </td>",
"       <td>",
"        Shellfish",
"       </td>",
"       <td>",
"        Gastroenteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pufferfish (Tetrodotoxin)",
"       </td>",
"       <td>",
"        Most commonly in Japan; rare cases in United States",
"       </td>",
"       <td>",
"        Pufferfish (Fugu)",
"       </td>",
"       <td>",
"        Neurologic - can progress to paralysis and respiratory failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amnesic shellfish",
"       </td>",
"       <td>",
"        First recognized off the coast of Prince Edward Island, Canada",
"       </td>",
"       <td>",
"        Shellfish",
"       </td>",
"       <td>",
"        Gastroenteritis, neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible Estuary-Associated Syndrome (PEAS)",
"       </td>",
"       <td>",
"        Has been found in the Tar-Pamlico and Neuse River estuaries",
"of North Carolina and in the Pocomoke River on Maryland's eastern shore",
"       </td>",
"       <td>",
"        Various",
"       </td>",
"       <td>",
"        Respiratory and eye irritation, neurocognitive",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24540=[""].join("\n");
var outline_f23_61_24540=null;
var title_f23_61_24541="Chemicals immune dysfunction";
var content_f23_61_24541=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F60126&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F60126&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemicals associated with immune system dysfunction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Chemical",
"      </td>",
"      <td class=\"subtitle1\">",
"       Immunologic effects",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Polycyclic aromatic hydrocarbons",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Benzopyrenes",
"      </td>",
"      <td>",
"       Reduced antibody production",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Benzanthracenes",
"      </td>",
"      <td>",
"       Reduced T cell cytotoxicity, carcinogenesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Benzene",
"      </td>",
"      <td>",
"       Lymphopenia, marrow suppression, carcinogenesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Polyhalogenated aromatic hydrocarbons",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Polychlorinated biphenyls",
"      </td>",
"      <td>",
"       Altered lymphocyte populations, decreased delayed type hypersensitivity, increased respiratory infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Polybrominated biphenyls",
"      </td>",
"      <td>",
"       Decreased T cell number and function",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Polychlorinated dibenzofurans",
"      </td>",
"      <td>",
"       Depressed cellular immunity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Aromatic amines",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Benzidine",
"      </td>",
"      <td>",
"       Depressed cellular immunity, bladder carcinomas",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Estrogenic xenobiotics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       DDT",
"      </td>",
"      <td>",
"       Thymic atrophy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Zearalenol",
"      </td>",
"      <td>",
"       Myelotoxicity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tetrahydrocannabinol",
"      </td>",
"      <td>",
"       Depressed cellular immunity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Diethylstilbestrol",
"      </td>",
"      <td>",
"       Reduced natural killer activity, reduced antibody synthesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Pesticides",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Organochlorines (including DDT)",
"      </td>",
"      <td>",
"       Lymphopenia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Organophosphates",
"      </td>",
"      <td>",
"       Thymic atrophy, reduced T cell cytotoxicity, reduced antibody synthesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Methyl isocyanate",
"      </td>",
"      <td>",
"       Increased CD4+ T cells, decreased mitogen response",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Organometals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Organotins",
"      </td>",
"      <td>",
"       Impaired generation of CTL thymic atrophy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Methylmercury",
"      </td>",
"      <td>",
"       Inhibition of complement",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dimethylnitrosamine",
"      </td>",
"      <td>",
"       Reduced antibody production, carcinogenic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Heavy metals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Arsenic, cadmium, copper, gold, iron, lead, zinc",
"      </td>",
"      <td>",
"       Bone marrow suppression, lymphopenia, carcinogenesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Asbestos",
"      </td>",
"      <td>",
"       Reduced NK function, reduced CD4/CD8 ratio, cytotoxic to alveolar macrophages, depressed CMI, polyclonal B cell activation, autoimmunity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Silica production",
"      </td>",
"      <td>",
"       Decreased antibody, prolonged allograft rejection, cytotoxic to alveolar macrophages, depressed CMI, polyclonal B cell activation, autoimmunity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Air pollutants",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ozone",
"      </td>",
"      <td>",
"       Decrease resistance to experimental infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sulfur dioxide",
"      </td>",
"      <td>",
"       Respiratory tract infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Nitrogen dioxide",
"      </td>",
"      <td>",
"       Decreased alveolar macrophage phagocytosis and bacterial capacity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Fungal toxins",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ochratoxin",
"      </td>",
"      <td>",
"       Depressed antibody production",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"       Trichothecenes",
"      </td>",
"      <td>",
"       Decreased T and B cell mitogen responses, leukopenia, delayed skin graft rejection",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibition of macrophage activation, hepatic carcinoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ethanol",
"      </td>",
"      <td>",
"       Reduced T cell function, reduced macrophage function, reduced antibody production, impaired neutrophil chemataxis, increased respiratory tract infection",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24541=[""].join("\n");
var outline_f23_61_24541=null;
var title_f23_61_24542="TEE pacerwire vegetation";
var content_f23_61_24542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/74493/tee_pacerwire_veget_conv.mp4?title=TEE+pacerwire+vegetation\" style=\"width:320px;height:244px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TEE pacerwire vegetation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dan Sexton, MD. Duke University.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24542=[""].join("\n");
var outline_f23_61_24542=null;
var title_f23_61_24543="Potential PCV coverage";
var content_f23_61_24543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    Potential serotype coverage of PCV7, PCV10, and PCV13 of serotypes causing IPD, AOM, AC, and those carried by healthy Israeli children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 354px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AC: acute conjunctivitis; AOM: acute otitis media; IPD: invasive pneumococcal disease; NP: nasopharyngeal carriage.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 2009; 28:277. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_61_24543=[""].join("\n");
var outline_f23_61_24543=null;
